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Abstract
	 To fortify their cytoplasmic membrane and protect it from osmotic rupture, most 
bacteria surround themselves with a peptidoglycan (PG) exoskeleton. The PG 
synthases that build this structure are called penicillin-binding proteins (PBPs). Since 
they are the targets of penicillin and related antibiotics, the structures and in vitro 
biochemical functions of the PBPs have been extensively studied. However, the in vivo 
functions of the PBPs and the factors they work with to build the PG meshwork remain 
poorly understood.
! PBPs work in the context of multicomponent complexes organized by 
cytoskeletal elements. A major outstanding question has been whether or not these 
complexes contain factors required for PBP function. I addressed this using Escherichia 
coli as a model system by taking advantage of the synthetic lethal phenotype resulting 
from simultaneous inactivation of the major PG synthases: PBP1a and PBP1b. Using a 
screen for mutants synthetically lethal with the inactivation of PBP1b, I identified LpoA 
as a factor required for PBP1a function. A colleague in the lab performed the analogous 
screen for mutants synthetically lethal with the inactivation of PBP1a and identified 
LpoB as a factor required for PBP1b function. We showed that the Lpo factors are outer 
membrane lipoproteins that form specific trans-envelope complexes with their cognate 
PBPs in the inner membrane and that LpoB can stimulate the activity of PBP1b in vitro. 
iii
Our results reveal unexpected complexity in the control of PBP activity and indicate that 
they likely receive regulatory input from the outer membrane in addition to cytoskeletal 
elements in the cytoplasm. 
! To investigate the role of LpoB in morphogenesis further, I took a genetic 
approach that has identified PBP1b* variants capable of functioning in vivo in the 
absence of LpoB. Preliminary characterization of these variants indicates that LpoB has 
cellular functions in addition to PBP1b activation and that LpoB may be important for 
coordinating the two different catalytic activities of PBP1b. Future study of these 
mutants is likely to uncover important insights into PBP function and their control by 
the Lpo factors. These insights may open new avenues for the development of novel 
therapeutics that target the PBPs. 
iv
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Chapter 1:
Peptidoglycan Structure and Assembly
1
Overview
	 Gram-negative bacteria, like Escherichia coli, contain complex cell envelopes 
that consist of three different layers: an inner membrane (IM) and an outer membrane 
(OM), with a layer of crosslinked polysaccharide called peptidoglycan (PG) found in the 
periplasmic space between them (Figure 1.1). Because bacteria are encased within 
this exoskeleton, their growth and morphogenesis are intimately linked to PG 
synthesis, and the shape of the organism is defined by the PG network (46). This large, 
polymeric shell is synthesized by PG synthases called the penicillin-binding proteins 
(PBPs). Because they are the targets of penicillin and related antibiotics, the structure 
and biochemical function of the PBPs have been extensively studied (59, 77, 88). 
Despite this, we still know surprisingly little about how these enzymes build the PG 
layer in vivo.  
	
Composition of the PG
 PG is an essential component of the bacterial cell envelope whose main function 
is to preserve cell integrity in spite of internal turgor pressure (31, 89). This exoskeleton 
is unique to bacteria and is mainly composed of linear glycan strands crosslinked by 
short peptide chains. The glycan strands are composed of alternating subunits of N-
acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) linked by β(1,4)-
glycosidic bonds (Figure 1.2A) (31, 91). Attached to each MurNAc sugar is a 
pentapeptide (pep5) chain that is used to form crosslinks between adjacent glycan 
strands. In Gram-negative bacteria the peptide sequence is most often L-alanine, 
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Figure 1.1. The cell envelope of E. coli.  Gram-negative bacteria like the rod-shaped 
E. coli have a three layered cell envelope consisting of an inner membrane (IM) that 
protects the cytoplasm, an outer membrane (OM), and a periplasmic layer in between 
that contains a thin peptidoglycan layer (PG, in green).
3
Figure 1.2. The structure of E. coli peptidoglycan.  A schematic showing of the 
organization of the PG. A. Composed of alternating units of N-acetylglucosamine (G) 
and N-acetylmuramic acid (M), bacterial PG forms a large continuous meshwork (green 
arrows). Green dots represent attached peptides. Below the structure is an 
architectural representation of the PG surrounding the entire cell. Glycan strands (green 
hoops) are thought to be oriented perpendicular to the long axis of the rod-shaped 
bacterium while the peptide crosslinks (black lines) are parallel to that axis. The degree 
of crosslinking varies by organism. (Legend continued on next page.)
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Figure 1.2 (Continued) Red boxes are insets that are shown in B and C.  B. A 
schematic illustrating the disaccharide building block of PG with the five peptides 
attached to N-acetylmuramic acid. L-Ala, L-alanine; D-Glu, D-glutamate; mDAP, meso-
diaminopimelic acid; D-Ala, D-alanine. C. A representation of the 3-4 crosslink found 
between the D-Ala of one disaccharide unit and the mDAP of another. The terminal D-
Ala residues are released because of crosslinking and carboxypeptidation reactions 
(see text for details).
5
D-glutamic acid, meso-diaminopimelic acid (mDAP) and D-alanyl-D-alanine (D-Ala-D-
Ala) in nascent PG, where the final D-Ala is lost upon PG maturation (88, 89) (Figure 
1.2B and C). However, in most Gram-positive bacteria, which lack an outer membrane 
and have a thicker PG layer, the peptide stem contains an L-Lysine in position 3 
instead of mDAP (89). 
	 Most variation in the PG structure occurs in the crosslinks. The 3-4 crosslink is 
the most common. It forms when the side chain of the amino group at position 3 links 
to the carboxyl group of the D-Ala at position 4 (Figure 1.2C). This linkage is either 
direct or occurs through an interpeptide bridge (as in many Gram-positive bacteria) 
(89). The size of the interpeptide bridge, however, can range from one to seven 
residues. For example, Staphylococcus aureus contains a penta-glycine interpeptide 
bridge that links L-Lys (position 3) to D-Ala (position 4) (56).  
	 As in most Gram-negative species, the crosslinks found in E. coli are formed 
between the penultimate D-Ala on one glycan strand to the mDAP on an adjacent 
peptide chain (Figure 1.2C). This 3-4 crosslink is the result of D,D-transpeptidation 
reactions responsible for incorporating new PG precursors into the existing cell wall 
(31, 62). In addition to 3-4 crosslinks, E. coli and many other bacteria also form 3-3 
crosslinks between two adjacent mDAP residues. These crosslinks are synthesized by 
L,D-transpeptidases (28, 29) that were recently identified in both Gram-positive and 
Gram-negative bacteria (44, 45). The functional significance of 3-3 crosslinks is not 
known. However, several groups have proposed that this type of crosslink may be 
important in cases where the bacterium is being assaulted by penicillins or their 
derivatives because penicillin does not inhibit the transpeptidase activity of L,D-
6
transpeptidases (31, 45). These crosslinks may also be important under conditions 
where little to no pentapeptides are present in the cell (31, 45).
	
The PG assembly pathway
	 The pathway for PG biogenesis occurs in three main stages and spans multiple 
cellular compartments. The initial steps of assembly occur in the cytoplasm where the 
monomeric unit of PG, MurNAc(pep5)-GlcNAc, is made. First, the activated sugar 
UDP-GlcNAc is converted to UDP-MurNAc by the enzymes MurA and MurB (Figure 
1.3A) (82, 83). This is then followed by the sequential addition of the amino acids 
comprising the stem peptide attached to the D-lactoyl group of MurNAc. These 
reactions are catalyzed by the extensively studied Mur ligases (MurC, MurD, MurE and 
MurF) to add L-Ala, D-Glu, mDAP, and D-Ala-D-Ala, respectively (82). 
	  The essential enzyme, MraY, transfers phospho-MurNAc-pep5 from UDP-
MurNAc-pep5 to undecaprenyl-phosphate (a C55 isoprenyl-phosphate lipid carrier) to 
form Lipid I at the cytoplasmic surface of the IM (Figure 1.3B) (82, 83). Lipid I formation 
is likely to be a rate-limiting step due to the limited availability of undecaprenyl-
phosphate (82, 83). Lipid II is formed by the attachment of GlcNAc to Lipid I by MurG, 
a glycosyltransferase using UDP-GlcNAc as a substrate.
 In the next phase of PG assembly, Lipid II is translocated from the cytoplasmic 
side of the IM to the periplasmic side. In recent years, two candidates have been 
proposed to be the elusive “flippase” that catalyzes this translocation. Work by Ruiz 
implicates the essential E. coli protein MviN (recently renamed MurJ) in this role 
because when depleted, PG synthesis is reduced and an increase in 
7
Figure 1.3. Peptidoglycan biogenesis occurs in different cellular compartments.  
An overview of the three stages of PG assembly is provided. In the first stage (A) UDP-
N-acetylglucosamine is first converted to UDP-N-acetylmuramic acid (M) in the 
bacterial cytoplasm. Then the five peptide residues are subsequently addition (green 
dots colored as in Figure 2B). See text for enzyme activities. The next stage (B) occurs 
at the cytoplasmic face of the inner membrane where the M-pentapeptide unit is linked 
to a C55-lipid carrier, undecaprenyl, by the enzyme MraY to form Lipid I. MurG then 
adds UDP-G to Lipid I to make Lipid II. This PG precursor is then flipped to the 
periplasmic side of the inner membrane (IM) by a flippase (see text for details) (48, 58). 
(Legend continued on next page.)
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Figure 1.3 (Continued) (C) In the periplasm, Lipid II is polymerized into glycan strands 
that are crosslinked into the existing PG layer (green). A multi-enzyme PG synthetic 
complex is thought to perform these activities (see text for details). OM, outer 
membrane.
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cytoplasmic PG precursors is observed (58). This is also supported by work from Kato 
and coworkers who reported similar results (32). However, MviN homologs in Bacillus 
subtilis were not found to be essential (22). Contradicting these results, a recent report 
by Mohammadi et al. presented biochemical evidence that the Lipid II is flipped to the 
periplasmic side of the IM by the essential divisome component FtsW rather than MviN 
(48). They showed that, when purified, the transmembrane protein, FtsW, translocated 
Lipid II across proteoliposome membranes in vitro. No such activity was observed 
when purified MviN was tested in their assay (48). In vivo evidence linking FtsW with 
flippase activity is lacking, however. Thus, a definitive identification of the Lipid-II 
flippase awaits further experimentation. 
	 The final stage of PG assembly occurs in the periplasmic compartment of the 
cell (Figure 1.3C). Once exposed to the periplasmic face of the IM, the disaccharide 
moiety of Lipid II is polymerized and crosslinked into the existing PG layer by the 
penicillin-binding proteins (PBPs). Undecaprenyl-diphosphate is released and then 
subsequently recycled for additional rounds of PG synthesis.
The penicillin-binding proteins
	 Penicillin, an antibiotic targeting the bacterial cell wall, was key in the 
identification of the PBPs. It forms a covalent complex with these enzymes and inhibits 
their transpeptidase (TP) activity. Thus, radiolabelled penicillin was used as a probe to 
identify the PBPs (9). E. coli, like many other bacteria, encodes a number of PBPs 
classified into two main groups: the high-molecular weight (HMW) PBPs and the low-
molecular weight (LMW) PBPs (30, 59) (Table 1.1). The HMW-PBPs are all integral 
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membrane proteins with large domains facing the periplasm (Figure 1.4). Class A 
HMW-PBPs (PBP1a, PBP1b, and PBP1c) have both peptidoglycan glycosyltransferase 
(PGT) and TP activities for polymerizing the glycan strands and crosslinking them, 
respectively. Class B HMW-PBPs (PBP2 and PBP3) only have TP domains.
	 In contrast, the LMW-PBPs are all secreted periplasmic proteins and have 
hydrolytic activity for breaking bonds in PG (Table 1.1). They are either D-Ala-D-Ala 
carboxypeptidases (DD-CPs) that hydrolyze the D-Ala-D-Ala bonds of pentapeptides 
(PBP4, 5, 6, and 6b), or they are D,D-endopeptidases (DD-EPs) that cleave D-Ala-
mDAP crosslinks (PBP4 and 7) (59). Because of their activities, the LMW-PBPs are 
thought to be regulatory factors that help control where and when PG is made by 
limiting the supply of donors available to make crosslinks, and by opening up spaces in 
the existing PG structure to allow the insertion of new material as the cell grows (52).
	
Reactions catalyzed by the HMW PBPs
	 Glycosyltransferase reaction. Sequence alignments amongst the PGTs reveal 
five conserved motifs in the catalytic cleft. Motif 1 (EDxxFxxHXG) (where x indicates a 
random amino acid) and motif 3 (RKxxE) contain conserved glutamic acids proposed 
to be involved in catalysis (59). Motif 2 (GxSTxxQQxxK) divides the cleft into two 
pockets and may play a role in substrate recognition. Both motif 4 (KxxYxxxYxN) and 
motif 5 (RxxxxL) are thought to maintain the overall fold of the PGT domain (41, 59).  
	 To gain better insight into the PGT reaction mechanism, the crystal structures of 
three PGT enzymes were recently solved: S. aureus PBP2 (41), PBP1a from the 
thermostable Aquifex aeolicus (97), and E. coli PBP1b (68). All three structures show 
11
Table 1.1. The penicillin binding proteins of E. colia. 
Class Protein Gene Activityb Essential? Localization
HMW
Class A PBP1a ponA (mrcA) PGT/TP No IM
PBP1b ponB (mrcB) PGT/TP No IM
PBP1c pbpC PGT/TP No IM
Class B PBP2 pbpA TP Yes IM
PBP3 ftsI TP Yes IM
LMW
Class C PBP4 dacB D,D-EP No Periplasm
PBP4b yefW D,D-CP No Periplasm
PBP5 dacA D,D-CP No Periplasm
PBP6 dacC D,D-CP No Periplasm
PBP6b dacD D,D-CP No Periplasm
PBP7 pbpG D,D-EP No Periplasm
AmpH ampH D,D-Peptidase No Periplasm
aReferences: (30, 59, 88, 90)
bHMW, high molecular weight; LMW, low molecular weight; PGT, peptidoglycan 
glycosyltransferase; TP, transpeptidase; EP, endopeptidase; CP, carboxypeptidase
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Figure 1.4. The high molecular weight PBPs of E. coli. The five E. coli proteins are 
subdivided into two classes based on their activities. The bifunctional class A enzymes 
PBP1a, PBP1b, and PBP1c contain modular domains exhibiting either peptidoglycan 
glycosyltransferase (PGT) or transpeptidase (TP) activities.  PBP1a and PBP1b both 
contain an additional domain thought to interact with their cognate Lpo factors (see 
text for details). The class B proteins PBP2 and PBP3 are essential monofunctional 
enzymes only exhibiting TP activity. These enzymes also contain a non-penicillin 
binding domain (nPB) that is thought to mediate protein-protein interactions. The active 
sites for the specified domains are listed below the enzymes. While PBP1c has no 
observable TP activity, the putative catalytic serine based upon sequence alignments is 
listed. ODD, outer membrane PBP1a docking domain (78); UB2H, UvrB domain 2 
homolog (68).
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hydrophobic surface sites in the portion of the protein closest to the IM, suggesting 
that the PGT is partially embedded within the membrane (68). In this way, the PGT may 
easily access the membrane-bound substrate Lipid II for the reaction. The crystal 
structures also show that the PGT domain consists mostly of α-helices with a fold 
similar to that of λ-lysozyme, a bacteriophage hydrolase that cleaves the β(1,4)-
glycosidic bond.
	 In addition to the structures, the development of chemical and biochemical 
synthetic routes to Lipid II production (11, 63, 95) has promoted significant progress in 
our understanding of the PGT reaction. Several lines of evidence indicate that glycan 
polymer elongation proceeds by successive attacks of the growing glycan chain 
(donor) on the reducing end of Lipid-II (acceptor) (63, 75, 93). This is catalyzed by the 
deprotonation of the 4-OH nucleophile of GlcNAc by the catalytic glutamate of motif 1 
(Figure 1.5). Concurrently, glutamate of motif 3 stabilizes the leaving diphospho-
undecaprenyl group, potentially via a divalent metal (63).  
 Transpeptidation reaction.  The crystal structure of S. aureus PBP2a solved by 
Lim and Strynadka shows that the TP domain consists of two subdomains: a five 
stranded β-sheet covered by three α-helices and an all-helical domain (40). The active 
site lies at their interface and contains nine residues broadly conserved in the PBPs 
(underlined in the motifs below). The active site serine is positioned at the beginning of 
helix α2 and is followed by a lysine to form a S*xxK (where S* denotes the active site 
serine). This motif defines a superfamily of serine acyltransferases in bacteria (30). In 
the formation of crosslinks by the HMW PBPs, the conserved lysine residue is thought 
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Figure 1.5. The peptidoglycan glycosyltransferase (PGT) reaction. The chemical 
reaction catalyzed by the PGT synthases predicted to proceed via acid-base chemistry 
is shown. The attachment of the Lipid II to the non-reducing end of the growing glycan 
polymer (illustrated as Lipid IV) is mediated by a catalytic glutamate residue in the 
active site of the PGT enzyme. See text for detailed mechanism.
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to deprotonate the active site serine. This deprotonated serine then attacks the 
penultimate D-Ala of the substrate strand (donor) to form an acylenzyme intermediate 
with the simultaneous release of the terminal D-Ala (26, 75). This intermediate is 
thought to be deacylated by a second motif (SxN) situated in a loop between helices 
α4 and α5 (59). In E. coli, a crosslink is then formed between the mDAP residue of a 
second peptide chain (acceptor) to the penultimate D-Ala on the donor strand strand 
(Figure 1.6) (26, 59).
	 While the third conserved motif (KTG(T/S)) is not directly involved in catalysis, it 
is thought to recognize the incoming substrate (59). In the TP domains of the HMW 
PBPs, the residue following motif 3 is either a serine or threonine for class A PBPs or 
an alanine for class B PBPs. While the functional significance of this residue is 
unknown, it is likely playing a class-specific role (59). Further work by Ghosh and 
Young showed that residues following motif 3 in PBP5 are involved in shape 
maintenance (25). Finally, the ninth conserved residue in the catalytic cleft is a glycine 
located at the rear of the active site (59). It is thought to impart binding specificity of the 
PBPs to the penultimate D-Ala of pep5 (1, 59).
The class A HMW PBPs of E. coli 
	 Penicillin-binding protein 1a (PBP1a). Like all class A HMW PBPs (Figure 1.4), 
E. coli PBP1a is a bifunctional PG synthase containing a PGT domain and a TP 
domain. Using Lipid II as a substrate in vitro, PBP1a is able to polymerize and crosslink 
glycan strands. The average glycan strand length produced by PBP1a is 20 
disaccharide units with 20% of the pentapeptides involved in crosslinking (10) while a 
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Figure 1.6. The mechanism of transpeptidation (TP). In the first step, the 
deprotonated active site serine attacks the penultimate D-Ala residue of a donor strand 
to form an acyl-enzyme intermediate between the TP enzyme and the peptide chain.
(Legend continued on next page.)
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Figure 1.6 (Continued) The final D-Ala is released concomitantly. In the second step, 
the nucleophilic amine of the acceptor strand then attacks the acyl-enzyme 
intermediate to produce crosslinked peptide side chains. The crosslink is highlighted 
by the red arrow in the final step. This overall mechanism is conserved among bacteria. 
Note that the TP enzyme is not drawn to scale.
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report by Wang et al. found that the limiting length for the PGT domain of PBP1a was 
30 disaccharide units (92). Poor TP activity was observed after Lipid II had been 
exhausted, suggesting that ongoing glycan strand polymerization is needed for TP 
function (10). Also, no TP activity was observed when a PGT mutant of PBP1a was 
mixed with a PBP1a TP mutant (10). This has also been observed for other class A 
PBPs and likely points to an interaction between the two domains of PBP1a leading to 
TP activation (3, 10, 51, 74). 
 Even though the biochemical activities of PBP1a have been extensively 
characterized (2, 10, 42, 88, 92), the physiological role of PBP1a remains unclear. Cells 
lacking PBP1a do not exhibit any significant growth defect, change in cell shape, or 
sensitivity towards β-lactam antibiotics (54, 96). However, cells without PBP1b (see 
below) are more sensitive to these same antibiotics, consistent with the idea that 
PBP1a has a higher affinity to most β-lactams as compared to PBP1b (70, 88). Also, 
experiments by Vollmer and coworkers highlighted unique differences between cells 
lacking PBP1a, PBP1b, or both. Only cells without PBP1b lose cell integrity when the 
essential PBP2, PBP3, or the cell division protein FtsQ are inactivated (10, 23, 88). 
Also, PBP1a is only able to dimerize with itself and not with PBP1b (19, 98). These 
results, along with the genetic evidence above, suggest that both proteins have distinct 
cellular functions. However, PBP1a and PBP1b are partially redundant because neither 
is essential, and only inactivation of both PBP1a and PBP1b leads to a synthetic lethal 
phenotype (70, 73).
	 Even though the structures of other class A HMW PBPs have been solved (41, 
97), E. coli PBP1a contains an additional domain not present in these crystal 
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structures. Recently, bioinformatics work by Typas et al. discovered this domain named 
ODD, for outer-membrane PBP1a docking domain, in PBP1a that may be required for 
interactions with its binding partners (78). 
	
 Penicillin-binding protein 1b (PBP1b). PBP1b is thought to play a prominent 
role in PG synthesis (39, 71). Even though PBP1b is not essential, cells lacking it show 
little to no PG synthetic activity (36, 37, 54) and are more sensitive to β-lactam 
antibiotics (96). PBP1b exists in three different isoforms: α, β, and γ. PBP1b-α is the 
full-length protein, while PBP1b-β is considered an artifact that results from proteolytic 
processing of the first 24 residues due to in vitro preparation (69). The γ isoform arises 
from a translational start site beginning 46 residues downstream from the full-length 
PBP1b start site (69). While the functional significance of the α and γ isoforms is 
unclear, it has been proposed that PBP1b-α may be involved in cell division while 
PBP1b-γ may play a role during elongation of the PG at the lateral wall (17, 88). While 
analyzing the three PBP1b isoforms, Chalut et al. found only full-length PBP1b is able 
to suppress cell lysis when cells were treated with cephaloridine (a cephalosporin that 
preferentially binds PBP1a) and aztreonam (that preferentially binds PBP3) (17), thus 
suggesting a specific role for PBP1b-α in cell division.
 Similar to PBP1a, PBP1b also forms dimers in vivo (19, 98). This is not 
dependent on disulfide bond formation (18), and the N-terminal cytoplasmic tail is not 
involved in the dimerization process (17). Studies performed by truncating the protein 
show that dimerization is mediated by an interaction in the N-terminal region of the 
protein before residue G405 (98). Also, two dimensional gel analysis indicates that only 
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homodimers of PBP1b isoforms (α-α, β-β, and γ-γ) are formed (98). Recent work by 
Vollmer and coworkers has shown that PBP1b dimer formation is likely required for 
robust synthetic activity (3, 10, 88).
 Recently, the crystal structure of E. coli PBP1b was solved with the PGT 
inhibitor, moenomycin, in the presumed Lipid II binding cleft (68). This structure had an 
additional small domain located between the PGT and TP domains. This UB2H (UvrB 
domain 2 homolog) domain is not present in other class A HMW PBP crystal structures 
(41). It is only present in γ-proteobacteria (78). Originally, this domain was thought to 
play a proofreading and editing role based upon its homology to UvrB in the nucleotide 
excision repair system for DNA damage (68). Sung et al. showed that PBP1b variants 
lacking this domain are partially functional and filament at high temperatures. However, 
Typas et al. were not able to confirm these results. Rather, they proposed that UB2H is 
a domain that interacts with other factors, similar to the ODD domain of PBP1a (78).
 Penicillin-binding protein 1c (PBP1c). Even though the domain structure of 
PBP1c is similar to both PBP1a and PBP1b (Figure 1.4), two major differences exist 
between these proteins. First, the PGT domain of PBP1c lacks three highly conserved 
residues thought to be required for glycan strand polymerization (R136 and E140 of 
motif 3 and R218 in motif 5) (59), however, it still exhibits PGT activity in ether-
permeabilized cells and in crude membrane vesicle extracts (61). Additionally, it is still 
inhibited by the moenomycin, similar to PBP1a and PBP1b (61). These results suggest 
that residues other than those described enable PBP1c to polymerize glycan strands. 
Second, while PBP1c has a TP domain similar to the other class A HMW PBPs, it is 
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unaffected by most β-lactam antibiotics and exhibits significantly different binding 
affinities for them as compared to other PBPs (38, 61, 88). Combined with the 
observed lack of TP activity (61), these results are consistent with the idea that PBP1c 
acts as a monofunctional PGT in vivo. The TP domain instead may act as a scaffold to 
interact with other proteins like PBP1b, PBP3 and MltA (57, 61, 87). While the 
physiological importance of PBP1c is unclear, it is likely that PBP1c has a specific 
function that differs from PBP1a or PBP1b, especially since it cannot support cell 
growth in their absence (59, 61, 88).
Two modes of PG synthesis in rod-shaped cells
	 To determine if different PBPs played specific roles in cell growth and 
morphogenesis, Spratt treated cells with an array of different penicillin derivatives to 
determine if any had specific effects on cell shape or cell division. He found that 
treating cells with either mecillinam or cephalexin led to drastic morphological changes 
where rod-shaped E. coli turned into spheres or filamentous cells, respectively (66, 67). 
Competitive binding experiments revealed that mecillinam specifically bound PBP2, 
highlighting a role for it in maintaining the rod-shape of the cell. Cephalexin, on the 
other hand, was shown to have a high affinity for PBP3, suggesting a primary role for it 
in cell division (66, 67). This work combined with experiments monitoring the 
incorporation of new material into the PG led to the hypothesis that for rod-shaped 
bacteria like E. coli, two distinct complexes are associated with two different phases of 
PG growth: an elongation phase and a division phase (14, 15). During elongation, new 
material is inserted along the cylindrical portion of the PG. Following elongation, the 
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mode of PG growth switches to a concentrated zone of synthesis at the site of cell 
division (14, 15).
The PBPs are part of multi-enzyme complexes in vivo 
 A growing body of evidence suggests that the different modes of PG biogenesis 
are carried our by multi-enzyme complexes controlled by an underlying cytoskeletal 
structure. MreB, an actin-like cytoskeletal protein (21, 53), appears to work with 
PBP1a, PBP2, RodA, MreC, and MreD to control PG synthesis along the cylindrical 
portion of E. coli (14, 15, 77). When MreB is either depleted or inhibited by the drug 
A22, rod-shaped cells become spheres (27, 33, 72), similar to PBP2 inhibition by 
mecillinam. This is consistent with the idea that MreB is required for rod shape (27, 33, 
72). Also MreB localizes in a helical pattern similar to the pattern observed when new 
PG material is inserted into the lateral wall (16, 65, 76). This result further implicated 
MreB in lateral PG synthesis. To investigate this, Garner et al. recently compared the 
localization dynamics of MreB and the elongation machinery in Bacillus subtilis (24). 
They observed that the dynamic movement of MreB is blocked when PG synthesis is 
inhibited by drugs or when essential components of the elongation complex were 
depleted (24). This suggests that MreB acts to guide the lateral wall PG synthetic 
complex but not to drive PG synthesis. This idea is also supported by evidence from 
Carballido-López and coworkers (20).
	 During the division phase, the essential FtsZ, a tubulin-like protein, coordinates 
the formation of the divisome (or Z-ring) at the site of cell division and is required for 
the recruitment of all downstream divisome factors (5, 6, 15, 50). Inhibition or depletion 
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of FtsZ blocked cell division and caused rod-shaped cells to filament thus implicating 
FtsZ in shape determination (5, 7, 43, 60). In E. coli, the divisome starts to assemble 
when FtsZ and its associated proteins FtsA and ZipA localize to future sites of cell 
division. The latter two components are required to help stabilize the forming Z-ring at 
the IM. Other Fts proteins are then recruited in a hierarchical manner (Figure 1.7) along 
with factors needed for PG synthesis and PG splitting at the septum (12, 43, 85, 86). 
PBP1b is thought to primarily work during cell division based on observed interactions 
with the division proteins PBP3 (FtsI) and FtsN (4, 49).
	 While it is clear that these cytoskeletal structures are playing major roles in PG 
biogenesis, we currently know very little about the organization of these cytoskeletal 
assemblies and exactly how they are controlling the PG construction process.
	
Hydrolytic enzymes involved in PG synthesis
	 In order for the PG layer to grow, bonds in the existing PG structure need to be 
broken to insert new material. Components of the multi-enzyme PG synthetic 
complexes with PG hydrolase activity are thought to perform this function (31, 34, 35, 
78, 84, 87). In addition to PG growth, hydrolases are also required for PG turnover, PG 
recycling, and cell division (31). During division the septal PG shared by two daughter 
cells needs to be split for cytokinesis to occur. This septal PG then forms the poles of 
these daughter cells (8, 79). 
	 PG hydrolases need to be properly controlled to prevent breaches in the PG 
layer from forming. This is especially important for Gram-negative bacteria that have a 
thin PG layer. Thus these factors are tightly regulated both spatially and temporally, 
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especially the enzymes involved in cell separation (55, 64, 80, 81, 94). Work from our 
lab has shown that the activity of the E. coli cell separation amidases (AmiA, AmiB and 
AmiC) is controlled by a group LytM-domain containing proteins (80). Genetic 
experiments and biochemical studies using labelled PG revealed that these amidases, 
which cleave the peptide chain from glycan strands, are only active in the presence of 
their cognate LytM domain-containing factor (80). Additionally, our lab recently showed 
that the regulator of AmiA and AmiB activity, EnvC, is itself regulated by a 
transmembrane component of the divisome, FtsEX (94). Although FtsEX is an ABC 
transporter-like complex that is recruited to the divisome (Figure 1.7), its role has 
remained unclear. However, we showed that EnvC needs to directly interact with FtsX 
to localize to the divisome (94). Additionally, mutations in the nucleotide binding 
component of the complex, FtsE predicted to abolish ATPase activity, do not affect the 
localization of EnvC or the FtsEX complex. However, these ATPase-defective 
complexes failed to promote daughter cell separation, suggesting that ATP-driven 
conformational changes in the complex might regulate the ability of EnvC to activate 
the amidases (see Appendix 1) (94). Such a role for FtsEX appears to be widely 
conserved as Sham and co-workers have connected the complex to the major cell 
separation protein PcsB of S. pneumoniae (64).
	 While a clearer picture is emerging for how hydrolases are controlled during 
septal PG splitting, little is known about the PG hydrolases involved in lateral wall 
growth or how they are regulated. It is widely believed that PG synthesis and PG 
hydrolysis are coordinated by the multi-enzyme PG biogenesis complexes. The overall 
idea is that the PG hydrolases may work only when they join an active complex 
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Figure 1.7. Recruitment of proteins to the division site. Once FtsZ is localized to the 
midcell, proteins are recruited to the division complex (divisome) in a hierarchical 
manner. The recruitment order of these proteins is illustrated in (A). Localization of each 
protein to the divisome is dependent on the protein preceding it. A schematic of the 
trans-envelope division complex that spans multiple cellular compartments is shown in 
(B) (13, 55).
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containing PBPs. Indeed, several studies have identified interactions connecting PBPs 
with PG hydrolases (47, 78, 87). However, the functional significance of these 
complexes has not been established. 
Research statement
	 Although we know a great deal about PBP structure and biochemical activity, 
surprisingly little is understood about how the multi-enzyme complexes containing 
PBPs function to build the PG matrix. Just as the PG hydrolase must be regulated, it is 
likely that the PBPs themselves are controlled by components of the synthetic 
complexes. Such regulators have been difficult to identify because functional 
redundancy has hampered genetic analysis of PBP function. The work described in this 
thesis began by developing a strategy to turn the redundancy of the E. coli PBPs into 
an advantage. Based on the essentiality of the PBP1a/PBP1b combination, we 
reasoned that factors required to promote PBP1a activity could be identified by 
screening for mutants synthetically lethal with the loss of PBP1b (slb mutants) and vice 
versa. Using this technique, we identified the E. coli outer membrane lipoproteins LpoA 
(YraM) and LpoB (YcfM) as essential PBP cofactors. We showed that they form specific 
trans-envelope complexes with their cognate PBP1 and are critical for PBP1 function 
in vivo. Overall, our results showed that these PBP accessory factors play a crucial role 
in PG biogenesis (see Chapter 2) (54).
	 However, while we had shown that one of these cofactors, LpoB is critical for 
PBP1b activity in vivo and activates the PGT activity of PBP1b in vitro, the role of LpoB 
still in PG assembly remained unclear. To investigate the role of LpoB further, we 
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sought to identify variants of PBP1b that bypass the need for LpoB function in vivo. To 
isolate these ponB* alleles, we took advantage of the cefsulodin hypersensitive 
phenotype shared by ponB and lpoB mutants. We reasoned that the cefsulodin 
hypersensitivity of lpoB mutants results from a defect in PBP1b activity. Therefore, 
ponB* alleles with partially restored PBP1b function might be isolated by selecting for 
lpoB mutants with increased cefsulodin resistance. Using this strategy, several PBP1b* 
variants were isolated. The characterization of these PBP1b* variants is detailed in 
Chapter 3.  
	 The final chapter (Chapter 4) of this thesis focuses on our current understanding 
of how PG synthesis fits into the overall process of cellular growth. Although much 
progress has been made in our understanding of the bacterial cell envelope and PG 
biogenesis over the years, many unanswered questions still remain.  For example, we 
still do not know how the switch between the elongation and division modes of PG 
synthesis is controlled or how cytoskeletal structures organize PG biogenesis. 
Moreover, the precise roles of PG hydrolases in the PG assembly process are not 
known or how their potentially lethal activity is regulated, especially during lateral PG 
growth. While much remains to be understood, the work described in this thesis 
represents a significant advance in the area of PBP regulation and it paves the way for 
future studies aimed at determining the detailed mechanism of PG biogenesis in vivo. 
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Graphical Abstract
Figure 2.0. Graphical abstract. The figure above represents a graphical abstract of the 
content of this chapter.
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Summary 
	 Most bacteria surround themselves with a peptidoglycan (PG) exoskeleton 
synthesized by polymerases called penicillin-binding proteins (PBPs). Because they are 
the targets of penicillin and related antibiotics, the structure and biochemical functions of 
the PBPs have been extensively studied. Despite this, we still know surprisingly little about 
how these enzymes build PG in vivo. Here, we identify the Escherichia coli lipoproteins 
LpoA and LpoB as essential PBP cofactors. We show that LpoA and LpoB form specific 
trans-envelope complexes with their cognate PBP and are critical for PBP function in vivo. 
We further show that LpoB promotes PG synthesis by its partner PBP in vitro and that it 
does so by stimulating glycan chain polymerization. Overall, our results indicate that PBP 
accessory proteins play a central role in PG biogenesis and, like the PBPs they work with, 
these factors are attractive targets for antibiotic development.
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Introduction  
	 To fortify their cytoplasmic membrane and protect it from osmotic rupture, most 
bacteria surround themselves with a peptidoglycan (PG) exoskeleton. This tough 
polysaccharide layer is constructed from long glycan chains crosslinked to one another via 
attached peptides to form a continuous matrix that envelops the cell (Figure 2.1A).  
Because bacteria are encased within this polymeric shell, their growth and morphogenesis 
is intimately linked to PG synthesis and remodeling; PG expansion is essential for growth, 
and the shape of the organism is defined by the PG network (31). 
 The PG synthesis pathway is of tremendous practical importance as it is the target 
of many of our most effective antibiotics, notably penicillin and related β-lactams. Since its 
discovery over eighty years ago, penicillin has served as a key probe of the PG assembly 
process as well as a widely used therapeutic. It covalently modifies and inhibits PG 
synthases called high molecular weight penicillin-binding proteins (HMW-PBPs) (37), 
which henceforth will be referred to simply as PBPs. Bacteria typically encode two 
varieties of PBPs: class A and class B (37). Both types are integral membrane proteins 
with relatively large domains facing the cell exterior. Class A PBPs are thought to be the 
primary cellular PG synthases since they are bifunctional and have both peptidoglycan 
glycosyl transferase (PGT) and transpeptidase (TP) domains capable of polymerizing the 
glycan strands of PG and crosslinking them, respectively (Figure 2.1A and 2.1B). Class B 
PBPs are mono-functional and only have TP activity. 
	 Although purified bifunctional PBPs can polymerize and crosslink PG in vitro from 
lipid-II substrate (Figure 2.1B) (4, 10), the PBPs alone are insufficient for the proper 
assembly of the cell-shaped PG network in vivo. To build a dynamic, uniformly-shaped PG 
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mesh that grows in step with the rest of the cell, PBP activity must be spatially and 
temporally controlled (31). Adding to the complexity, rod-shaped bacteria like Escherichia 
coli and Bacillus subtilis must properly switch between different modes of PG growth: 
elongation of the cylindrical portion of the rod and synthesis of the hemispherical polar 
caps during division. It is therefore not surprising that, besides the PBPs, an array of 
additional proteins have been implicated in PG assembly (13, 31). Recent work indicates 
that many of these factors are organized into multi-enzyme PG synthesizing complexes by 
cytoskeletal polymers of FtsZ (tubulin-like) and MreB (actin-like), which are thought to 
direct their activity to appropriate subcellular locations (Figure 2.1B). Studies from a 
number of laboratories have identified likely components of these complexes, including: (i) 
many, if not all, of the enzymes required for lipid-II synthesis (MurA-MurG), (ii) both classes 
of synthetic PBPs, (iii) various PG hydrolases, and (iv) several essential integral membrane 
proteins of unknown function, such as SEDS-domain proteins like RodA or FtsW and the 
elongation specific factors MreC and MreD (13, 31, 51). Many questions regarding the 
function and composition of these PBP-containing, multi-enzyme complexes remain to be 
addressed. One of the most fundamental, however, is whether such complexes promote 
PG synthesis simply by providing the PBPs with access to substrate via lipid-II synthesis 
and flipping (Figure 2.1B), or whether they also contain critical accessory factors that 
facilitate and/or regulate PBP activity by affecting lipid-II utilization or the incorporation of 
nascent PG into the existing network.	
	 Here, we report the discovery of protein cofactors essential for the in vivo function 
of the bifunctional PBPs. They were identified using directed genetic screens in the model 
Gram-negative bacterium, E. coli. We have designated them LpoA (YraM) and LpoB (YcfM)
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Figure 2.1. Cell wall structure and assembly. A. Schematic of bacterial cells with the cell 
wall (PG layer) in green. Gram-negative cells have a relatively thin PG layer surrounded by 
an additional (outer) membrane. Above the cells is a schematic detailing the structure of 
PG, which continues in all directions to envelop the cell (green arrows). M, N-
acetylmuramic acid; G, N-acetylglucosamine. Dots represent the attached peptides. B. 
Overview of PG assembly. A generic multi-protein complex (grey) containing a class A PBP 
(purple) is shown. For simplicity, the other PG assembly factors thought to participate in 
the final stages of PG construction are not specifically labeled. See text for details. PGT, 
peptidoglycan glycosyltransferase domain; TP, transpeptidase domain.
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for lipoprotein activators of bifunctional PBP activity from the outer membrane. We 
demonstrate that they directly affect PBP activity through the formation of specific trans-
envelope Lpo-PBP complexes. In addition, we show that LpoB promotes PG synthesis by 
its partner PBP in vitro and that it does so by stimulating glycan chain polymerization. 
Overall, our results indicate that PBP accessory proteins play a central role in PG 
biogenesis and, like the PBPs they work with, these factors are attractive targets for 
antibiotic development. An accompanying report from Typas et al. (44) describes the 
independent discovery of the Lpo factors using large-scale phenotyping and proteomic 
approaches. 
Results
Rationale for the synthetic lethal screens. E. coli, like many bacteria, encodes multiple 
class A PBPs: PBP1a, PBP1b, and PBP1c (37). Prior genetic studies indicated that cells 
remain viable if either PBP1a or PBP1b is inactivated, but not if they both are (28, 54). This 
suggests that there are at least two major PG synthesizing complexes in the cell, one 
containing PBP1a and the other PBP1b, an idea supported by crosslinking studies in 
Haemophilus influenzae and immunoprecipitation studies in E. coli (2, 14). Based on this, 
we reasoned that we could identify critical components of these multi-enzyme PBP 
complexes by performing a screen for mutations synthetically lethal with the loss of either 
PBP1a or PBP1b. For example, if factor X is an important component of a PBP1a 
synthetic complex, one might expect mutations that inactivate factor X to be just as lethal 
when PBP1b is depleted as the inactivation of PBP1a is. Therefore, a screen for mutants 
synthetically lethal with the loss of PBP1b should yield factor X mutants as well as ponA 
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(PBP1a) mutants. The converse is also true. Important components of the PBP1b 
synthetic complex should be identified by a screen for mutants synthetically lethal with the 
loss of PBP1a. 
Screening for mutants synthetically lethal with the loss of PBP1a or PBP1b. Our 
synthetic lethal screen employed methodology we used previously to identify new cell 
division factors and regulators of division site placement (7, 8). To apply the screen to the 
PBPs, we initially searched for mutants synthetically lethal with the loss of PBP1b function 
(slb mutants). Our parental strain for the screen had chromosomal deletions removing both 
lacZ and ponB (PBP1b). The strain also harbored an unstable plasmid containing both the 
ponB and lacZ genes under control of the inducible lactose promoter (Plac). Since PBP1b 
is not essential, cells frequently lost the plasmid when they were grown on non-selective 
media containing the Plac inducer, IPTG, and the LacZ indicator, X-gal. They formed either 
white (LacZ-) colonies or blue-sectored colonies resulting from plasmid loss before or 
during colony formation, respectively (Figure 2.2A and 2.2B). To find slb mutants, we 
mutagenized the parental strain with a transposon and plated the resulting library on 
indicator medium to look for rare solid-blue colonies (Figure 2.2A and 2.2B). Mutants 
forming such colonies presumably could not lose the plasmid because the transposon 
insertion rendered PBP1b essential. To confirm this, we tested the slb candidates for 
growth with or without IPTG. Mutants truly dependent on PBP1b for growth should require 
the presence of IPTG to induce ponB expression from the plasmid. 
 We screened a total of 30,000 colonies and isolated 16 slb mutants. Less than half 
of these (5/16) were completely dependent on IPTG for growth. Three of the IPTG-
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dependent mutants had transposon insertions that mapped to the gene for PBP1a (ponA), 
indicating that the screen worked as expected (Figure 2.2D). Two of the remaining IPTG-
dependent mutants had transposons that mapped within lpoA (yraM) (Figure 2.2C and 
2.2D). The lpoA reading frame codes for a 678 amino acid protein with an LppC domain 
that is well conserved among the γ-proteobacteria but has an unknown function (1, 21). 
LpoA is also predicted to have a lipoprotein signal sequence for targeting it to the outer 
membrane (see below). Besides the ponA and lpoA alleles, most of the remaining slb 
isolates showed a synthetically sick phenotype in combination with a PBP1b defect. They 
all had transposon insertions that mapped to genes encoding factors previously implicated 
in cell division and will be described as part of a separate report. 
	 We also performed the converse screen for mutants synthetically lethal with the loss 
of PBP1a function (sla mutants). The screen design was identical to the one described 
above except that the parental strain was deleted for the ponA (PBP1a) gene and gfp-
ponA was encoded on the unstable plasmid. A total of 41 sla mutants displaying IPTG-
dependent growth were isolated. The majority (34/41) were found to have transposon 
insertions disrupting the gene coding for PBP1b (Figure 2.2D), and 7/41 sla mutants had 
transposon insertions disrupting the gene coding for LpoB (YcfM) (Figure 2.2C and 2.2D). 
LpoB is a 213 amino acid protein of previously unknown function that, like LpoA, is 
predicted to have a lipoprotein signal sequence for targeting it to the outer membrane (see 
below). Since the bias in the isolation of ponB mutants might have prevented us from 
identifying additional sla loci, we repeated the sla screen in a strain containing a second 
copy of ponB. In this case, only one mutant was isolated and it contained a transposon 
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insertion in lpoB. We therefore conclude that ponB and lpoB are likely to be the only sla 
loci in the genome. 
Specificity of the synthetically lethal combinations and their terminal phenotypes. To 
test the specificity of the synthetic lethal combinations, we constructed strains 
TU121(attλTB309) [ΔponA(Para::ponA)] and MM11 [Para::ponB] in which the production of 
either PBP1a or PBP1b was controlled by the arabinose promoter, respectively. In the case 
of TU121(attλTB309), the native ponA locus was deleted and a second copy of ponA 
under arabinose promoter control was integrated at the λ att site. For MM11, the native 
ponB promoter was replaced with the arabinose promoter. Growth of TU121(attλTB309) 
[ΔponA(Para::ponA)] derivatives lacking PBP1b or LpoB was severely inhibited on media 
without arabinose (Figure 2.2E). Growth of the corresponding LpoA- strain was unaffected 
(Figure 2.2E). Similarly, MM11 [Para::ponB] derivatives defective for PBP1a or LpoA failed 
to grow without arabinose supplementation, while the corresponding LpoB- strain showed 
robust growth (Figure 2.2E). Thus, LpoA is specifically required in the absence of PBP1b 
and LpoB is specifically required in the absence of PBP1a. 
	 The terminal phenotype of PBP1a depletion in the absence of PBP1b is cell lysis, 
and vice versa (Figure 2.2F and 2.2G) (54). To determine if cells lacking specific Lpo-PBP1 
combinations also lyse, we followed the growth and morphology of strains lacking Lpo 
factors after initiating PBP1 depletion. When PBP1a was depleted, cells lacking PBP1b or 
LpoB displayed a dramatic lysis phenotype. About three generations following the 
initiation of PBP1a depletion, the optical density of the mutant cultures began to decline 
rapidly (Figure 2.2F). This coincided with the appearance of cell ghosts and lysing cells 
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with membrane blebs in the cultures (Figure 2.3). The only difference between the PBP1b- 
and LpoB- cells upon PBP1a depletion was that the LpoB- cells consistently began lysing 
about 10 minutes later than PBP1b- cells (Figure 2.2F). Similar results were obtained when 
we compared the effect of PBP1b depletion on cells defective for PBP1a or LpoA. In both 
cases, the terminal phenotype was lysis (Figure 2.2G). As on plates, growth of PBP1a- 
LpoA- or PBP1b- LpoB- cells in liquid was normal (data not shown). Importantly, the 
synthetic lethal phenotypes resulting from the lpoA or lpoB deletions were corrected by 
their expression in trans, indicating that the phenotypes observed were not due to an 
adverse effect of the deletions on the expression of nearby genes (Figure 2.4). In addition, 
Bocillin labeling and immunoblotting indicated that the defects observed for the LpoA/B- 
mutants were not due to a decrease in PBP1 protein levels (Figure 2.5).
 Although PBP1a and PBP1b appear to be largely redundant, the phenotypes of 
cells lacking individual PBP1s are not identical. Loss of PBP1b leads to a hypersensitivity 
to β-lactam antibiotics that is not observed for PBP1a- mutants (38, 54). In addition, 
inhibition of the class B PBPs, PBP2 with mecillinam or PBP3 with cephalexin, normally 
leads to the formation of spherical or filamentous cells, respectively, that are slow to lyse 
(40). Similar treatments of mutants lacking PBP1b, however, rapidly induce cell  lysis (23, 
38). Although the reasons for the aberrant β-lactam phenotypes of PBP1b mutants are not 
known, we used these observations to further investigate the equivalence of LpoB and 
PBP1b defects. We found that LpoB defective mutants indeed shared a β-lactam 
hypersensitivity phenotype with PBP1b- mutants (Figure 2.6). Moreover, LpoB- cells also 
lysed rapidly when treated with mecillinam or cephalexin (Figure 2.6B-D). Thus, a LpoB- 
mutant has all of the hallmarks of a PBP1b- defect. 
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Figure 2.2. Synthetic lethal screens and terminal phenotypes. A-B. Colonies of 
transposon mutants used for the slb mutant screen grown on an indicator plate (LB-IPTG-
Xgal) for 2 days at 30oC. The arrow points to a rare solid-blue colony that retained the 
unstable plasmid. The boxed region in (A) is enlarged in (B). C. Schematics indicating the 
approximate locations of the transposon insertions in the lpo genes. Triangles represent 
transposon insertion points (green: transcription of the KanR cassette is in the same 
direction as the target gene; red: transcription is in the opposite direction). D. Plating 
defects of representative slb and sla mutants isolated in the screens. (Legend continued 
on next page.)
51
Figure 2.2 (continued). Cells of TU122/pTU110 [ΔponB/Plac::ponB lacZ] (top) or TU121/
pCB1 [ΔponA/Plac::gfp-ponA lacZ] (bottom) and their derivatives with the indicated 
transposon insertions were grown overnight at 30oC. Culture densities were normalized, 
10-fold serial dilutions were prepared for each, and 5 µl of each dilution was spotted onto 
LB with or without IPTG as indicated. E. Cells of TU121(attλTB309) [ΔponA(Para::ponA)] 
(top) or MM11 [Para::ponB] (bottom) and their derivatives were grown overnight at 37oC. 
Serial dilutions were prepared as in (D) and dilutions were spotted onto the indicated 
media. F-G. Strains used in (E) were grown in LB-arabinose at 37oC to an OD600 = 0.6-1.1. 
They were then pelleted, washed three times with LB, and resuspended in LB-glucose at 
an OD600 = 0.08 or 0.02 for TU121(attλTB309) (F) or MM11 derivatives (G), respectively. 
Cell growth following subculture (t = 0) was then monitored by regular OD600 
measurements.
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Figure 2.3. Terminal phenotype of PBP1a- PBP1b- and PBP1a- LpoB- cells.  At t = 50, 
60, 70, and 80 minutes an aliquot of cells from the cultures in Figure 2.2F were fixed. 
Following completion of the growth measurements, fixed cells were visualized by phase 
contrast microscopy. Representative images are shown. Arrows highlight lysed cell ghost 
and lysing cells with membrane blebs. Bars equal 3 microns.
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Figure 2.4. Complementation of lpo deletions by expression of lpo genes in trans. 
Cells of CB4(attλTB309) [ΔponA ΔlpoB(Para::ponA)] (A) or MM13 [Para::ponB ΔlpoA] (B) with 
or without the indicated plasmids were grown over night in M9-arabinose at 37oC. Culture 
densities were normalized, 10-fold serial dilutions were prepared for each, and 5 µl of each 
dilution was spotted onto the indicated solid media. Plates were incubated overnight at 
37oC and photographed. Plasmids used were: pCB25 [Plac::lpoB], pMM12 [Plac::lpoA], and 
pMLB1113 [Plac::lacZ]. Plasmids pCB25 [Plac::lpoB] and pMM12 [Plac::lpoA] possess native 
ribosome binding sites and 5’UTRs for lpoB and lpoA, respectively. pMM12 presumably 
has a higher basal level of expression than pCB25 since it can correct the PBP1B- LpoA- 
phenotype of MM13 without IPTG induction whereas pCB25 requires IPTG to correct the 
PBP1A- LpoB- phenotype of CB4(attλTB309). Alternatively, relative to LpoB, lower levels of 
LpoA are required to support growth.
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Figure 2.5. PBP levels in the lpo mutants. A. Cells of TB28 [WT], MM8 [ΔlpoA], CB6 
[ΔlpoB], TU121 [ΔponA], and TU122 [ΔponB] were labeled with Bocillin. Proteins in whole-
cell extracts were separated on a 10% SDS polyacrylamide gel, and fluorescently labeled 
PBPs were visualized using a fluorescence scanner (Typhoon). Duplicate samples are 
shown for TB28 [WT], MM8 [ΔlpoA], and CB6 [ΔlpoB]. B-C. Whole cell extracts of the 
strains used in A were prepared and PBP1a or PBP1b levels determined by 
immunoblotting with antisera generated against purified proteins.
55
Figure 2.6. LpoB defective cells are hypersensitive to β-lactams. A. Minimal inhibitory 
concentrations (MIC) for the indicated β-lactams are tabulated for the strains with the 
indicated deletion mutations. Similar results were obtained for three independent 
measurements. B-C. Cells of TB28 [WT], TU121 [ΔponA], TU122 [ΔponB], MM22 [ΔlpoA] 
and CB26 [ΔlpoB] were grown to mid log in LB at 37oC and treated with either mecillinam 
(B) (10 µg/ml) or cephalexin (C) (10 µg/ml) at the indicated time points (arrows). Cell growth 
was then followed by regular OD600 measurements.
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At least one Lpo factor is required for growth. Our results thus far suggest that LpoA is 
important for PBP1a function and that LpoB is important for PBP1b function. If this is true, 
then the combined loss of LpoA and LpoB should phenocopy the lysis and lethality 
observed when PBP1a and PBP1b are simultaneously inactivated. Accordingly, when 
LpoA was depleted in the absence of LpoB, cells lysed and failed to grow on media 
lacking inducer for lpoA expression (Figure 2.7A and 2.7B).  
The Lpo factors are essential for PBP1 function. To determine whether or not the Lpo 
proteins are essential for PBP1 function, we tested the ability of PBP1a/b overproduction 
to suppress the synthetic lethal phenotypes associated with a LpoA/B- defect. 
Overproduction of PBP1a by approximately 4 fold from plasmid pCB62 [Plac-con::ponA] was 
not sufficient to suppress the Slb phenotype of MM13 [Para::ponB ΔlpoA] cells upon 
PBP1b depletion in liquid or solid medium (Figure 2.7C, 2.7E, and 2.7G). Only a minor 
delay in the timing of lysis was observed for MM13 cells harboring pCB62 relative to 
pTB284 [Plac-con::gfp] (Figure 2.7C). Similarly, an approximately 8 fold overproduction of 
PBP1b from pCB72 [Plac-con::ponB] failed to rescue the lytic phenotype and plating defects 
of CB4(attλTB309) [ΔponA ΔlpoB(Para::ponA)] cells depleted of PBP1a (Figure 2.7D, 2.7F, 
and 2.7G). We conclude that the Lpo proteins are essential for the in vivo function of their 
cognate PBP as opposed to factors that simply stimulate PBP activity but are not critical 
for their function. 
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Figure 2.7. Lpo factors are essential for growth and PBP1 function. A. Cells of 
MM22(attHKMM10) [ΔlpoA(Plac::lpoA-gfp)] and its derivatives were grown overnight in LB-
IPTG (50µM) at 37oC. Serial dilutions were prepared as in Figure 2, and spotted onto the 
indicated solid media. Identical results were obtained when LpoB was depleted in the 
absence of LpoA (data not shown). B. Cultures of cells from (A) were grown to an OD600 of 
0.3-0.4 in LB-IPTG (50µM) at 37oC. The cells were then pelleted, washed three times with 
LB, and resuspended in LB-glucose at an OD600 = 0.02. Cell growth following subculture (t 
= 0) was then monitored by regular OD600 measurements. C-D. Cells of MM13 [Para::ponB 
ΔlpoA] (C) or CB4(attλTB309) [ΔponA ΔlpoB(Para::ponA)] (Legend continued on next 
page.)
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Figure 2.7. (continued). (D) containing the low-copy plasmids pTB284 [Plac-con::gfp], 
pCB62 [Plac-con::ponA], or pCB72 [Plac-con::ponB] were grown to an OD600 of 0.5-0.7 in LB-
Ara-Spc (C) or M9-Ara-Spc (D) at 37oC. They were then washed, diluted into LB-IPTG 
(1mM), and growth at 37oC was followed as in (B). E-F. To determine the extent of PBP1a 
or PBP1b overproduction in the cultures from (C) and (D), respectively, extracts were 
prepared from cells harvested at times indicated by the arrows above the growth curves 
(C-D). Immunoblot analysis was then performed to determine the levels of PBP1a (E) or 
PBP1b (F) in strains MM13/pCB62 or CB4(attλTB309)/pCB72, respectively, relative to 
corresponding control strains harboring pTB284. Numbers above lanes indicate the 
amount of total protein loaded. G. Cultures of TB28 [WT], MM13, or CB4(attλTB309) 
containing the aforementioned plasmids were diluted, plated on the indicated media 
containing Spc, and incubated overnight at 37oC. Plasmids pCB62 [Plac-con::ponA] and 
pCB72 [Plac-con::ponB] possess native ribosome binding sites and 5’UTRs for ponA and 
ponB, respectively. pCB72 likely has a higher basal level of expression than pCB62 since it 
can correct the PBP1B- LpoA- phenotype of MM13 without IPTG induction. Plac-con is a 
synthetic lac promoter with consensus -35 and -10 elements.
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Lpo factors localize throughout the outer membrane. Based on the sequence of their 
signal peptides, LpoA and LpoB are both predicted to be outer membrane lipoproteins 
(Figure 2.8A). To test this, we used a cytological assay for lipoprotein transport developed 
by Pugsley and co-workers (29). In this assay, cells expressing a fluorescent protein fused 
to a lipoprotein or lipobox-containing signal sequence are visualized following osmotic 
shock. This treatment induces the formation of plasmolysis bays where the inner 
membrane retracts from the rest of the cell envelope. Thus, a fluorescently labeled 
lipoprotein that is retained in the inner membrane will localize to the invaginations of the 
plasmolysis bays whereas an outer membrane lipoprotein will retain a peripheral 
localization pattern. 
	 Before osmotic shock, GFP fusions to LpoA and LpoB displayed a patchy, non-
uniform peripheral localization pattern (Figure S2.9E and S2.9G), indicating that they are 
broadly distributed throughout the envelope. In unconstricted cells, GFP-LpoA and GFP-
LpoB retained their peripheral distribution following osmotic shock, suggesting that they 
are indeed outer membrane proteins (Figure 2.10A and 2.10D). This was confirmed using 
membrane fractionation experiments (Figure S2.8B-E). In dividing cells, the GFP-LpoA 
and GFP-LpoB signals became enriched at the septum following osmotic shock (Figure 
S2.9F and S2.9H). This was also observed for GFP-PBP1b, but not GFP-PBP1a (Figure 
S2.9A-D). It is not clear why plasmolysis leads to the enrichment of these fusion proteins 
at the septum, but this may reflect some propensity of the native proteins to be recruited 
to the division apparatus (11, 44). 
	 To determine the importance of outer membrane localization and/or lipidation for 
Lpo factor function, we generated LpoA-GFP and LpoB-GFP variants with D+2 D/E+3 
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substitutions in their signal sequences to cause their retention in the inner membrane 
(Figure 2.8A), as well as variants in which the entire lipoprotein signal sequence was 
replaced with that of DsbA, a secreted periplasmic protein. All variants displayed the 
expected localization pattern following osmotic shock (Figure 2.10A-F). Fusions with the 
DsbA signal sequence appeared to fill the periplasm of the plasmolysis bays (Figure 2.10B 
and 2.10E), and those with the D+2 D/E+3 substitutions appeared to co-localize with 
invaginations of the inner membrane where it retracted from the envelope (Figure 2.10C 
and 2.10F). We tested the ability of these variants to support the function of their cognate 
PBP1 by assaying whether or not they could correct the synthetic lethal phenotypes of 
Lpo/PBP1 mutant combinations. As shown in Figure 2.10G, LpoA variants with a DsbA 
signal peptide or the D+2 D+3 double substitution were not active, suggesting that LpoA 
must be targeted to the outer membrane to promote PBP1a function. Immunoblot analysis 
showed that all of the LpoA variants were produced at levels similar to the wild-type 
protein (data not shown), indicating that the observed defects were not due to reduced 
protein accumulation. In contrast to the results with LpoA, all of the LpoB variants were 
functional (Figure 2.10H), suggesting that LpoB does not need to be lipidated or 
transported to the outer membrane to support PBP1b function. 
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Figure 2.8. Lpo protein signal sequences and membrane fractionation. A. Shown are 
the signal sequences of LpoA and LpoB. Lipo-box signatures are underlined, and 
predicted cleavage and lipidation site is indicated by the arrowhead. Background: In 
Gram-negative bacteria, lipoproteins are synthesized with specialized N-terminal signal 
sequences containing a lipobox motif with a consensus sequence of L-3-A/S-2-G/A-1-C+1 
(43). Following translocation through the Sec machinery, prolipoproteins are lipidated at C
+1 and cleaved between residues -1 and +1 (43). Once fully processed, a mature 
lipoprotein is typically either retained in the outer leaflet of the inner membrane or 
transported to the inner leaflet of the outer membrane by the Lol system (43). (Legend 
continued on next page.)
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Figure 2.8. (continued). While most lipoproteins are transported to the outer membrane, 
those with an aspartic acid (D) in the +2 position are typically retained in the inner 
membrane (43). Retention is also influenced by the residue in the +3 position with D, E, or 
Q at +3 providing an exceptionally strong retention signal in combination with D at the +2 
position (43). B-E. Results from membrane fractionations. Total membranes were isolated 
from TB28 [WT] cells were layered onto a sucrose step gradient (2.2, 1.44, and 0.77 M 
sucrose) and centrifuged at 100,000xg for 17 hours. Fractions (1ml) were then collected 
from the top of the gradient and analyzed for NADH oxidase activity, an inner membrane 
marker (B). Activity peaked in fraction 4. Total protein in each fraction was visualized by 
SDS-PAGE and coomassie staining (C). Bands corresponding to the major outer 
membrane porins were significantly enriched in fraction 8. Fractions were also analyzed for 
LpoA (D) or LpoB (E) by immunoblotting. Both proteins were also significantly enriched in 
the outer membrane fraction (#8).
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Figure 2.9. Subcellular localization of PBP1s and Lpo factors before and after 
plasmolysis. Cells of TU121(attHKTB307) [ΔponA(Plac::gfp-ponA)] (A-B), 
TU122(attHKMM6) [ΔponB(Plac::gfp-ponBγ)] (C-D), (Legend continued on next page.)
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Figure 2.9. (continued). MM22(attHKMM10) [ΔlpoA(Plac::lpoA-gfp)] (E-F), and 
CB26(attHKCB28) [ΔlpoB(Plac::lpoB-gfp)] (G-H) were grown in M9 Maltose supplemented 
with 50, 25, 50, or 100 µM IPTG, respectively, to an OD600 of 0.5-0.6. They were then either 
visualized without (A, C, E, and G) or with plasmolysis (B, D, F, and H) using GFP (panel 1) 
or DIC (Panel 2) optics. Plasmolysis was performed as in Figure 2.10. Plasmolysis bays 
appear as depressions in DIC as opposed to phase light areas using phase contrast. 
LpoA-GFP, LpoB-GFP, GFP-PBP1a and GFP-PBP1b were found to be broadly distributed 
throughout the cell periphery in a patchy, non-uniform pattern in live cells (A, C, E, and G). 
Similar results for PBP1b localization were reported previously when this was investigated 
by immunofluorescence microscopy (11), except that a modest enrichment of PBP1b at 
the septum was reported. We did not observe such an enrichment of GFP-PBP1b at the 
septum. Curiously, however, we observed strong enrichment of LpoA-GFP, LpoB-GFP, and 
PBP1b-GFP at division sites when cells were plasmolyzed (D, F, and H). GFP-PBP1a, on 
the other hand, displayed a largely peripheral distribution whether or not cells were 
plasmolyzed (B). The biological significance of this plasmolysis-induced septal localization 
is not clear, but may be the reason for the discrepancies between live-cell and 
immunofluorescence microscopy with respect to PBP1b localization. Plasmolyzed cells 
are “flattened” relative to live cells, similar to cells processed for immunofluorescence. This 
flattening likely leads to a more apparent peripheral signal for fluorescently labeled 
membrane proteins (compare cells with and without plasmolysis). Thus, what appears to 
be enriched protein localization at the septa may in fact be due to the presence of two 
closely opposed membranes at these sites with the potential for the effect being magnified 
due to cell flattening. (Legend continued on next page.)
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Figure 2.9. (continued). Alternatively, our GFP fusions could be partially defective for 
septal localization even though they corrected phenotypes associated with mutants 
lacking the corresponding native protein and appear to be largely intact in immunoblots 
(data not shown).
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Figure 2.10. LpoA and LpoB are outer membrane lipoproteins. A-F. Cytological assay 
of membrane localization. Cells of MM13 [Para::ponB ΔlpoA] (A-C) or CB4(attλTB309) 
[ΔponA ΔlpoB(Para::ponA)] (D-F) harboring the integrated expression constructs (A) 
attHKMM10 [Plac::lpoA-gfp], (B) attHKCB42 [Plac::ssdsbA-lpoA-gfp], (C) attHKMM50 
[Plac::lpoA(D+2D+3)-gfp],(D) attHKCB28 [Plac::lpoB-gfp], (E) attHKCB41 [Plac::ssdsbA-lpoB-
gfp], or (F) attHKMM51 [Plac::lpoB(D+2E+3)-gfp] were grown at 30oC to mid-log in M9-
arabinose supplemented with 100 µM IPTG. The cells were then plasmolyzed and 
visualized using GFP (panels 1) and phase contrast (panels 2) optics. Arrows highlight 
clear examples of protein localization (outer membrane, A and D; periplasm B and E; inner 
membrane, C and F). Bar equals 2 microns. G-H. Functionality of signal sequence 
mutants. Cultures of cells from (A-F) were diluted and plated on the indicated media as 
described in Figure 2. Please also see data in Figure 2.8 and Figure 2.9.
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Specific interaction of the Lpo factors with their cognate PBP. Overall, our results 
suggest that the Lpo factors are promoting the in vivo activity of the PBP1s.  To test 
whether they do so directly, we purified untagged versions of PBP1a and PBP1b, and 
6xHis tagged versions of LpoA (H-LpoA) and LpoB (H-LpoB) lacking their signal 
sequences and lipid modification signals. We then used a pull-down assay to investigate 
potential PBP1-Lpo interactions. When PBP1a (4µM) was incubated with H-LpoA (4µM), it 
was found in the eluate from Ni-NTA beads following two wash steps (Figure 2.11A). 
Purified FtsZ (4µM) was included in the binding reactions as a negative control. It was not 
retained on the beads, indicating that the washes were effective. In contrast to the results 
with PBP1a, only a very small amount of PBP1b co-purified with H-LpoA (Figure 2.11B). 
Conversely, when PBP1a (4µM) or PBP1b (4µM) were incubated with H-LpoB (4µM), 
PBP1b was specifically retained on NiNTA beads (Figure 2.11C and 2.11D). Thus, as 
implied by the genetic results, LpoA specifically associates with PBP1a, while LpoB 
specifically associates with PBP1b.  
	 Similar amounts of Lpo and PBP1 proteins appeared to elute from the Ni-NTA resin, 
suggesting that the PBP1-Lpo stoichiometries in the isolated complexes were close to 1:1. 
Accordingly, the cellular copy numbers of the Lpo factors measured using semi-
quantitative immunoblotting mirrored those determined for their cognate PBPs. About 500 
molecules per cell each of LpoA and PBP1a were detected while PBP1b and LpoB were 
found to have copy numbers of about 1000 and 2300 molecules per cell, respectively. The 
in vivo PBP1:Lpo stoichiometry is therefore in the range of 1:1 to 1:2. The measured 
PBP1a/b levels were 2-4 times higher than those determined previously using radiolabeled 
penicillin as a probe (20), but were consistent with past measurements of PBP1b levels by
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Figure 2.11. LpoA and LpoB specifically interact with their cognate PBP. A-D. H-LpoA 
(A-B) or H-LpoB (C-D) was incubated with PBP1a (A and C) or PBP1b (B and D) for 60 
min at room temperature in binding buffer [20mM Tris (pH 7.4), 0.1% Triton-X-100, and 
either 300mM or 150mM NaCl for A-B or C-D, respectively]. Ni-NTA resin (Qiagen) was 
then added to each reaction and they were further incubated for 2 hr at 4oC with rotation. 
The resin was pelleted by centrifugation, washed twice with binding buffer containing 
20mM imadazole, and the proteins retained on the resin were eluted with sample buffer 
containing EDTA (100 mM). Proteins in the initial reaction (input), initial supernatant (UB), 
wash supernatants (W1 and W2), and eluate were separated on a 12% SDS 
polyacrylamide gel and stained with Coomassie Brilliant Blue. FtsZ was included in each 
reaction as a non-specific control. All proteins were present in the initial binding reaction at 
a concentration of 4 µM. Positions of molecular weight markers (numbers in kDa) are given 
to the left of each gel.
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immunoblotting (12). Radiolabeled penicillin thus appears to underestimate PBP levels 
when used for copy number determinations. 
Lpo factors promote PBP activity in vivo and in vitro. To assess the effect of the Lpo 
proteins on PG assembly, we compared the chemical composition of wild-type PG with 
PG isolated from PBP1a- PBP1b- or LpoA- LpoB- cells just before they lysed (Table 2.1). 
For the analysis, purified PG was digested with a muramidase (mutanolysin) that cleaves 
the β-1,4 linkages between the N-acetylmuramic acid (M) and N-acetylglucosamine (G) 
sugars of PG (Figure 2.1A). The resulting mixtures of muropeptides, primarily consisting of 
monomeric G-M disaccharides with attached peptides or dimeric G-M disaccharides 
connected by crosslinked peptides, were separated by HPLC and the component 
muropeptides quantitated. The absence of either the PBP1s or the Lpo proteins caused a 
strikingly similar alteration in relative PG composition. PG from the mutants showed a 
decrease in peptide crosslinking, from 22% in the wild-type control down to 18-19% 
(Table 2.1). In addition, a dramatic increase (4-7 fold) in pentapeptide-containing 
muropeptides was observed in the PG isolated from the mutants (Table 2.1). Since the 
terminal D-Ala is cleaved from pentapeptides as part the PBP crosslinking reaction, the 
observed increase in pentapeptides in the mutant PG preparations coupled with the 
reduction in crosslinking is consistent with a failure in the efficient incorporation of new PG 
material into the existing cell wall network. 
	 Next, we examined the effect of LpoB on PG synthesis in vitro using ether-
permeabilized (EP) cells. In the latter stages of the PG synthesis pathway, lipid-II (Figure 
2.1B) is made from the activated sugar precursors UDP-M-pentapeptide (UDP-M-pep5) 
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Table 2.1. PG composition in cells depleted of PBP1s or Lpo factors.
Strain
WT
(n=3)
Para::ponB 
ΔponA
(n=2)
Plac::lpoA 
ΔlpoB
(n=3)
Muropeptides % total
G-M Monomer (total) 52.4 ± 2.0 60.2 ± 1.0 58.6 ± 0.9
pentapeptide 0.2 ± 0.1 0.9 ± 0.1 1.4 ± 0.7
tetrapeptide 38.6 ± 3.1 42.6 ± 0.5 40.7 ± 1.0
tripeptide 6.7 ± 0.6 11.4 ± 0.9 4.5 ± 2.9
GM-Dimer (total) 39.3 ± 3.2 34.0 ± 2.6 36.1 ± 0.7
GM-Trimer (total) 3.1 ± 0.6 2.4 ± 1.3 1.4 ± 0.1
anhydro-GM (total) 1.4 ± 0.0 0.9 ± 0.0 1.4 ± 0.3
%crosslinkage 21.7 ± 1.2 18.6 ± 0.5 19.0 ± 0.4
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and UDP-G. PG synthesis can be reconstituted and measured in ether-permeabilized (EP) 
cells by supplying them with purified UDP-M-pep5 and UDP-[14C]G and monitoring the 
incorporation of label into the detergent-insoluble PG fraction (Mirelman et al., 1976). 
PBP1b appears to be the major PBP responsible for PG synthesis in this system because 
EP cells from PBP1b- mutants are almost completely defective in label incorporation 
whereas the absence of PBP1a has little to no effect (Figure 2.12A) (41). EP cells thus 
provide a convenient system for following PBP1b activity in a cellular context. To 
determine if LpoB is required for PBP1b activity in this system, we prepared EP cells from 
a LpoB- mutant and tested their ability to synthesize PG. LpoB- EP cells behaved 
identically to those prepared from a PBP1b- mutant and were dramatically reduced in their 
ability to incorporate UDP-[14C]G into the detergent-insoluble PG fraction (Figure 2.12A). 
Remarkably, the addition of purified untagged LpoB completely restored the ability of 
LpoB- EP cells to synthesize PG (Figure 2.12A), indicating that the PG synthesis defect 
was due solely to the absence of LpoB. As expected based on prior results with PBP1a- 
mutants, a LpoA defect did not affect PG synthesis in EP cells (Figure 2.12A).
	 To further investigate LpoB function, we monitored its effect on the PGT activity of 
PBP1b in a purified system using radiolabled lipid-II substrate. LpoB specifically enhanced 
the initial rate of PBP1b transglycosylation by an average of 1.5x (Figure 2.12B). However, 
it did not affect the activity of PBP1a, nor did LpoA affect the PGT activity of either PBP 
(Figure 2.12B-C). Although the effect of LpoB on the rate of PBP1b PGT activity was 
relatively modest, it specifically affected the length of glycan chains produced by PBP1b. 
Much shorter polymers were produced in the presence of LpoB than those formed in its 
absence (Figure 2.12D). We propose that this indicates that LpoB stimulates the initiation 
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Figure 2.12. LpoB activates PBP1b PGT activity and affects polymer length. A. PG 
synthesis in EP cells. EP cells from the indicated strains were incubated with or without 
LpoB (0.5-4 µM, as indicated). Reactions were initiated with the addition of UDP-M-
pentapeptide (4 nmol) and UDP-[14C]G. After 60 min they were boiled in 4% SDS and 
filtered. Labeled PG retained on the filter was quantified by liquid scintillation counting. B-
C. PBP PGT activity was measured by the incorporation of lipid-II into peptidoglycan in 
the presence of penicillin G. [14C]G-labeled lipid-II (4-8 μM) was incubated with or without 
LpoA or LpoB (50 nM) prior to the addition of PBP1a or PBP1b (50 nM), which initiated the 
reaction. (Legend continued on next page.)
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Figure 2.12 (continued). At the indicated time points, reactions were quenched and 
analyzed for remaining substrate and PG product by paper chromatography. Results of 
single experiments are shown. They are representative of multiple trials (see 
Supplementary Information). D. Glycan chains generated in reactions similar to those in 
(B-C) were separated on an acrylamide gel (9%) and visualized using a phosphorimager. 
Lipid-II substrate was present at 4 µM in each reaction and protein amounts are indicated 
above the gel lanes.
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of glycan strand formation (see Discussion). Overall, we conclude that LpoB is absolutely 
required for PBP1b function in a cellular context and is capable of directly and specifically 
modulating PBP1b PGT activity in a purified system. 
Discussion
	 Despite the fundamental role of PG assembly in bacterial growth and its long 
history as an effective antibiotic target, we are only just beginning to uncover the 
molecular mechanisms underlying this complex process. Over the years, a great deal of 
effort has focused on the structural and biochemical characterization of the PBPs, the 
major PG synthases. This has led to important insights into the mechanisms by which 
these enzymes catalyze PG polymerization and crosslinking, how they are inhibited by 
antibiotic molecules, and why certain variants confer antibiotic resistance (37). While much 
still remains to be learned about the biochemical function of the PBPs, progress in this 
area has significantly outpaced our knowledge of the in vivo function of the PBPs and how 
they cooperate with other cellular factors to build the cell-shaped PG mesh. One of the 
principal reasons for this is that functional redundancy among PG assembly factors has 
limited the effectiveness of genetic analysis. Here, we turned this redundancy into an 
advantage by employing synthetic lethal screens to uncover the E. coli lipoproteins LpoA 
and LpoB as the first set of essential PBP cofactors (Figure 2.13). Our results suggest 
that, like other polymerases, the PBPs may generally require accessory factors to augment 
or regulate their activity. Moving forward, these factors will surely play a significant role in 
advancing both our understanding of PBP function in vivo and PBP enzymology in vitro. 
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Figure 2.13. Model for Lpo protein function. Shown are schematic diagrams of putative 
PBP-containing complexes in E. coli drawn as in Figure 2.1. The partial redundancy of 
PBP1a (lavender) and PBP1b (brown) suggest that they form part of independent PG 
synthesizing (sub)complexes that can substitute for one another. LpoA is an essential 
component of the PBP1a complex (left) that potentially stimulates the transpeptidase 
activity of this PBP (see text for details). LpoB is an essential component of the PBP1b 
complex and activates its PGT activity. 
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The outer membrane and PG biogenesis. Although PG precursor biosynthesis occurs 
inside the cell, the final stages of PG assembly take place at the cell surface (Figure 2.1B). 
This presents an interesting challenge for bacteria, which must somehow coordinate PG 
assembly outside the cytoplasmic membrane with processes that control growth and 
division on the inside. Recent results indicate that this coordination is, at least in part, 
mediated by the MreB and FtsZ cytoskeletons (31). 
 Because they surround their PG layer with a second (outer) membrane, Gram-
negative bacteria face the additional challenge of coordinating PG synthesis with outer 
membrane assembly. The discovery of LpoA and LpoB as outer membrane activators of 
the PBPs suggests that they may play an important role in coupling outer membrane 
biogenesis and PG synthesis. While further work is required to test this possibility, it 
highlights the potential for the PG synthetic machinery receiving regulatory input from the 
outer membrane as well as cytoskeletal elements in the cytoplasm. An equally attractive 
possibility is that the outer membrane localization of the Lpo factors might facilitate a 
“template” function for the existing PG matrix. The glycan strands of PG are thought to be 
oriented perpendicular to the long-axis of the cell (22) (Figure 2.14). Adjacent “tracks” of 
glycan strands are therefore likely to restrict the lateral diffusion of trans-envelope 
complexes formed between the Lpo proteins in the outer membrane and the PBPs in the 
inner membrane. We envision that this arrangement would force the insertion of new PG 
material along a consistent path directed by the “tracks” in the existing structure (Figure 
2.14). Thus, as implied by earlier work (24, 39), the PG layer itself may collaborate with 
cytoskeletal elements to provide a robust mechanism for shape-maintenance and the 
regular expansion of the PG network. Importantly, the Lpo factors may represent just one 
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Figure 2.14. Model for the control of glycan strand insertion by trans-envelope Lpo 
factor-PBP complexes. Shown is a schematic detailing a model in which adjacent glycan 
strands in the existing PG structure (green) restrict the lateral diffusion of trans-envelope 
Lpo factor-PBP complexes in the membrane to promote the insertion of new PG material 
(red) along a regular path (upper panels). Such a model is consistent with the observed 
insertion of single-stands of new PG between two old strands (16, 19), and previous 
studies suggesting a templating function for the existing matrix (24, 39). In the absence of 
the Lpo factors and/or additional components of the PG synthetic machinery that link the 
PBPs to the outer membrane (e.g. MltA and MipA for PBP1b) (49), PBP complexes may 
stray from their original path of synthesis resulting in the less orderly insertion of new 
material (lower panels). (Legend continued on next page.)
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Figure 2.14 (continued). By directing the path of PG synthesis by envelope-spanning PBP 
complexes, we envision that the existing PG matrix collaborates with cytoskeletal 
elements to provide a robust mechanism for cell shape maintenance and the ordered 
duplication of the PG layer with each cell cycle.
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set of potential connections between the PBPs and the outer membrane. Indeed, it was 
shown previously that PBP1b is connected to the outer membrane through its interactions 
with the bridging protein MipA that, in turn, associates with the outer membrane PG 
hydrolase MltA (49). In contrast to LpoB, neither MipA or MltA are required for PBP1b 
activity. However, the ability of these and potentially other proteins to connect PBP1b to 
the outer membrane may be one reason why an outer membrane localization is not 
absolutely required for LpoB to support PBP1b function. 
Biochemical activities of LpoA and LpoB. In addition to promoting PBP1b activity in EP 
cells and stimulating PBP1b PGT activity in vitro, LpoB also caused PBP1b to produce 
dramatically shorter glycan chains. A wide range of glycan strand lengths has been 
detected in purified cellular PG, but essentially nothing is known about how strand length 
is determined in vivo and whether or not it is regulated. The observation that LpoB affects 
the length distribution of glycan chains produced by PBP1b suggests the attractive 
possibility that it regulates PBP1b product length by stimulating the termination of glycan 
synthesis. However, such a role is difficult to reconcile with the observation that LpoB is 
essential for PG synthesis by PBP1b in EP cells. We therefore favor a model in which LpoB 
stimulates the initiation of glycan chain synthesis to explain its effect on product length 
distribution in PBP1b PGT assays. This model is based on the previous observation that 
the length distribution of polymers produced by a variety of purified PBPs was unaffected 
by the PBP:substrate ratio (50). Surprisingly, even in reactions with a 1:1 PBP:substrate 
ratio, where at most only a few turnovers would be expected, long glycan strands with a 
size distribution typical of the PBP being assayed were produced. This suggests that the 
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initiation step of glycan chain synthesis is rate-limiting and that the subsequent elongation 
process is rapid and processive (50). Thus, consistent with our observations, activation of 
glycan strand initiation by LpoB would be predicted to result in a greater number of 
elongating PBP1b polymerases in PGT reactions such that lipid-II is exhausted before 
longer polymer lengths can be achieved. Because LpoB is not absolutely required for 
PBP1b activity in a purified system, a subset of PBP1b molecules in PGT reactions lacking 
LpoB must be capable of initiating glycan strand formation. Initiation may be tightly 
controlled in the context of multi-protein complexes formed in vivo, however, leading to a 
strict LpoB dependence for PBP1b PGT activity in the cell. Further work will be required to 
investigate the potential role of LpoB in glycan chain initiation, and whether, in such a 
capacity, it serves as critical PBP1b regulator that helps coordinate its PGT activity with 
the activity of other components of the PG or outer membrane assembly machinery. 
	 While our results clearly show that LpoA is essential for PBP1a function in vivo, we 
have yet to detect a biochemical activity that sheds light on the specific role of LpoA in the 
reactions catalyzed by PBP1a. One potential reason for this is that lipidation and outer 
membrane localization of LpoA was shown to be essential for its activity in vivo and the 
protein we purified was not lipidated. Interestingly, the structure of the C-terminal domain 
of H. influenzae LpoA was recently solved and was found to share similarities with 
periplasmic solute binding proteins like maltose binding protein (1). The closest structural 
relative to LpoA is E. coli LivJ (PBD ID# 1z15), a branched-chain amino acid binding 
protein (1). This suggests that LpoA may associate with the peptide moieties of PG to 
facilitate crosslinking of nascent material into the PG matrix by PBP1a. Consistent with 
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this idea, in the accompanying report from Typas et al. (44), the authors present evidence 
that LpoA greatly enhances the formation of crosslinked PG by purified PBP1a.
A specific role for PBP1b-LpoB complexes in cell division? At least two distinct multi-
enzyme complexes are thought to be necessary for proper PG biogenesis in rod shaped 
cells: one organized by MreB for cell elongation and the other organized by the division 
protein FtsZ (13). Although they are individually dispensable for growth, at least one type 
of PBP1 protein is thought to be required for the activity of each of these complexes. It 
therefore seems likely that PBP1a and PBP1b, along with their associated Lpo activators, 
are both capable of productively interfacing with the MreB- and FtsZ-directed PG 
synthesizing machineries. Consistent with this possibility, in normal, unplasmolyzed cells, 
GFP fusions to the PBP1s and the Lpo factors were found to localize in patches and foci 
that were broadly distributed around the cell periphery (Figures 2.9 and 2.10). In addition, 
immunofluorescence localization of PBP1b performed previously also found it to be 
present in many foci throughout the cell cylinder, although a modest enrichment at the 
division sites of constricting cells was also reported (11). 
	 While PBP1a and PBP1b appear to be largely interchangeable in their capacities to 
support growth, it is likely that they display some level of functional specialization in wild-
type cells. Accordingly, PBP1b has been shown to interact with the division-specific, class 
B PBP, PBP3, and the division factor FtsN (11, 35). This suggests that PBP1b, along with 
LpoB, may play a specific role in the division process that PBP1a-LpoA sub-complexes 
are unable to perform. Interestingly, a number of mutants with lesions in genes coding for 
factors involved in septal PG biogenesis were isolated using our screen for cells with a Slb 
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phenotype. Rather than identifying additional co-factors needed for PBP1a activity like 
LpoA, we favor the interpretation that these division mutants have a Slb phenotype 
because PBP1b- cells are partially defective for cell division and are thus sensitized to 
further insults to the division machinery. A similar class of division mutants was not 
recovered in the corresponding screen for sla mutants, nor did the alleles identified in the 
Slb screen display synthetic phenotypes with the absence of PBP1a when this was tested 
directly (data not shown). The phenotype of the PBP1b-/division mutant combinations in 
each case was a high frequency of cell lysis, suggesting that the absence of PBP1b 
combined with a defect in one of these division factors often results in catastrophic 
failures in septal PG assembly. Further analysis of these mutants and their connection to 
PBP1b function should allow us to elucidate how PBP1b participates in the construction 
of the polar PG caps, and whether or not this role is unique to PBP1b-LpoB containing 
complexes.
Lpo factor conservation and the prospect for additional PBP accessory proteins. 
LpoA is broadly conserved among the γ-proteobacteria while LpoB is primarily restricted 
to the enterobacteriaceae family within this class (21). We therefore suspect that 
organisms belonging to bacterial classes other than the γ-proteobacteria are likely to 
possess PBP accessory proteins distinct from LpoA and LpoB that also promote the 
function of their PBPs. Some of these factors may play critical roles in the PG assembly 
process itself, while others may help coordinate PG synthesis with additional envelope 
components like the outer membranes of other proteobacteria or the teichoic acids of 
Gram-positive organisms.
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	 We anticipate that several of the many PBP-interacting proteins identified previously 
will also prove to be PBP accessory proteins that directly assist the PBPs in PG assembly. 
Prime candidates are the PG hydrolases. These enzymes break bonds in the PG 
meshwork and have long been thought necessary for providing space in the existing 
matrix for the insertion of new material. Although this possibility remains attractive on a 
theoretical basis, experimental support for it is still lacking. Addressing the role of these 
and other PBP-interacting factors in PBP function represents an important challenge for 
future work. 
PBP accessory factors and antibiotic development. The discovery of penicillin and its 
ability to inhibit the PBPs to induce bacteriolysis ushered in the antibiotic age of clinical 
medicine. Since then, the PBPs have proven to be one of the most important drug targets 
ever identified. Sadly, antibiotic resistance continues to erode the effectiveness of our 
current cache of antibacterial therapies, including penicillin derivatives and other β-
lactams (42). Regardless of their precise biochemical function, the discovery of accessory 
factors essential for the in vivo function of the PBPs suggests new avenues for antibiotic 
development to help combat drug-resistant bacteria. The observation that LpoA is 
essential in H. influenzae (52) suggests that direct targeting of PBP accessory proteins 
might be effective in some circumstances. Additionally, further study of the mechanisms 
by which these accessory factors influence PBP activity is likely to reveal novel ways to 
block PBP function for therapeutic purposes.
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Materials and Methods
Media, bacterial strains, and plasmids
	 Cells were grown in LB (1% tryptone, 0.5% yeast extract, 0.5% NaCl) or minimal 
M9 medium supplemented with 0.2% casamino acids and 0.2% sugar (arabinose; Ara, 
glucose; Glu, or maltose; Malt). The bacterial strains and plasmids used in this study are 
listed in Tables S2 and S3, respectively, and a detailed description of their construction is 
given below. 
 The bacterial strains and plasmids used in this study are listed in Tables S2 and S3, 
respectively. A detailed description of plasmid construction is given below. All strains used 
for in vivo experiments are derivatives of MG1655 (25), and all deletion alleles were 
sourced from the Keio knockout collection (3). All expression constructs used for in vivo 
experiments except those used in Figures 2.4 and 2.7 are derivatives of the CRIM 
plasmids developed by Wanner and co-workers (26). They were integrated into phage 
attachment sites (HK022 or λ) as described previously (8, 26). Single copy integrants were 
identified using diagnostic PCR (26). Integrated vectors were transferred between strains 
by P1-mediated transduction (32). The plasmids used in Figure 2.7 were low-copy 
pSC101 derivatives and those used in Figure 2.4 were medium-copy pBR derivatives. 
Plasmids used in this study are described below. In all cases PCR was performed using 
KOD polymerase (Novagen) according to the instructions. Unless otherwise indicated, 
MG1655 chromosomal DNA was used as the template. Restriction sites for use in plasmid 
constructions are italicized and underlined in the primer sequences given below. Plasmid 
DNA and PCR fragments were purified using the Qiaprep spin miniprep kit (Qiagen) or the 
Qiaquick PCR purification kit (Qiagen), respectively.
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Table 2.2. Bacterial strains used in this study. 
Strain Genotypea Source/Referenceb
DH5α
F– hsdR17 deoR recA1 endA1 phoA supE44 thi-1 
gyrA96 relA1 Δ(lacZYA-argF)U169 
ϕ80dlacZΔM15 
Gibco BRL
BL21(λDE3) ompT rB– mB– (PlacUV5::T7gene1) Novagen
Rosetta(λDE3)  ompT rB- mB- gal dcm (PlacUV5::T7gene1) Novagen
MG1655 rph1 ilvG rfb-50 (25)
TB10 rph1 ilvG rfb-50 λΔcro-bio nad::Tn10 (27)
TB28 MG1655 ΔlacIZYA::frt '(7)
BW25113 Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) rph-1 Δ(rhaD-rhaB)568 hsdR514 (3)
JW3359-1 BW25113 ΔponA(mrcA)::KanR (3)
JW0145-1 BW25113 ΔponB(mrcB)::KanR (3)
JW3116-1 BW25113 ΔlpoA(yraM)::KanR (3)
JW5157-1b BW25113 ΔlpoB(ycfM)::KanR (3)
TU115 TB28 ΔponA(mrcA)::KanR P1(JW3359-1) x TB28
TU116 TB28 ΔponB(mrcB)::KanR P1(JW0145-1) x TB28
TU121 TB28 ΔponA(mrcA)::frt TU115/pCP20
TU122 TB28 ΔponB(mrcB)::frt TU116/pCP20
MM5 TB10 (KanR araC Para)::ponB recombineering
MM8 TB28 ΔlpoA(yraM)::KanR P1(JW3116-1) x TB28
MM9 TB28 (KanR araC Para)::ponB P1(MM5) x TB28
MM10 ΔponA(mrcA)::frt (KanR araC Para)::ponB P1(MM5) x TU121
MM11 TB28 (frt araC Para)::ponB MM9/pCP20
MM13 ΔlpoA(yraM)::KanR (frt araC Para)::ponB P1(JW3116-1) x MM11
MM22 TB28 ΔlpoA(yraM)::frt MM8/pCP20
MM25 TB28 ΔlpoA(yraM)::frt ΔponB(mrcB)::KanR P1(JW0145-1) x MM22(attMM10)
MM26 TB28 ΔlpoA(yraM)::frt ΔlpoB(ycfM)::KanR P1(JW5157-1b) x MM22(attMM10)
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Table 2.2. Bacterial strains used in this study. (Continued)
Strain Genotypea Source/Referenceb
MM30 TB28 ΔponA(mrcA)::frt ΔlpoA(yraM)::KanR P1(JW3116-1) x TU121(attTB309)
CB3 TB28 ΔponA(mrcA)::frt ΔponB(mrcB)::KanR P1(JW0145-1) x TU121(attTB309)
CB4 TB28 ΔponA(mrcA)::frt ΔlpoB(ycfM)::KanR P1(JW5157-1b) x TU121(attTB309)
CB5 TB28 (frt araC Para)::ponB ΔlpoB(ycfM)::KanR P1(JW5157-1b) x MM11
CB6 TB28 ΔlpoB(ycfM)::KanR P1(JW5157-1b) x TB28
CB26 TB28 ΔlpoB(ycfM)::frt CB6/pCP20
a The KanR cassette is flanked by frt sites for removal by FLP recombinase. An frt scar remains following 
removal of the cassette using FLP expressed from pCP20. 
b Strain constructions by P1 transduction are described using the shorthand: P1(donor) x recipient. In all 
cases transductants were selected on LB Kan plates. Strains resulting from the removal of a KanR cassette 
using pCP20 are indicated as: Parental strain/pCP20.
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Table 2.3. Plasmids used in this study.
Plasmid Genotypea Origin Reference/source
plysSRARE cat lysT7 proL leuW metT argW thrT glyT tyrU thrU argU ileX p15A Novagen
pCP20 bla cat cI857 repA(ts) PR::flp pSC101 (17)
pTB102 cat cI857 repA(ts) PR::intHK022 pSC101 (8)
pInt-ts bla cI857 repA(ts) PR::intλ pSC101 (26)
pTB145 bla lacIq PT7::h-ulp1(403-621) pBR/colE1 (6)
pTB146 bla lacIq PT7::h-sumo pBR/colE1 (6)
pTB284 aadA Plac-con::gfp pSC101 This study
pTB307 attHK022 bla lacIq Plac::gfp-ponA R6K This study
pTB309 attλ cat Para::ponA R6K This study
pTU110 cat lacIq Plac::ponB mini-F This study
pCB1 cat lacIq Plac::gfp-ponA mini-F This study
pCB7 bla lacIq PT7::h-sumo-lpoB(21-213) pBR/colE1 This study
pCB21 bla lacIq PT7::h-sumo-ponA pBR/colE1 This study
pCB22 bla lacIq PT7::h-sumo-ponB pBR/colE1 This study
pCB25 bla lacIq Plac::lpoB pBR/colE1 This study
pCB28 attHK022 bla lacIq Plac::lpoB-sfgfp R6K This study
pCB39 bla lacIq PT7::h-lpoB(21-213) pBR/colE1 This study
pCB40 bla lacIq PT7::h-lpoA(28-678) pBR/colE1 This study
pCB41 attHK022 bla lacIq Plac::ssdsbA-lpoB-sfgfp R6K This study
pCB42 attHK022 bla lacIq Plac::ssdsbA-lpoA-sfgfp R6K This study
pCB62 aadA Plac-con::ponA pSC101 This study
pCB72 aadA Plac-con::ponB pSC101 This study
pMM6 attHK022 bla lacIq Plac::gfp-ponB(γ) R6K This study
pMM10 attHK022 bla lacIq Plac::lpoA-sfgfp R6K This study
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Table 2.3. Plasmids used in this study. (Continued)
Plasmid Genotypea Origin Reference/source
pMM12 bla lacIq Plac::lpoA pBR/colE1 This study
pMM18 bla lacIq PT7::h-sumo-lpoA(28-678) pBR/colE1 This study
pMM44 attHK022 bla lacIq Plac::sslpoA-mcherry R6K This study
pMM45 attHK022 bla lacIq Plac::sslpoB-mcherry R6K This study
pMM46 attHK022 bla lacIq Plac::sspal(D+2)-mcherry R6K This study
pMM47 attHK022 bla lacIq Plac::sspal-mcherry R6K This study
pMM50 attHK022 bla lacIq Plac::lpoA(D+2D+3)-sfgfp R6K This study
pMM51 attHK022 bla lacIq Plac::lpoB(D+2E+3)-sfgfp R6K This study
a A 6xHis tag for purification is indicated by the letter h. PT7, PR, Plac, and Para indicate the phage T7, λR, 
lactose, and arabinose promoters, respectively. Plac-con is a synthetic lac promoter with consensus -10 and 
-35 elements. Numbers in parenthesis indicate the codons included in the relevant clones. 
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pTU110:
 pTU110 [cat Plac::ponB lacZ] was constructed from pRC7 [bla lacZ] (18) in four 
steps. First, slmA was amplified with the primers 5’-GTCCGAATTCACATTTCGTT 
TGCGGTCATAGCG-3’ and 5’-GCCTAAGCTTTTACTGCAACTGTGCCGCAATTAGC-3’. The 
resulting fragment was digested with EcoRI and HindIII and ligated with appropriately 
digested pRC7 to generate pTB68 [bla Plac::slmA lacZ]. Second, the bla gene was 
replaced with the cat gene amplified from pKD3 (17) with the primers 5’-
TTGAAGACGAAAGGG CCTCGTGATACGCCTATTTTTATAGATGAATATCCTCCTT 
AGTTCC-3’ and 5’-TCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAAGTG 
TAGGCTGGAGCTGCTTCG-3’ by recombination in E. coli TB10 strain (MG1655 
nadA::Tn10 λcI857 ∆(cro-bioA)) (27), generating pTB236 [cat Plac::slmA lacZ]. Thirdly, the 
EcoRI-HindIII fragment of pTB236 containing slmA was replaced with the EcoRI-HindIII 
fragment of pTB25 (7) containing envC to generate pTB238 [cat Plac::envC lacZ]. Lastly, 
ponB was amplified with the primers 5’-GTCAGAATTCGGGCTTTTGCGCCTGAATATTG-3’ 
and 5’-GTCACTCGAGATGGGATGTTATTTTACCGGATGGC-3’. The resulting fragment was 
digested with EcoRI and XhoI and replaced the EcoRI-SalI fragment of pTB238 to 
generate pTU110 [cat Plac::ponB lacZ].
pMM6:	
 The ponB gene from pTU110 [cat lacIq Plac::ponB] was amplified using the primers 
5’-GTACGGATCCCCGCGCAAAGGTAAGGG-3’ and 5’-GTCACTCGAGATGGGATGTTATTT 
TACCGGATGGC-3’. This PCR fragment was then digested with BamHI and XhoI and 
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ligated with BamHI and SalI digested pTB183 (5) to create pMM6 [attHK022 bla lacIq 
Plac::gfp-ponB(ϒ)]. 
pMM10:
 To generate pMM10 [attHK022 bla lacIq Plac::lpoA-sfgfp], the lpoA gene was 
amplified using the primers 5’-GTACCATATGGTACCCTCAACATTTTCTCGTTTG-3’ and 5’-
GTACCTCGAGACTGACGGGGACTACCTGAC-3’. The PCR product was digested with 
NdeI and XhoI and ligated with appropriately digested pTB225 (45).
pMM12:
 pMM12 was constructed through the intermediate pMM7 [attHK022 bla Plac::lpoA]. 
pMM7 was created by amplifying the lpoA gene using the primers 5’-GTACTCTAGACG 
TATTGCCGATTTAATATTGAGCATTGC-3’ and 5’-GTACAAGCTTCGCTTGTGCTTCCCAC 
GCATC-3’. The resulting PCR product was digested with XbaI and HindIII and ligated with 
appropriately digested pTB183 (5). Subsequently, pMM7 was digested with XbaI and 
HindIII and the resulting lpoA containing fragment was ligated into the appropriately 
digested pTB28 [bla lacIq Plac::amiC-gfp] (9) to create pMM12 [bla lacIq Plac::lpoA].
pMM18:
 To construct pMM18, the primers 5’-GTACGAGCTCGGCACCCATACTCCCGA 
TCAG-3’ and 5’-GTACCTCGAGTTAACTGACGGGGACTACCTGAC-3’ were used to amplify 
the part of the lpoA gene which code for LpoA residues 28 to 678.  The resulting PCR 
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product was then digested with the restriction enzymes SacI and XhoI and ligated with 
appropriately digested pTB146 (6) to generate the h-sumo fusion. 
pMM44-pMM47:
	 For pMM44, pMM45, pMM46 and pMM47, an important intermediate construct 
was pMM43 [attHK022 bla lacIq Plac::lpoA-mCherry]. To make pMM43, an mCherry 
containing XhoI-HindIII fragment from pTU136 (45) was used to replace the corresponding 
gfp fragment of pMM10. The synthetic nucleotides described below were annealed and 
ligated into NdeI and XhoI digested pMM43 to create pMM44, pMM45, pMM46 and 
pMM47.
 For pMM44 [attHK022 bla lacIq Plac::sslpoA-mCherry], the synthetic oligonucleotides 
encoding the lpoA signal sequence were 5’-TATGGTACCCTCAACATTTTCTCGTTTGAAA 
GCCGCGCGTTGTCTGCCTGTTGTTCTGGCAGCCCTGATTTTCGCCGGTTGTGGCACCCA
TACTCCCGATC-3’ and 5’-TCGAGATCGGGAGTATGGGTGCCACAACCGGCGAA 
AATCAGG GCTGCCAGAACAACAGGCAGACAACGCGCGGCTTTCAAACGAGA 
AAATGTTGAGGGTACCA-3’. 
 pMM45 [attHK022 bla lacIq Plac::sslpoB-mCherry] was constructed using synthetic 
oligonucleotides encoding the lpoB signal sequence: 5’-TATGACAAAAATGAGTCGCT 
ACGCCTTGATTACCGCGCTGGCGATGTTTCTCGCCGGGTGTGTGGGGCAACGTGAACCT
C-3’ and 5’-TCGAGAGGTTCACGTTGCCCCACACACCCGGCGAGAAACATCGCCA 
GCGCGG TAATCAAGGCG TAGCGACTCATTTTTGTCA-3’.
 The synthetic oligonucleotides encoding for a mutated pal signal sequence 5’-
TATGCAACTGAACAAAGTGCTGAAAGGGCTGATGATTGCTCTGCCTGTTATGGCAATTGCG
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GCATGTGATTCCAACAAGAACGCCC-3’ and 5’-TCGAGGGCGTTCTTGTTGGAATCACA 
TGCCGCAATTGCCATAACAGGCAGAGCAATCATCAGCCCTTTCAGCACTTTGTTCAGTTG
CA-3’ were used to create pMM46 [attHK022 bla lacIq Plac::sspal(D+2)-mCherry].
 Finally, the synthetic oligonucleotides 5’-TATGCAACTGAACAAAGTGCTGAAAGGG 
CTGATGATTGCTCTGCCTGTTATGGCAATTGCGGCATGTTCTTCCAACAAGAACGCCC-3’ 
and 5’-TCGAGGGCGTTCTTGTTGGAAGAACATGCCGCAATTGCCATAACAGGC 
AGAGCAATCATCAGCCCTTTCAGCACTTTGTTCAGTTGCA-3’ encoding the wild-type pal 
signal sequence were used to make pMM47 [attHK022 bla lacIq Plac::sspal-mCherry].
pMM50:
 pMM50 [attHK022 bla lacIq Plac::lpoA (D+2D+2)-sfgfp] is identical to pMM10 except 
that the Gly and Thr codons following the lpoA lipobox Cys codon were changed to Asp 
codons using site-directed mutagenesis. The primers used for this mutagenesis were 5’-
GATTTTCGCCGGTTGTGACGACCATACTCCCGATCAG-3’ and its reverse complement.
pMM51:
 The Val and Gly codons following the lpoB lipobox Cys codon in pCB28 were 
changed to Asp and Glu codons, respectively, using site-directed mutagenesis to create 
pMM51 [attHK022 bla lacIq Plac::lpoB (D+2E+2)-sfgfp]. The primers used were 5’-
GTTTCTCGCCGGGTGTGATGAGCAACGTGAACCTGCAC-3’ and its reverse complement.
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pTB279:
 pTB279 [Plac-con::gfp] was constructed in three steps. To generate the pTD16 
intermediate, the backbone of pTB183 (Bendezú et al., 2009) including bla, the replication 
origin, attHK022 site, and λtL3 terminator was amplified with the primers 5’-
ATGAGTCGACAAGCTTATCGATCTCAC-3’ and 5’-GTCAAGATCTCCGCGGTTGAAGACG 
AAAGGGCCTCG-3’. The lacIq gene and promoter from pMLB1113 (18) were amplified 
using the primers 5’-GTCAGTCGACCCGGATCCGGTCTAGAGGCTCGAGG 
GGAATTCCACCATCGAATGGTGCAAAACCTTTCGCG-3’ and 5’-GTCAAGATCTGCCGG 
AAGCATAAAGTGTAAAGCC-3’. The two PCR products were digested with BglII and SalI 
and ligated. To generate pTD17, gfpmut2 was amplified from pTB183 using the primers 5’-
TTAGGCACCCCAGGCTTTACAC-3’ and 5’-GTCAGTCGACTTATTTGTATAGTTCATCC 
ATGCCATGTGTAATC-3’. The resulting fragment was digested with XbaI and SalI and 
ligated with appropriately digested pTD16. To generate pTB279, the synthetic primers 5’-
AATTCAATTGTGAGCGCTCACAATTCAAGCACCCCAGGCTTGACACTTTATGCTTCCGGCT
CGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCAT-3’ and 5’-CTAGATGAAATT 
GTTATCCGCTCACAATTCCACACATTATACGAGCCGGAAGCATAAAGTGTCAAGCCTGGGG
TGCTTGAATTGTGAGCGCTCACAATTG-3’ containing the Plac-con promoter sequence were 
annealed and ligated with pTD17 digested with EcoRI and XbaI. 
pTB307:
 To construct pTB307 [Plac::gfp-ponA], the ponA gene was amplified with the primers 
5’-GTCAGGATCCAAGTTCGTAAAGTATTTTTTGATCCTTGCAGTC-3’ an 5’-
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GTCAAAGCTTTGTCAGCAAACTGAAAAGGCGC-3’. The resulting fragment was digested 
with BamHI and HindIII and ligated with appropriately digested pTB183 (6). 
pTB309:
 pTB309 [Para::ponA] was constructed in 2 steps. First, the malF-mCherry containing 
the XbaI-SalI fragment of pTB275 (Uehara et al., 2009) was ligated with similarly digested 
pTB277 (45) to generate pTB283 [cat Plac::envC lacZ]. The ponA gene was amplified using 
the primers 5’-GTCATCTAGACCGCGCGTTTGTTTATAAACTGCC-3’ and 5’-
GTCAAAGCTTTGTCAGCAAACTGAAAAGGCGC-3’ and the resulting fragment was 
digested with XbaI and HindIII and ligated with XbaI-HindIII digested pTB283. 
pCB1:
 	 The gfp-ponA containing EcoRI-HindIII fragment of pTB307 (this study) was ligated 
with similarly digested pTB238 [cat Plac::envC lacZ] to generate pCB1 [cat Plac::gfp-ponA].
pCB6:
	 pCB6 [attHK022 bla lacIq Para::gfp-ponB] was generated in 2 steps.
First, the ponB gene was amplified using the primers 5’-
GTACGGATCCGCCGGGAATGACCGCGAG-3’ and 5’-
GTCACTCGAGATGGGATGTTATTTTACCGGATGGC-3’. This PCR fragment was digested 
with BamHI and XhoI, and ligated into BamHI-SalI-digested pTB183 (Bendezú and de 
Boer, 2008) to create pMM5 [attHK022 bla lacIq Plac::gfp-ponB]. 
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pCB6 was then made by digesting pMM5 with NotI and XbaI, and ligating the resulting 
fragment into appropriately digested pTB265 ((45).
pCB7:
 To construct pCB7 [bla lacIq PT7::h-sumo-lpoB(21-213)], the primers 5’-
GGTGGTTGCTCTTCCGGTGTGGGGCAACGTGAACCTG-3’ and 5’-GTCACTCGAG 
TTATTGCTGCGAAACGGCACCTTT-3’ were used to amplify the part of the lpoB gene 
coding for LpoB residues 21 to 213.  This PCR product was then digested with the 
restriction enzymes SapI and XhoI, and ligated with appropriately digested pTB146 (6)) to 
generate the h-sumo fusion. 
pCB21:
	 pCB21 [kanR lacIq PT7::h-sumo-ponA] was constructed in 2 steps. 
The ponA gene was amplified with the primers 5’-
GGTGGTTGCTCTTCCGGTGTGAAGTTCG TAAAGTATTTTTTGATCCTTGCAGTCTG-3’ an 
5’-GTCAGAGCTCCAGCAAACTGAAAAGGC GCCGAAG-3’. The resulting fragment was 
digested with SapI and SacI, and ligated with appropriately digested pTB146 (6) to 
generate pCB2 [bla lacIq PT7::h-sumo-ponA]. In order to change the antibiotic resistance 
from Amp to Kan, pCB2 was digested with XbaI and NotI, and the resulting fragment was 
ligated with appropriately digested pET-28a-amiD (46), creating pCB21.
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pCB22:
	 pCB22 [kanR lacIq PT7::h-sumo-ponB] was constructed in 2 steps. 
The ponB gene was amplified with the primers 5’-GTCAGAGCTCATGGCCG 
GGAATGACCG-3’ and 5’-GTCACTCGAGTTAATTACTACCAAACATATCCTTGA 
TCCAACC-3’. The resulting fragment was digested with SacI and XhoI, and ligated with 
appropriately digested pTB146 (6) to create pCB17 [bla lacIq  PT7::h-sumo-ponA]. To 
change the antibiotic resistance from Amp to Kan, pCB17 was digested with XbaI and 
XhoI, and the resulting fragment was ligated with appropriately digested pET-28a-amiD 
(46), yielding pCB22.
pCB25:
 To generate pCB25 [bla lacIq  Plac::lpoB], the lpoB gene was amplified with his native 
RBS using the primers 5’-GTCATCTAGATTGTAAGGGGTGAATCTTGATGACAAA 
AATGAG-3’ an 5’-GTCAAAGCTTTTATTGCTGCGAAACGGCACCTTT-3’. The resulting 
fragment was digested with XbaI and HindIII, and ligated with appropriately digested 
pTB28 [bla lacIq Plac::amiC-gfp] (9). 
pCB28:
	 pCB28 [attHK022 bla lacIq Plac::lpoB-sfgfp] was constructed in 4 steps. 
pTB282 [attHK022 bla lacIq Plac::ssdsbA-linker-sfgfp] was generated with the 
synthetic oligomers 5’-TATGAAAAAGATTTGGCTGGCGCTGGCTGGTTTAG 
TTTTAGCGTTTAGCGCATCGGCGGCGCAGTATGAAGGATCCCAGCAG 
CTCGAGCCTTATGCGTCTGCGCAGCCTAGGCAA-3’ and 5’-GATCTTGC 
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CTAGGCTGCGCAGACGCATA AGGCTCGAGCTGCTGGGATCCTTCATAC 
TGCGCCGCCGATGCGCTAAACGCTAAAACTAAACCAGCCAGCGCCAGCCAAATCT
TTTTCA-3’. These oligomers were annealed; resulting in the formation of dsDNA 
with overhangs complementary to the NdeI and BamHI restriction sites. pTB225 
[attHK022 bla lacIq Plac::zipA-sfgfp] (45) was digested with NdeI and BamHI, and the 
resulting plasmid backbone was ligated with the complementary synthetic dsDNA.
 pTU137 [attHK022 bla lacIq Plac::cTAP] was generated by amplifying cTAP from 
pP30D -YTAP (48) using the primers 5’-GTCACCTAGGTCCATGGAAAAG 
AGAAGATGGAAAAAG-3’ and 5’-GTCAAAGCTTGTCGACTCAGGTTGACTT 
CCCCGCGG-3’. The resulting PCR fragment was digested with AvrII and HindIII, and 
ligated with appropriately digested pTB282. 
 To create pCB24 [attHK022 bla lacIq Plac::lpoB-cTAPtag], the lpoB gene was 
amplified with the primers 5’-CGTACCATATGACAAAAATGAGTCGCTACGCCTT-3’ an 5’-
GTCACTCGAGTTGCTGCGAAACGGCACC-3’. The resulting PCR fragment was digested 
with NdeI and XhoI, and ligated with appropriately digested pTU137. 
	 Finally, pCB24 was digested with NdeI and XhoI, and the resulting fragment was 
ligated with appropriately digested pTB282, creating pCB28.
pCB39:
	 The construction of pCB39 [bla lacIq PT7::h-lpoB(21-213)] involved many 
intermediates that will be described in 7 distinct steps. 
 pTB285 was made by site-directed mutagenesis of pTB277 [attλ cat Para] (45) in 
order to remove the BamHI restriction site present in the Para promotor region. 
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 pTB286 [attλ cat Pbad::ssdsbA-linker-sfgfp] was generated by digesting pTB282 
[attHK022 bla lacIq] with the restriction enzymes XbaI and HindIII, and ligating the resulting 
fragment into similarly digested pTB285.
 pTB288 [attλ cat Para::ssdsbA-blaN] was created by amplifying the blaN gene with 
the primers 5’-GTCACCTAGGCAAGATCCGGCTGGTCACCCAGAAACGCTGGTGAAAG-3’ 
and 5’-GTCAAAGCTTGTCGACTTAGCCAGTTAATAGTTTGCGCAACG-3’. This PCR 
product was digested with the restriction enzymes AvrII and HindIII, and ligated with 
appropriately digested pTB286.
 pTB292 [attλ cat Para::ssdsbA-cJUNCC-blaN] was generated using the synthetic 
oligonucleotides 5’-GATCCGCGAGCATTGCACGCCTGGAAGAGAAAGTTAAGA 
CCCTGAAAGCGCAGAATTATGAACTGGCGTCTACCGCGAACATGCTCCGTGAACAGGTTG
CGCAACTGGGTGCGCCGC-3’ and 5’-TCGAGCGGCGCACCCAGTTGCGCAACCTGTTC 
ACGGAGCATGTTCGCGGTAGACGCCAGTTCATAATTCTGCGCTTTCAGGGTCTTAACTTT 
CTCTTCCAGGCGTGCAATGCTCGCG-3’. These oligonucleotides were annealed, and the 
resulting dsDNA with overhangs for BamHI and XhoI was ligated with appropriately 
digested pTB288.
 To create pTB260 [bla lacIq  PT7::h-sumo-sfgfp], the sfgfp gene was amplified from 
pTB225 with the primers 5’-GTCACTCGAGGGTCCGGCTGGTCTGTCTAAAGGTGAAG-3’ 
and 5’-CTAGAAGCTTATTTGTAGAGCTCATCCATGCCGTG-3’. The resulting PCR product 
was digested with the restriction enzymes XhoI and HindIII and ligated with appropriately 
digested pTB146 (6).
 pCB13 [bla lacIq  PT7::h-sumo-sfgfp-lpoB(21-213)] was generated by amplifying the 
part of the lpoB gene coding for LpoB residues 21 to 213 using the primers 5’-
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GTCATGGATCCGTGGGGCAACGTGAACCTG-3’ and 5’-GTCAAAGCTTTT 
ATTGCTGCGAAACGGCACCTTT-3’. The resulting PCR product was digested with the 
restriction enzymes BamHI and HindIII, and ligated with appropriately digested pTB260.
 Finally, pCB39 [bla lacIq PT7::h-lpoB(21-213)] was generated by digesting pCB13 
with BamHI and HindIII, and ligating the resulting fragment with appropriately digested 
pTB292 [attλ cat Para::ssdsbA-cJUNCC-blaN].
pCB40:
 pCB40 [bla lacIq PT7::h-lpoA(28-678)] was constructed by amplifying the part of the 
lpoA gene coding for LpoA residues 28 to 678 using the primers 5’-
GTCATGGATCCGGCACCCATACTCC-3’ and 5’-GTACAAGCTTTGGTGGTTAACT 
GACGGGG-3’. This PCR product was digested with the restriction enzymes BamHI and 
HindIII, and ligated with appropriately digested pTB292 [attλ cat Para::ssdsbA-cJUNCC-
blaN]. 
pCB41:
 pCB41 [bla lacIq Plac::ssdsbA-lpoB(21-213)-sfgfp] was constructed by amplifying the 
part of the lpoB gene coding for LpoB residues 21 to 213 using the primers 5’-
GTCATGGATCCGTGGGGCAACGTGAACCTG-3’ and 5’-GTCACTCGAGTTGCTGC 
GAAACGGCACC-3’. The resulting PCR product was digested with the restriction enzymes 
BamHI and XhoI, and ligated with appropriately digested pTB282 [attHK022 bla lacIq 
Plac::ssdsbA-linker-sfgfp]. 
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pCB42:
 pCB42 [bla lacIq Plac:: ssdsbA-lpoA(28-678)-sfgfp] was constructed by amplifying 
the lpoA gene coding for LpoA residues 28 to 678 using the primers 5’-
GTCATGGATCCGGCACCCATACTCC-3’ and 5’-GTACCTCGAGACTGACGGG 
GACTACCTGAC-3’. The resulting PCR product was digested with the restriction enzymes 
BamHI and XhoI, and ligated with appropriately digested pTB282 [attHK022 bla lacIq 
Plac::ssdsbA-linker-sfgfp]. 
pCB62:
	 The construction of pCB62 [aadA Plac::ponA] involved many intermediates and will 
be described in 6 distinct steps. 
	 First, pTB287 [aadA Plac-con::ssdsbA-linker-SF-GFP] was generated by digesting 
pTB282 [attHK022 bla lacIq Plac::ssdsbA-linker-sfgfp] with XbaI and HindIII, and ligating the 
resulting fragment with appropriately digested pTB284. 
 pTB289 [aadA Plac-con::ssdsbA-blaC] was made by amplifying the blaC gene with 
primers 5’-GTCACCTAGGCAAGATCCGGCTGGTCTACTTACTCTAGCTTCCCGGCAAC-3’ 
and 5’-GTCAAAGCTTGTCGACAACTTGGTCTGACAGTTACCAATGC-3’. This PCR product 
was digested with the restriction enzymes AvrII and HindIII, and ligated with appropriately 
digested pTB287.
 pTD33 [aadA Plac-con::tolB-blaC] was created by amplifying the tolB gene with 
primers 5’-GTCATCTAGAGTGGGCCATCGGTCCAGATAAG-3’ and 5’-GTCA 
CTCGAGCAGATACGGCGACCAGGCAG-3’. This PCR product was digested with the 
restriction enzymes XbaI and XhoI, and ligated with appropriately digested pTB289.
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	 pCB56 [bla lacIq Plac::lpoA] was constructed by digesting pMM10 (this study) with 
XbaI and XhoI, and ligating this fragment with appropriately digested pFB120 [Plac::mreC-
LE] (5). 
	 pCB59 [aadA Plac::lpoA] was generated by digesting pCB56 with XbaI and HindIII, 
and ligating the resulting fragment with appropriately digested TD33.  
	 Finally, pCB62 [aadA Plac::ponA] was made by digesting pCB59 with XbaI and 
HindIII, and ligating the resulting fragment with appropriately digested TB309.
 
pCB72:
 pCB72 [aadA Plac::ponB] was constructed in 3 steps. First, pTD34 was made by 
amplifying the ponB gene using primers 5’-GTCATCTAGAGAAAATCGGGCTT 
TTGCGCCTG-3’ and 5’-GTCACTCGAGATTACTACC AAACATATCCTTGATCCAACCGG-3’. 
This PCR product was then digested with the restriction enzymes XbaI and XhoI, and 
ligated with appropriately digested pTB289 [aadA Plac-con::ssdsbA-blaC]. pCB20 [attλ cat 
Para::ponB-BlaN] was then generated by digesting pTD34 with the restriction enzymes XbaI 
and XhoI, and ligating the resulting fragment with appropriately digested pTB288 [attλ cat 
Para::ssdsbA-blaN]. 
	 Finally, pCB72 was made by digesting pCB20 with the restriction enzymes XbaI and 
XhoI, and ligating the resulting fragment with appropriately digested pCB59 [aadA 
Plac::lpoA]. 
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Synthetic lethal screens 
 Screens for mutants with a Sla or Slb phenotype were performed as described 
previously (7). For the Sla or Slb screens, TU121/pCB1 [ΔlacIZYA ΔponA/Plac::gfp-ponA 
lacZ] or TU122/pTU110 [ΔlacIZYA ΔponB/Plac::ponB lacZ], respectively were mutagenized 
with the EzTn-Kan transposome (Epicentre) as described previously (7) yielding libraries of 
40,000 or 75,000 independent mutants, respectively. Mutant libraries were then plated on 
LB plates supplemented with IPTG and X-gal (40 µg/ml) as described (7) to identify 
mutants causing a synthetic lethal defect. IPTG was used at 50 or 250 µM, respectively for 
the Slb and Sla screens. For the Slb screen, 30,000 colonies were screened yielding 16 
solid-blue isolates that displayed varying degrees of IPTG-dependent growth. For the Sla 
screen, 50,000 colonies were screened yielding 41 solid-blue isolates dependent on IPTG 
for growth. Transposon insertions were mapped using arbitrarily-primed PCR as described 
(7). Details of the mapping results for the Slb screen are presented in the Results section. 
For the Sla screen, 34/41 isolates had insertions mapping within ponB, while the remaining 
7 isolates had insertions mapping within lpoB. 
 Due to the high percentage ponB mutants isolated in the Sla screen, the screen 
was repeated with strain TU121(attCB6)/pCB1 [ΔlacIZYA ΔponA (Para::ponB)/Plac::gfp-
ponA lacZ], which contains an extra copy of ponB under control of the arabinose 
promoter. In this case, the screening plates also contained 0.1% arabinose. 
TU121(attCB6)/pCB1 was mutagenized with EzTn-Kan transposome (Epicentre) as above, 
yielding a library of approximately 100,000 independent mutants. We screened 35,000 
colonies and only isolated one sla mutant. It had a transposon insertion that mapped 
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within lpoB. The positions of insertions that mapped to lpoA and lpoB are presented in 
Table 2.4. 
Protein purification
 The PBP1 proteins were overexpressed and purified with a 6xHis-SUMO (H-SUMO) 
tag fused to their N-termini (6, 30, 34). The sequence of the affinity tag in all cases was 
MRGSHHHHHHMASG. PBP1a and PBP1b were purified from RosettaTM 2(DE3)/pCB21 
and RosettaTM 2(DE3)/pCB22; respectively. Overnight cultures were grown in LB 
supplemented with kanamycin (20 µg/ml), chloramphenicol (34 µg/ml) and glucose (0.2%). 
The cultures were diluted 1:100 into 4 L of LB supplemented with kanamycin (20 µg/ml) 
and chloramphenicol (34 µg/ml), and cells were grown at 37oC to an OD600 of 0.6. The 
cultures were cooled for 15 min at 4 oC before addition of IPTG to 1 mM and kanamycin at 
15 µg/ml. Cultures were then grown overnight at room temperature and the cells were 
harvested by centrifugation. Cell pellets were resuspended in 40 ml buffer A (20 mM Tris-
HCl 7.4, 150 mM NaCl, 1% CHAPS, 1 mM PMSF, 1 mM EDTA) and stored at -80oC. Cells 
were thawed and disrupted by passing them through a french pressure cell three times at 
10,000 psi. Cell debris and membranes were pelleted by centrifugation at 40,000 x g for 
30 mins at 4oC. 
	 PBP1a was efficiently solubilized with 1% CHAPS and was thus found in the soluble 
fraction whereas PBP1b remained in the insoluble fraction. For the PBP1a preparation, the 
supernatant was filter sterilized and kept at 4 oC prior to purification. To solubilize PBP1b, 
the pellet was resuspended in 10 ml of Buffer B (20 mM Tris-HCl pH 7.4, 1M NaCl, 2 % 
reduced Triton-X100), and incubated overnight at 4 oC with stirring. After a centrifugation 
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Table 2.4. Transposon mapping results. 
Tn allele gene positiona orientationb
sla33 lpoB(ycfM) after nt 512; second bp of codon 171 minus
sla44 lpoB(ycfM) after nt 140; second bp of codon 47 minus
sla96 lpoB(ycfM) after nt 466; first bp of codon 156 minus
sla98 lpoB(ycfM) after nt 124; first bp of codon 42 minus
sla99 lpoB(ycfM) after nt 324; third bp of codon 108 plus
sla104 lpoB(ycfM) after nt 324; third bp of codon 108 plus
sla148 lpoB(ycfM) after nt 140; second bp of codon 47 minus
sla8c lpoB(ycfM) after nt 565; first bp of codon 189 plus
slb30 lpoA(yraM) after nt 632; second bp of codon 211 plus
slb51 lpoA(yraM) after nt 131; second bp of codon 44 plus
aposition relative to first nt of target gene ATG codon.
borientation of KanR cassette transcription relative to target gene transcription.
callele isolated in screen with extra copy of ponB.
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at 40,000 x g for 30 mins at 4oC, the supernatant was filter sterilized and the pellet was 
resuspended in 7 ml of Buffer B for another round of solubilization. After centrifugation, the 
supernatant was filter sterilized and pooled with the supernatant from the first 
solubilization. 
	 H-SUMO-PBP1 proteins were purified by metal-affinity purification using ProPurTM 
IMAC midi spin columns (Nunc) according to the instructions. Columns were equilibrated 
in buffer C (20mM Tris, pH7.4, 500mM NaCl, 0.1% reduced Triton) with 10 mM imidazole, 
washed with buffer C containing 50 mM imidazole, and fusion proteins were eluted with 
buffer C containing 300 mM imidazole. The purified PBP1a and PBP1b proteins were 
dialyzed against buffer C and buffer D (20 mM Tris, pH7.4, 1 M NaCl, 0.1% reduced 
Triton), respectively. The H-SUMO tag was cleaved with 6xHis-tagged SUMO protease (H-
SP) as described (47), and protein preparations were concentrated using Amicon 
Centrifugal Filter Units (MWCO 10 KDa). Cleavage reactions were passed through Ni-NTA 
resin (ProPurTM IMAC midi spin column) to remove free H-SUMO and H-SP, yielding pure 
preparations of untagged PBP1 proteins. The columns were washed with buffer C 
containing 20 mM imidazole to completely recover the PBP1 proteins. The final PBP1a 
and PBP1b preparations were dialyzed against buffer C or D with 10% glycerol, 
respectively. Proteins were concentrated using Amicon Centrifugal Filter Units and stored 
at -80oC. 
  Similar to the PBP1s, untagged versions of LpoA(28-678) and LpoB(21-213) were 
prepared using H-SUMO fusions. LpoA was purified from RosettaTM/pLysRARE/pMM18 
cells. An overnight culture was grown in LB supplemented with ampicillin (50 µg/ml), 
glucose (0.2%) and chloramphenicol (10 µg/ml). The culture was diluted 1:100 into 1L LB 
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and grown to an OD600 of 0.56 at 37oC. IPTG was added to 1mM, and the culture was 
grown for 6 h at 30oC. Cells were harvested by centrifugation, pellets were resuspended in 
35 ml buffer E (50mM Tris-HCl pH 8.0, 300mM NaCl, 25mM imidazole, 10% glycerol), and 
stored at -80oC. Cells were thawed and disrupted by passing them through a french 
pressure cell two times at 15,000 psi. This was followed by centrifugation at 100,000 x g 
for 1 h at 4oC to pellet cell debris and membranes. The cell extracts were then loaded onto 
a 1 ml NiNTA FF column (GE Healthcare) pre-equilibrated with buffer E using an AKTA 
purifier 10 system. The column was washed with 39 ml buffer E, and the H-SUMO-LpoA 
fusion protein was eluted with a linear step gradient of 25mM imidazole to 1M imidazole in 
buffer E over 18 column volumes. The peak fractions containing the eluted protein were 
collected and dialyzed against buffer F (50mM Tris-HCl pH 8.0, 300mM NaCl, 10% 
glycerol). The H-SUMO tag was cleaved using H-SP and protein preparations were passed 
over 2 ml NiNTA agarose (Qiagen) equilibrated with buffer F. Purified LpoA was then 
dialyzed against buffer G (50mM Tris-HCl pH 8.0, 25mM NaCl, 10% glycerol). The isolated 
LpoA protein was then loaded onto a 6 ml Resource Q column (GE Healthcare) 
equilibrated with buffer G for anion exchange chromatography. LpoA was then eluted off 
the column using a linear gradient of 25mM NaCl to 1M NaCl in buffer G over 32 column 
volumes. Peak fractions of purified LpoA were collected and dialyzed against buffer H 
(50mM Tris-HCl pH 8.0, 150mM NaCl, 10% glycerol). This sample was then aliquoted and 
stored at -80oC.
 LpoB(21-213) was purified from BL21(DE3)/pCB7. An overnight culture of this strain 
was grown in LB supplemented with ampicillin (50 µg/ml) and glucose (0.2%). The culture 
was diluted 1:100 into 1 L of LB supplemented with ampicillin (50 µg/ml), and cells were 
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grown at 37oC to an OD600 of 0.6. IPTG was added to 1 mM and the culture was grown for 
6 h at 30oC. Cells were harvested by centrifugation, the pellet was resuspended in 30 ml 
buffer I (50 mM Tris-HCl 7.4, 500 mM NaCl, 20 mM imidazole) and stored at -80oC. Cells 
were thawed and disrupted by passing them through a french pressure cell two times at 
15,000 psi. Cell debris and membranes were pelleted by centrifugation at 100,000 x g for 
1 h at 4oC. The resulting extract was loaded onto a 1 ml NiNTA FF column (GE Healthcare) 
pre-equilibrated with buffer I using an AKTA purifier 10. The column was washed with 10 
ml buffer I and the H-SUMO protein fusion was eluted with a linear 20-250 mM gradient of 
imidazole in buffer I over 25 column volumes. Peak fractions containing the eluted proteins 
were pooled and dialyzed against buffer J (20 mM Tris-HCl pH 7.4, 150 mM NaCl). The H-
SUMO tag was cleaved with H-SP and the protein preparation was passed over 1ml 
NiNTA resin (Qiagen) equilibrated with buffer J. The  isolated LpoB in the flow through was 
concentrated using Amicon Centrifugal Filter Units (MWCO 10 KDa) and stored at -80oC in 
buffer J containing 10 % glycerol.
 6xHis-tagged versions of LpoA [H-LpoA(28-678)] and LpoB [H-LpoB(21-213)] were 
purified from BL21(DE3)/pCB39 and pCB40, respectively. Overnight cultures were grown 
in LB supplemented with ampicillin (50 µg/ml) and glucose (0.2%). The cultures were 
diluted 1:100 into 0.5 L of LB supplemented with ampicillin (50 µg/ml), and cells were 
grown at 37oC to an OD600 of 0.6. IPTG was added to 1 mM and cultures were grown for 3 
h 30 mins at 30oC. Cells were harvested by centrifugation, pellets were resuspended in 15 
ml of buffer I and stored at -80oC. Cells were thawed and disrupted by sonication after 
addition of Bacterial Protease ArrestTM (G Biosciences) according to the instructions. Cell 
debris and membranes were pelleted by centrifugation at 100,000 x g for 1 h at 4oC. 
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Proteins were purified using ProPurTM IMAC mini spin columns (Nunc) according to the 
instructions. Columns were equilibrated in buffer I with 10 mM imidazole, washed with 
buffer E containing 50 mM imidazole, and eluted with buffer I containing 300 mM 
imidazole. The purified H-LpoA(28-678) and H-LpoB(21-213) proteins were concentrated 
using Amicon Centrifugal Filter Units and stored at -80oC in buffer J containing 10 % 
glycerol.
Antibody preparation
	 Polyclonal antibodies against PBP1a, PBP1b, LpoA, and LpoB were prepared by 
Covance Custom Immunology. Untagged proteins prepared as described above were 
used in their standard antibody production service. 
Biochemical Assays
 In vitro PG synthesis was measured in ether-permeabilized (EP) cells as described 
previously with modifications (33). Ether-treated cells (0.18 mg protein) prepared from 
cultures grown to an OD600 of 0.4-0.5 were first incubated with or without 4 µM LpoB on 
ice for 1 h in 100 µl of reaction buffer (50 mM Tris-HCl pH 8.3, 50 mM NH4Cl, 20 mM 
MgCl2, and 1 mM DTT). The reaction was initiated by addition of 4 nmol of UDP-M-
pentapeptide (gift from Kyoko Suefuji and James T. Park) and 0.33 nmol of UDP-[14C]G 
(300 mCi/mmol; American Radiolabeled Chemicals), followed by incubation at 30˚C for 1 
h. The reaction was terminated by addition of 0.4 ml of heated 5% SDS and the samples 
were incubated at 100˚C for 30 min. The SDS insoluble material was collected on filters 
(Durapore 0.22 µm membrane filter, Millipore), washed with water, and dried. The dry filters 
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were then immersed in 3 ml of Ecolite(+)TM (MP biomedicals) and the radioactivity was 
quantified by scintillation counting.
 For transglycosylase assays, [14C]GlcNAc-labeled lipid II (4-8 μM), prepared as 
described previously (53), was incubated in buffer containing 50 mM Hepes at pH 7.5, 10 
mM CaCl2, 1,000 units/ml penicillin-G and 20% DMSO.  LpoB (50 nM), LpoA (50 nM) or an 
equal volume of storage buffer was added prior to addition of PBP1a or PBP1b (50 nM), 
which initiated the reaction. Reactions were quenched with an equal volume of ice-cold 
10% Triton X-100 at indicated time points (1 – 6 min). Conversion into PG was measured 
as described previously (15). Briefly, reactions were spotted on cellulose chromatography 
paper (3MM Whatman). Substrates and products were separated with isobutyric acid/1 M 
NH4OH (5:3) and quantified by liquid scintillation counting (Beckman LS 6000). The 
enhancement of PBP1b PGT activity by LpoB was repeated eight times resulting in an 
average activation of 1.5x. The activation observed in panel B of Figure 2.12 was 1.5x.
 To analyze glycan strand lengths, PBP reactions with or without added lipoprotein 
were carried out as described above, except for differing preincubation procedures and 
higher protein concentrations. PBPs (0.4 µM) were preincubated with or without 
lipoproteins (0.4-0.8 µM as indicated in Figure 2.12) at 4°C for 15 min. Reactions were 
initiated upon addition of protein(s) to lipid-II (4 µM) and incubated at RT for 5 min prior to 
heat inactivation (90°C, 5 min). Gel electrophoresis analysis was carried out as described 
previously (4). Briefly, samples were dried and resuspended in sample  buffer (125 mM 
Tris-HCl (pH = 6.8), 40% glycerol, 9% SDS (sodium dodecyl sulfate), 0.004% 
bromophenol blue) before being loaded onto a 20 × 20 cm gel (9% acrylamide, 1 mm 
thick) and separated at 30 mA until the dye front was 1.5 cm from the bottom.  Gels were 
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dried overnight, and exposed to a phosphorimager screen for >1 week. Imaging was 
performed with a Typhoon phosphorimager (GE Healthcare).
Bocillin labeling
 Cultures of TB28, TU121, TU122, MM8 and CB6 were grown overnight in LB at 
37oC. The cultures were diluted 1:200 into 50 ml LB and were grown to an OD600 between 
0.48 to 0.61 at 37°C. TB28, MM8 and CB6 cultures were grown in duplicate. Cell cultures 
were normalized to an OD600  of 0.48, the cells harvested by centrifugation at 4oC, and then 
resuspended in 1080 µl cold phosphate-buffered saline (PBS). Phenylmethylsulfonyl 
fluoride (G Biosciences) was added to a final concentration of 1 mM, and Bocillin-FL 
(Invitrogen) was added to a final concentration of 10 µM. Cell suspensions were mixed by 
vortexing, and polymixin B (Amresco) was then added to a final concentration of 500 µg/
ml. Suspensions were again mixed by vortexing and then incubated 1.5 hours at 37oC with 
rotation. Suspensions were then washed three times with cold PBS and resuspended in 
250 µl of PBS. Cell extracts were prepared by adding 250 µl 2X Laemmli sample buffer 
and incubating at 95oC for ten minutes. Whole cell extracts were separated on a 10% SDS 
polyacrylamide gel in the dark. The protein gels were rinsed with water immediately 
following electrophoresis and the labeled PBPs were visualized using a fluorescence 
imager (Typhoon 9400™, GE Healthcare) (excitation at 488 nm and emission at 526 nm).
Immunoblotting
 For Figure 2.5, cultures of TB28, TU121, TU122, MM8 and CB6 were grown 
overnight in LB media at 37°C. The cultures were diluted 1:100 in 8 ml of LB (with 
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duplicates of TB28, MM8 and CB6) and grown at 37°C to an OD600 between 0.4 to 0.6. 
Cells were harvested by centrifugation at 4°C and resuspended in PBS and 2X Laemmli 
sample buffer. Samples were incubated at 95°C for 10 min. For Figure 2.7, cells of MM13 
[Para::ponB ΔlpoA] (C) or CB4(attλTB309) [ΔponA ΔlpoB(Para::ponA)] (D) containing the low-
copy plasmids pTB284 [Plac-con::gfp], pCB62 [Plac-con::ponA], or pCB72 [Plac-con::ponB] were 
grown to an OD600 of 0.5-0.7 in LB-Ara-Spc (C) or M9-Ara-Spc (D) at 37oC. They were then 
washed, diluted into LB-IPTG(1 mM), and growth at 37oC was followed as in (B). At time 
points indicated by the arrows in (C) and (D), whole cell extracts were prepared from the 
growing cultures. For both experiments, the total protein concentration of the cell extracts 
was measured using the Non-Interfering™ Protein Assay (G Biosciences). As indicated in 
the figures, various quantities of total protein from each extract were separated on a 10% 
acrylamide gel and transferred to Protran® nitrocellulose membranes (Whatman, 0.22μm). 
Processing of the immunoblots was performed essentially as described previously (9). 
PBP1a and PBP1b antisera were used at a dilution of 1:10,000. 
PBP and Lpo protein copy number determination
	 To determine the copy numbers of PBP1a, PBP1b, LpoA and LpoB per cell, four 
independent cell extract preparations of TB28 [WT] were analyzed by immunoblotting with 
specific antibodies raised against the purified proteins. 
 Cells of TB28 [WT] were grown overnight in LB at 37oC and diluted 1:100 into 50 ml 
of LB. Four independent cultures were grown at 37oC to an OD600 of 0.5 and the colony 
forming units (cfu) of each culture were determined by plating serial dilutions on LB plates 
in duplicate. Cells of TU121 [ΔponA], TU122 [ΔponB], MM22 [ΔlpoA] and CB26 [ΔlpoB] 
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were also grown under the same conditions. Cells were harvested by centrifugation, 
resuspended in 0.625 ml of PBS and mixed 1:1 with 2x Laemmli sample buffer. Cells were 
disrupted by sonication after the addition of PMSF and EDTA to 1 mM, and extracts were 
heated at 100oC for 10 min. Total protein concentrations were determined using the Non-
interferingTM Protein Assay (G Biosciences) according to the instructions. Cell extracts 
were diluted to 1 mg/ml using a 1:1 PBS:Laemmli sample buffer solution and stored at 
-80oC. 
 To determine the amount of PBP1a, PBP1b, LpoA and LpoB in each of the four 
TB28 [WT] extracts, 5, 10 and 20 µg of total protein were loaded on 12 % SDS-
polyacrylamide gels along with increasing amounts of purified (untagged) PBP1a, PBP1b, 
LpoA or LpoB mixed with 10 µg of total protein from extracts of TU121 [ΔponA], TU122 
[ΔponB], MM22 [ΔlpoA] or CB26 [ΔlpoB], respectively. Proteins were transfered to PVDF 
membranes (Westran S, 0.22μm) and PBP1a, PBP1b, LpoA or LpoB were detected with 
rabbit antisera prepared against the purified proteins essentially as described previously 
(9). Membranes were blocked with Rapid Block (Amresco) according to the instructions, 
and incubated with the specific antisera diluted 1:10,000 for 30 minutes at room 
temperature.  After washing, blots were incubated with with goat anti-rabbit IgG 
conjugated with horseradish peroxidase (Sigma) diluted 1:35,000. Following incubation at 
room temperature for 30 minutes, blots were washed again and developed using the 
Super Signal West Pico (Pierce) chemiluminescent detection system. Bands were 
visualized with a BioRad Chemidoc XRS, and intensities were quantified using Adobe 
Photoshop. A standard curve plotting signal intensity versus protein concentration was 
generated for the purified protein samples and was used to determine the concentration of 
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protein in the TB28 extracts. The cell titers determined for each culture were then used to 
calculate the number of molecules per cell. 
Preparation of sacculi and muropeptide analysis
 Overnight cultures of TB28, MM10 and MM26 were grown in 2 mL LB, LB-
arabinose or LB-50μM IPTG, respectively. The cultures were then diluted 1:100 into 50 mL 
of LB (with inducer, as needed). Cultures were grown to an OD600 between 0.32 to 0.57 
(from all sets) at 37oC. Cells were harvested and washed three times with LB to remove 
inducer. The cells were then used to inoculate 500mL of LB + 0.2% glucose to achieve a 
final OD600 of 0.02. MM10 and MM26 cells were harvested by centrifugation just before the 
onset of lysis (OD600 of 0.31 and 0.29, respectively). TB28 [WT] control cells were similarly 
harvested at an OD600 of 0.30. Cell pellets were resuspended in 10 mL ice-cold 1X PBS. 
Sacculi were then prepared essentially as described by Uehara et al. (2009) with the 
following modifications. The PG preparations were treated with α-chymotrypsin (300 μg/
ml, final concentration) and incubated for at least 8 h at 37oC. The preparations were then 
treated again with α-chymotrypsin and incubated overnight at 37oC. After this incubation, 
5% SDS was added to a final concentration of 1%, followed by incubation at 65oC for at 
least 8 h. Following several washes with water, sacculi were then resuspended in water 
containing 0.02% sodium azide to a final concentration of about 109 sacculi/ml. Two or 
three independent sacculi preparations were analyzed for each strain (see Table 2.1). 
Muropeptide analysis was performed as described by (45).
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Cytological assay for membrane localization
 Cultures of the cells in Figure 2.10 were grown to mid-log in M9-Arabinose 
supplemented with 100 µM IPTG. Cells were harvested by centrifugation, washed in M9-
Arabinose, resuspended in plasmolysis buffer [15% sucrose, 25mM HEPES (pH 7.4), 
20mM sodium azide], and immediately imaged using phase contrast and GFP optics. 
Membrane Fractionation 
	 An overnight culture of TB28 [WT] was diluted 1:100 into 750 ml of LB and grown at 
37oC to an OD600 of 0.6. Cells were harvested by centrifugation at 5,000 xg for 10 minutes 
at 4oC. They were then resupended in 20 mM Tris-HCl pH 8.0 with 0.1 mg/ml DNaseI and 
passed through a french pressure cell twice at 16,000 psi. The resulting lysate was 
centrifuged at 10,000 xg for 10 minutes at 4oC to remove cell debris. The supernatant was 
then centrifuged at 100,000 xg for 60 minutes to pellet membranes. Membrane pellets 
were resuspended in 20 mM Tris-HCl 10% glycerol and then immediately loaded onto a 
sucrose step gradient (from bottom: 3.3 ml 2.2 M, 4 ml 1.44 M, 4 ml 0.77 M sucrose) and 
centrifuged at 100,000 xg for 17 hours at 4oC. Fractions (1 ml) were removed from the top 
of the gradient (#1-11; top to bottom). NADH oxidase activity was measured in each 
fraction as described previously (36). The proteins in each fraction were separated on an 
SDS-polyacrylamide gel. Total protein was detected by coomassie staining, and LpoA or 
LpoB were detected by immunoblotting as described above.  
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Summary
	 To fortify their cytoplasmic membrane and protect it from osmotic rupture, most 
bacteria surround themselves with a peptidoglycan (PG) exoskeleton synthesized by 
the penicillin-binding proteins (PBPs). We recently identified the Escherichia coli outer 
membrane lipoprotein, LpoB, as a PBP cofactor that forms a specific trans-envelope 
complex with PBP1b and is critical for LpoB function in vivo. To investigate the role of 
LpoB further, we sought to identify PBP1b* variants that would no longer require LpoB 
for their function. To isolate ponB* alleles encoding PBP1b* variants, we took 
advantage of the cefsulodin hypersensitive phenotype shared by ponB and lpoB 
mutants. We reasoned that the cefsulodin hypersensitivity of lpoB mutants results from 
a defect in PBP1b activity. Therefore, ponB* alleles with partially restored PBP1b 
function might be isolated by selecting for lpoB mutants with increased cefsulodin 
resistance. Using this strategy, several PBP1b* variants were isolated. Characterization 
of these mutants suggests that LpoB possesses a cellular function in addition to its 
role in promoting PBP1b activity.
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Introduction
 The peptidoglycan (PG) layer is a large, tough polysaccharide matrix that fortifies 
the cell membrane against internal osmotic pressure (13). This complex macromolecule 
is composed of glycan strands crosslinked by attached peptide chains to form a dense 
meshwork that provides structural integrity and shape to the bacterium (13, 24). The 
glycan strands are composed of alternating sugar subunits N-acetylglucosamine 
(GlcNAc) and N-acetylmuramic acid (MurNAc) that are linked by β(1,4)-glycosidic 
bonds (13, 27). Attached to each MurNAc sugar is a pentapeptide (pep5) chain (13). 
 The pathway for PG biogenesis occurs in three main stages and spans multiple 
cellular compartments. To build the basic monomeric unit of PG, MurNAc(pep5)-
GlcNAc, the activated sugar UDP-GlcNAc is first converted to UDP-MurNAc. After 
sequential addition of the pep5 by a series of cytoplasmic steps the essential enzyme, 
MraY, transfers phosho-MurNAc(pep5) from UMP to undecaprenyl-phosphate to form 
Lipid I at the cytoplasmic surface of the inner membrane (IM). GlcNAc is then added to 
Lipid I by MurG to form Lipid II, which is then flipped to the periplasmic face of the IM 
(26). Once exposed to the periplasm, this monomeric unit is polymerized and 
crosslinked into the existing PG layer by the cellular PG synthases called the high 
molecular weight penicillin-binding proteins (PBPs), the targets of β-lactam antibiotics 
like penicillin (20).
	 One class of PBPs are bifunctional enzymes that polymerize glycan strands and 
crosslink them using their peptidoglycan glycosyl transferase (PGT) and transpeptidase 
(TP) domains, respectively (10, 20). Because these enzymes have both activities, they 
are thought to be the primary PG synthetic enzymes in the cell (10, 20). These purified 
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PBPs retain low PG synthetic activity in vitro in the absence of additional components 
(2, 6). However, in vivo they are part of large multi-enzyme complexes organized by 
cytoskeletal elements that build the PG mesh that surrounds the cell (Figure 3.1).
	 Two distinct complexes are associated with the different phases of PG 
construction in rod-shaped bacteria: elongation and division (7, 8). During elongation, a 
complex organized by the actin-like MreB protein inserts along the cylindrical portion of 
the PG layer (7, 8). The mode of PG growth then switches to a concentrated zone of 
synthesis at the site of cell division (7, 8, 16). Here, the tubulin-like protein FtsZ directs 
an array of proteins to facilitate cell division and PG synthesis (7). While it is known that 
these cytoskeletal elements and their associated complexes play major roles in PG 
biogenesis, we currently know very little about how they promote PG assembly.
	 A major outstanding question has been whether or not the PG synthetic 
complexes contain factors that directly modulate PBP activity. Genetic analysis of PBP 
activity and regulation has been hindered by functional redundancy. One example of 
this is the overlapping functions shared by the three E. coli bifunctional PBPs: PBP1a, 
PBP1b, and PBP1c. Loss of any of these proteins is not lethal. However, simultaneous 
loss of PBP1a and PBP1b results in rapid cell lysis and death (28). Based on this, we 
reasoned that we could identify critical factors required for PBP function by performing 
a screen for mutants synthetically lethal with the loss of either PBP1a or PBP1b. For 
example, factors required to promote PBP1a activity could be identified by screening 
for mutants synthetically lethal with the loss of PBP1b. The converse is also true. Using 
this genetic strategy, we recently identified two outer membrane lipoproteins, LpoA and 
LpoB, as essential PBP cofactors in E. coli (19). These factors were found to directly 
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interact with their cognate PBP to form specific trans-envelope complexes that are 
critical for PBP function in vivo (19). Importantly, biochemical studies demonstrated 
that LpoB enhances both the PGT and TP activities of its cognate PBP (PBP1b) in vitro 
(19, 25). Our results thus suggest that PBP activity is indeed modulated in the multi-
enzyme PG synthetic complexes and that the PBPs in Gram-negative bacteria are 
likely receiving regulatory input from both membranes: cytoskeletal proteins in the IM 
and the Lpo factors in the outer membrane (OM).  
	 To further investigate the in vivo function of LpoB and the physiological 
significance of the observed effects of LpoB on PBP1b activity in vitro, we developed a 
genetic selection and screening strategy to identify PBP1b variants that bypass the 
functional requirement for LpoB. Characterization of these mutants suggests that LpoB 
possesses a cellular function in addition to its role in promoting PBP1b activity. Also, 
the activity of one of the variants suggests a possible mechanism by which LpoB might 
modulate the PGT activity of PBP1b.
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Figure 3.1. Multi-enzyme PG synthetic complex. The schematic above shows one of 
the multi-enzyme complexes involved in the final stages of PG assembly. This complex 
contains PBP1b (a class A PBP) and LpoB. The other PG assembly factors thought to 
participate at this step are not specifically labeled. Also previously we have shown that 
LpoB activates the PGT activity of PBP1b (as illustrated by the arrow). PG, 
peptidoglycan; OM, outer membrane; IM, inner membrane; M, N-acetylmuramic acid; 
G, N-acetylglucosamine; PGT, peptidoglycan glycosyltransferase domain; TP, 
transpeptidase domain. Dots represent the peptides attached to M.
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Results
Identification of PBP1b* variants that bypass the LpoB requirement for activity. To 
identify variants of PBP1b (designated PBP1b*) that no longer require LpoB for activity, 
we took advantage of a cefsulodin-hypersensitivity phenotype shared amongst ponB 
(the gene encoding PBP1b) and lpoB mutants. In these strains, the MIC for cefsulodin 
(a β-lactam that preferentially binds PBP1a/b) is approximately 1000-fold lower than 
that for wild-type (19). We reasoned that the cefsulodin hypersensitivity of lpoB 
mutants likely results from a defect in PBP1b activity and that ponB* alleles encoding 
PBP1b* variants might be identified by a selection for increased cefsulodin resistance 
in a LpoB- strain background. Therefore, cells of MM33(attλTB309) [ΔlpoB ΔponA 
(Para::ponA)] were plated at 30˚C on M9-arabinose agar supplemented with 0.01 µg/ml 
cefsulodin for the isolation of spontaneous drug resistant mutants (Figure 3.2A). 
Survivors plated with an efficiency of 10-8 relative to growth on agar lacking cefsulodin. 
Even though survivors were isolated at a low frequency, we suspected that a high 
background of uninteresting mutants might be isolated along with mutants with ponB* 
alleles, including those possessing PBP1a* variants with a reduced affinity for 
cefsulodin and/or mutants that overexpress drug efflux pumps. We specifically used 
MM33(attλTB309) to distinguish between these possibilities. This strain lacks LpoB and 
its only copy of ponA is under arabinose promoter control. Thus, growth of the parental 
strain is arabinose-dependent because the loss of both LpoB and PBP1a activity 
results in a synthetic lethal phenotype. We used this phenotype to our advantage and 
screened the cefsulodin resistant survivors for growth in the absence of PBP1a. 
Survivors that produce cefsulodin-resistant PBP1a variants or overproduce efflux
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Figure 3.2. Cefsulodin selection and arabinose-independency screen. The strategy 
for the selection and subsequent screen is diagrammed in (A). See text for details. 
Survivors that grew in the presence of 0.01 µg/ml of cefsulodin were patched onto M9 
media containing either 0.2% arabinose or 0.2% glucose. An example plate incubated 
at 37˚C of this step is shown in (B).
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pumps will be arabinose-dependent for growth because PBP1a activity will remain 
required for growth in the absence of LpoB-stimulated PBP1b activity. Mutants 
producing PBP1b* variants, on the other hand, should grow without arabinose because 
the PBP1b synthetic pathway will be functional without LpoB, eliminating the synthetic 
lethality of the PBP1a-/LpoB- combination. 
 We isolated approximately 600 mutants resistant to 0.01 µg/ml cefsulodin, and 
patched them on M9 agar supplemented with either 0.2% glucose or 0.2% arabinose 
(example shown in Figure 3.2B). Sixteen arabinose-independent mutants were 
identified, bringing the overall frequency of mutant isolation to approximately 10-10 
suggesting that only specific missense mutations confer the LpoB-bypass phenotype. 
We sequenced the ponB gene from all of the arabinose-independent isolates and 
found that they all possessed missense mutations such that they encoded PBP1b* 
variants with one of five substitutions (E313D, I202F, Q411R, Q411K and Q447K ) 
(Table 3.1). The ponB* mutants producing PBP1bI202F and PBP1bQ447K were 
temperature-sensitive, displaying the LpoB-bypass phenotype at 30°C, but not 37°C or 
42°C. To determine if the expression of these variants is sufficient for suppression of 
the LpoB-/PBP1a- synthetic lethality, we generated gfp-ponB or gfp-ponB* expression 
constructs in which the fusion was under control of the lactose promoter (Plac). The 
constructs were integrated into the chromosome of strain MM33(attλTB309) [ΔlpoB 
ΔponA (Para::ponA)] at the HK022 att site. The production of all GFP-PBP1b* variants 
allowed growth of MM33(attλTB309) on media lacking arabinose (LpoB-/PBP1a- 
conditions) whereas the production of GFP-PBP1b(wild-type) did not (Figure 3.3).
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Table 3.1. Mapping results of arabinose-independent isolates.
ponB* allele Gene Mutation
Amino acid 
substitutiona
Temperature 
isolated
ponB*39 ponB CAG ➝ CGG Q411R 37˚C
ponB*65b ponB ATC ➝ TTC I202F 30˚C
ponB*222b ponB GAG ➝ GAT E313D 37˚C
ponB*414b ponB ATC ➝ TTC I202F 30˚C
ponB*425 ponB CAG ➝ AAG Q447K 30˚C
ponB*426 ponB CAG ➝ AAG Q447K 30˚C
ponB*440 ponB CAG ➝ AAG Q411K 37˚C
ponB*496b ponB ATC ➝ TTC I202F 30˚C
ponB*498 ponB CAG ➝ AAG Q447K 30˚C
ponB*519b ponB GAG ➝ GAT E313D 37˚C
ponB*528 ponB CAG ➝ AAG Q447K 30˚C
ponB*536 ponB CAG ➝ AAG Q447K 30˚C
ponB*567 ponB CAG ➝ AAG Q447K 30˚C
ponB*583 ponB CAG ➝ AAG Q447K 30˚C
ponB*698 ponB CAG ➝ AAG Q447K 30˚C
ponB*699 ponB CAG ➝ AAG Q447K 30˚C
! aPosition relative to first codon of target gene ATG codon
! bAlleles isolated independently.
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Figure 3.3. The PBP1b* variants isolated suppress the PBP1a-/LpoB- synthetic 
lethal defect in trans. The parent strain from the selection and its derivatives were 
struck out on the minimal media plates indicated above. Plates in the top row were 
incubated at 30˚C while those in the bottom row were incubated at 37˚C. 
TU121(attλTB309) [ΔponA (Para::ponA)] in section 1 grows in all cases, as expected. 
MM33(attλTB309) [ΔponA ΔlpoB (Para::ponA)] in section 2 exhibits a synthetic lethal 
phenotype when grown under nonpermissive conditions. All other strains are derivatives 
of MM33(attλTB309) [ΔponA ΔlpoB (Para::ponA) (Plac::ponBγ*)] (3). The versions of 
PBP1b expressed in each section are: PBP1bwild-type (3); PBP1bQ411R (4); PBP1bI202F (5); 
PBP1bE313D (6); PBP1bQ447K (7). The suppression of the PBP1a-/LpoB- synthetic lethal 
phenotype is suppressed only when the PBP1b* variants are expressed with 500 μM 
IPTG. 
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We therefore conclude that the production of any of the PBP1b* variants identified in 
the above selection-screen is sufficient for the LpoB-bypass phenotype. 
Two classes of PBP1b* variants were identified. The ponB* alleles encode PBP1b* 
variants with amino acid substitutions that map to two different regions of the E. coli 
PBP1b crystal structure (22) (PDB: 3FWL, Figure 3.4). One substitution, E313D, 
changes a residue in the PGT domain that is present at the end of the presumed 
channel for growing glycan strands (Figure 3.4A and B). The other substitutions, 
however, clustered near the UB2H (UvrB domain 2 homolog) domain (Figure 3.4A and 
B), a newly evolved domain in the Enterobacteriaceae that folds between the PGT and 
TP domains of PBP1b (22, 25). Previous work by Typas et al. showed that LpoB binds 
to PBP1b through this domain (25). Thus, it is the LpoB-UB2H interaction that is likely 
responsible for PBP1b activation by LpoB. An attractive possibility is that the PBP1b* 
variants with substitutions near UB2H adopt an “activated” conformation that mimics 
that achieved upon association with LpoB (see Discussion). 
 To determine if the different PBP1b* variants could support the growth of LpoB- 
cells in the complete absence of PBP1a activity, as opposed to PBP1a depletion, we 
attempted to transduce a ΔponA::KanR allele into cells of CB7 [ponBWT ΔlpoB], MM47 
[ponBQ411R ΔlpoB], MM48 [ponBI202F ΔlpoB] and MM49 [ponBE313D ΔlpoB)]. Only 
transductions with MM49 [ponBE313D ΔlpoB)] yielded kanamycin resistant 
transductants. Because we could not obtain transductants in MM47 or MM48, we 
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Figure 3.4. Location of substitutions in PBP1b* variants. (A) Domain structure of 
PBP1b. Designation of domain boundaries are based on the crystal structure of E. coli 
PBP1b (PDB: 3FWM) and literature review. (Legend continued on next page.)
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Figure 3.4 (Continued). (B) Crystal structure of E. coli PBP1b with the location of the 
mutated residues highlight in red (PDB: 3FWM). The domains of PBP1b are colored as 
in (A). The PGT lipid II substrate channel and the TP active site are indicated. (C) Inset 
of the red box in (B). The mutated residues are highlighted in red with the residues 
listed above. (D) Sequence alignment of PBP1b homologs in organisms with LpoB 
homologs. Residues mutated (red) in the cefsulodin selection/arabinose-independency 
screen are well conserved amongst these species.
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thought PBP1b* expression could potentially be reduced in these strain backgrounds. 
However, western blot analysis confirmed that all PBP1b* variants were present at 
approximately wild-type (WT) levels (Figure 3.5). Similar results were obtained for 
transductions with a ΔlpoA::KanR allele, indicating that in the absence of LpoB, 
PBP1bE313D can support growth without PBP1a activity. The PBP1bI202F and 
PBP1bQ411R variants, on the other hand, appear to require basal level production of 
PBP1a from Para::ponA to support growth. Thus, two classes of PBP1b* variants were 
identified with different levels of LpoB-bypass activity in vivo. A substitution in the PGT 
domain results in full suppression of the LpoB-/PBP1a- phenotype, while substitutions 
near the UB2H domain only partially suppress this phenotype.
PG synthetic activity of the PBP1b* variants in vitro. Lipid II, the PBP1 substrate, is 
made from the activated sugar precursors UDP-N-acetylmuramic acid-pentapeptide 
(UDP-MurNac-pep5) and UDP-GlcNAc in the cytoplasm of the bacterial cell. This 
substrate is then flipped to the periplasm where it can be used by the PG synthetic 
machinery to make PG (see Introduction and Figure 3.1). PG synthesis can be 
monitored in ether-permeabilized cells (EPCs) by supplying them with purified UDP-
MurNAc-pep5 and radiolabelled UDP-[14C]GlcNAc and monitoring the incorporation of 
label into the SDS-insoluble PG fraction (18). EPCs made from PBP1b- mutants are 
defective in label incorporation, thus suggesting a major role for PBP1b during PG 
synthesis in the cell (14, 15, 23). We previously showed that ΔlpoB EPCs phenocopy 
PBP1b- cells and have dramatically 
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Figure 3.5. PBP1b* variants are expressed at wild-type PBP1b levels in vivo. To 
determine the extent of overproduction of PBP1b (wild-type and variant) in strains used 
for in vivo studies, cell extracts were prepared from MG1655 [wild-type], CB2 [ΔponB], 
CB7 [ΔlpoB], MM41 [ponB(Q411R)], MM42 [ponB(I202F)], MM43 [ponB(E313D)], MM47 
[ponB(Q411R) ΔlpoB], MM48 [ponB(I202F) ΔlpoB], and MM49 [ponB(E313D) ΔlpoB]. 
Cells were grown in LB at 30˚C in duplicate (as indicated by the number above lanes) to 
an OD600 = 0.33 to 0.71. Immunoblot analysis was then performed to determine the 
levels of PBP1b variant relative to the corresponding wild-type control. 15 μg of total 
protein was loaded in each lane. Numbers below each set of replicates indicate 
percent of PBP1b* variant levels present relative to WT control (at 100%).
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reduced PG synthetic activity, indicating that LpoB is required for PBP1b synthetic 
activity in EPCs (19). 
	 If the PBP1b* variants are LpoB-independent, they should exhibit WT levels of 
PG synthetic activity in the absence of LpoB. To determine if the PBP1b* LpoB-bypass 
variants exhibit WT levels of activity, we prepared EPCs from cells expressing 
PBP1b(WT) or PBP1b* (the same strains used above) with or without LpoB. PBP1bE313D 
EPCs lacking LpoB exhibited similar levels of PG synthetic activity to EPCs prepared 
from WT cells, where both PBP1b(WT) and LpoB are expressed (Figure 3.6A). 
However, EPCs prepared from LpoB- cells producing PBP1bQ411R or PBP1bI202F 
showed low-level PG synthetic activity comparable to LpoB- cells producing 
PBP1b(WT) (Figure 3.6A and B). Thus, the biochemical results parallel the genetic 
studies. The relatively strong bypass allele, PBP1bE313D retains PG synthetic activity in 
the absence of LpoB whereas the weaker alleles do not.
The PBP1b* variants are not fully LpoB-independent. Using the EPC assay, we 
showed that PBP1bE313D retained PG synthetic activity in the absence of LpoB in vitro. 
We therefore wondered if it was fully LpoB-independent in vivo. To investigate this, we 
determined whether production of the PBP1bE313D variant suppressed phenotypes 
associated with a LpoB- defect other than the synthetic lethality with the loss of PBP1a 
function. One such phenotype is an increased frequency of lysed cells observed in 
colonies of PBP1b- or LpoB- mutants (Figure 3.7B and C). When cells from these 
colonies are suspended in saline solution and visualized by phase contrast microscopy, 
phase-light “cell ghosts” indicative of cell lysis are observed at a low but reproducible 
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Figure 3.6. PG synthesis in ether-permeabilized (EP) cells. EP cells were prepared 
from MG1655 [wild-type], CB2 [ΔponB], CB7 [ΔlpoB], MM41 [ponB(Q411R)], MM42 
[ponB(I202F)], MM43 [ponB(E313D)], MM47 [ponB(Q411R) ΔlpoB], MM48 [ponB(I202F)  
ΔlpoB], and MM49 [ponB(E313D) ΔlpoB] at either 37˚C (A) or 30˚C (B). Reactions were 
initiated with the addition of UDP-MurNAc-pentapeptide (40 μM) and UDP-[14C]-
GlcNAc (American Radiolabeled Chemicals). After 60 min reactions were boiled in 4% 
SDS and filtered. Labeled PG retained on the filter was quantified by liquid scintillation 
counting (Packard Tri-Carb). Cultures were normalized by total protein content: 0.18 
mg total protein (A) or 0.14 mg total protein (B). Error bars indicate the standard 
deviation of three independent experiments. Statistical significance was calculated 
using a student’s paired t-test comparing each indicated strain to wild-type. The p-
values are as follows: ponB(Q411R) ΔlpoB, p = 0.08; ponB(E313D) ΔlpoB, p = 0.38; 
ponB(I202F), p = 0.24; ponB(I202F) ΔlpoB, p = 0.001.
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Figure 3.7. PBP1b* variants need LpoB to prevent low frequency of lysis. Cells of 
MG1655 [wild-type] (A), CB2 [ΔponB] (B), CB7 [ΔlpoB] (C), MM41 [ponB(Q411R)] (D), 
MM42 [ponB(I202F)] (E), MM43 [ponB(E313D)] (F), MM47 [ponB(Q411R) ΔlpoB] (G), 
MM48 [ponB(I202F) ΔlpoB] (H), and MM49 [ponB(E313D) ΔlpoB] (I) were grown 
overnight at room temperature on solid rich medium containing 50uM IPTG and 20 μg/
ml CPRG. Single colonies were resuspended in 1X PBS and 5 μL were spotted onto 
agarose pads containing 1.2% agarose and 0.5% NaCl for microscopy. Cells were 
visualized using phase-contrast microscopy. Arrows show cell bulging or single cells 
that have lysed. Scale bar is equivalent to 4 microns.
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frequency that is well above that for cells from wild-type colonies (Figure 3.7A). As 
expected, no cell ghosts were observed in cells from PBP1bE313D LpoB+ colonies 
(Figure 3.7F). However, the frequency of lysis observed for cells from PBP1bE313D 
LpoB- colonies was indistinguishable from a PBP1b(WT) LpoB- colony (Figure 3.7I). 
Thus, PBP1bE313D fails to correct the lysis phenotype observed for LpoB- cells. 
 To confirm the results above, we used a colorimetric assay that detects an 
increased frequency of lysis. This assay utilizes a membrane-impermeable LacZ 
substrate, chlorophenyl red-β-D-galactopyranoside (CPRG). On this medium, wild-type 
cells form white colonies because CPRG cannot enter cells and is not hydrolyzed by 
LacZ (Figure 3.8A). However, if a sub-population of cells in a colony are lysing, LacZ 
will be released into the surrounding medium and hydrolyze CPRG to produce a red 
color. Cells lacking PBP1b or LpoB form red colonies consistent with the increased 
frequency of lysed cells observed microscopically (Figure 3.8B and C). When cells of 
MM43 [ponBE313D] were plated on CPRG-agar, the resulting cell patch was white, 
indicating that production of PBP1bE313D does not result in elevated cell lysis in the 
presence of functional LpoB (Figure 3.8H). Cells of MM49 [ponBE313D ΔlpoB], on the 
other hand, formed patches that were pink in color (Figure 3.8I). This is an intermediate 
phenotype between the intense red colored patch of CB7 [ΔlpoB] cells and the lack of 
color development for MG1655 [WT] cells. Thus, the ponB(E313D) allele only partially 
suppresses the elevated lysis phenotype of ΔlpoB cells. This result suggests that either 
PBP1bE313D is not fully functional in the absence of LpoB or that LpoB has a cellular 
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Figure 3.8. The PBP1b* variants are responsive to LpoB in vivo. Cells of MG1655 
[wild-type] (A), CB2 [ΔponB] (B), CB7 [ΔlpoB] (C), MM41 [ponB(Q411R)] (D), MM47 
[ponB(Q411R) ΔlpoB] (E), MM42 [ponB(I202F)] (F), MM48 [ponB(I202F) ΔlpoB] (G), 
MM43 [ponB(E313D)] (H), and MM49 [ponB(E313D) ΔlpoB] (I) were struck out on rich 
media containing 50 μg/ml of CPRG and 50 μM IPTG and incubated at room 
temperature for two days.
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function in addition to PBP1b activation that helps make PG synthesis more robust 
thereby reducing the frequency of cell lysis. 
Discussion
	 To better understand how LpoB promotes PBP1b activity and whether or not 
this activator plays additional roles in PG biogenesis we isolated mutants encoding 
PBP1b variants that bypass the LpoB-requirement for their function. Five unique 
PBP1b* variants that result in a LpoB-bypass phenotype were identified. The 
substitutions cluster in two regions of the PBP1b structure: I202F, Q411R, Q411K and 
Q447K are located near the UB2H domain and between the PGT and TP domains, and 
E313D is located in the PGT domain. Interestingly, the strength of the LpoB-bypass 
phenotype correlates with the location of the substitutions. Changes located near the 
UB2H domain (I202F and Q411R) result in partial suppression of the LpoB- phenotype. 
PBP1b* variants with these substitutions are unable to support the growth of a LpoB- 
PBP1a- strain without basal level production of PBP1a from a Para::ponA expression 
construct integrated in the chromosome. PBP1bE313D, on the other hand, supported a 
sufficient level of PG biogenesis for growth without LpoB in the complete absence of 
the PBP1a system. The observed growth phenotypes correlated with PG synthesis 
measurements in ether-permeabilized cells. LpoB is normally required for normal levels 
of PG synthesis in this assay system. Cells producing PBP1bE313D were capable of 
synthesizing equivalent levels of PG to WT cells with or without LpoB. Conversely, like 
WT cells, cells producing PBP1bI202F or PBP1bQ411R required LpoB for PG synthetic 
activity. Since one would expect the partial bypass mutants to display at least some 
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increased activity in the absence of LpoB, it is currently unclear why they were 
identified in the selection for bypass mutants. Interestingly, however, the substitutions 
in the PBP1b* variants with the partial bypass phenotype map near the UB2H domain, 
the domain implicated in the interaction with LpoB by Typas and co-workers (25). Thus, 
it is likely that the amino acid substitutions near UB2H influence the conformation of 
PBP1b in a manner that mimics the interaction with LpoB and that this conformational 
change may promote PBP1b activity. Further biochemical characterization of the PGT 
and TP activities of these variants is therefore warranted and may shed light on the 
LpoB-bypass mechanism of the UB2H-proximal substitutions. 
 We previously showed that LpoB is able to increase the PGT activity of PBP1b 
1.5-fold and that LpoB leads to the production of shorter glycan strands by PBP1b in 
vitro (19). Typas and co-workers also found that LpoB can enhance the ability of 
PBP1b to form crosslinked PG in vitro (25). The relationship between these two 
observations is currently unclear, but it is possible that they are connected; shorter 
glycan strands may be better substrates for crosslinking in vitro. The location of the 
E313D substitution in the PGT domain suggests that it may also influence and perhaps 
enhance the PGT activity of PBP1b in the absence of LpoB, thus resulting in the 
bypass phenotype. Interestingly, E313 is located towards the end of a cleft in the PGT 
active site through which the growing glycan chain is thought to pass. An attractive 
model to explain the activation of PGT activity of PBP1b by LpoB is that the PGT 
domain exists in two conformations, an inactive “closed” conformation and an active 
“open” conformation, and that LpoB stimulates the adoption of the open conformation.  
Thus the E313D substitution could destabilize the closed conformation and thereby 
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promote PGT activation in the absence of LpoB. Studies of the PGT activity of 
PBP1bE313D with and without LpoB are underway to test this hypothesis. 
	 We reasoned that the isolation of LpoB-bypass variants of PBP1b would be 
useful tools to determine if LpoB plays other important roles in the cell in addition to 
PBP1b activation. The PBP1bE313D variant was illuminating in this respect. It possessed 
normal levels of PG synthetic activity in ether-permeabilized cells lacking LpoB and it 
was able to support growth in the absence of LpoB when the PBP1a-LpoA system was 
inactivated. However, PBP1bE313D failed to fully suppress the elevated lysis frequency 
observed in LpoB- cells. Since PBP1b activity seems to be fully restored in cells 
producing the E313D variant, this result suggests that LpoB is indeed important for 
aspects of cell envelope biogenesis other than PBP activation. Possibilities for this 
additional activity include: coordinating PG synthesis with OM biogenesis, coordinating 
PBP activity with PG hydrolase function, and/or supporting OM constriction during cell 
division as suggested by Typas and co-workers (25). Further work is required to 
determine which, if any, of these possibilities are correct. 
	 In conclusion, we have isolated PBP1b* variants that bypass the LpoB 
requirement for PBP1b activity. Future study of these mutants is likely to reveal 
important insight into PBP1b function and its control by LpoB. An analogous approach 
for studies of PBP1a and LpoA is also likely to be applicable to studies of PBP1a and 
its activation by LpoA. 
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Materials and Methods
	 Media and bacterial strains. Cells were grown in LB (1% tryptone, 0.5% yeast 
extract, 0.5% NaCl) or minimal M9 media (17) supplemented with 0.2% casamino 
acids and 0.2% sugar (glucose or arabinose as indicated). Concentrations of 
antibiotics used are as indicated.
	 The bacterial strains used in this study are listed in Table 3.2. All strains used for 
in vivo experiments are derivatives of MG1655 (11). Mutants lacking LpoA, LpoB, or 
PBP1a were constructed by successive rounds of P1 transduction (17) and the curing 
of the Kan-resistance marker (Kanr) cassettes flanked by frt sites using plasmid pCP20 
as described previously (9) (see Table 3.2 for construction details). The desired 
chromosomal modification was confirmed by using diagnostic PCR every time Kanr a 
cassette was transduced or cured. When a strain contained multiple lesions, diagnostic 
PCR was used to confirm the status of each lesion. No difference in phenotype was 
observed when strains containing the Kanr cassette were compared to the 
corresponding strains in which the cassette was removed by FLP recombinase. All 
deletion alleles were constructed to be in-frame deletions as part of the Keio collection 
(1). 
 Plasmids. The plasmids used in the present study are listed in Table 3.3. 
Vectors with R6K origins are all derivatives of CRIM plasmids developed by Haldimann 
and Wanner (12). The vectors were either maintained in the cloning strain DH5α(λpir), 
where they replicate as plasmids, or they were integrated into phage attachment sites 
(HK022 or λ) by using the helper vectors pTB102 or pINT-ts, respectively, as previously 
described (4, 12). Single-copy integrants were identified by using diagnostic PCR (12). 
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Table 3.2. Strains used in this study.
Straina Genotypeb Source, reference,or constructionc
MG1655 rph ilvG rfb-500 (11)
CAG12025 MG1655 zad-220::Tn10 (21)
JW3359
Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) 
rph-1 Δ(rhaD-rhaB)568 hsdR514 
ponA731::aph
(1)
JW5157
Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) 
rph-1 Δ(rhaD-rhaB)568 hsdR514  
ΔycfM767::aph
(1)
CB2 MG1655 ponB::aph (19)
CB7 MG1655 lpoB::aph (19)
MM41 MG1655 ponB(Q411R) CB2 x P1(MM36(attλTB309))
MM42 MG1655 ponB(I202F) CB2 x P1(MM37(attλTB309))
MM43 MG1655 ponB(E313D) CB2 x P1(MM38(attλTB309))
MM44 MG1655 ponB(Q411R) lpoB::aph MM41 x P1(JW5157)
MM45 MG1655 ponB(I202F) lpoB::aph MM42 x P1(JW5157)
MM46 MG1655 ponB(E313D) lpoB::aph MM43 x P1(JW5157)
MM47 MG1655 ponB(Q411R) lpoB<>frt MM44/pCP20
MM48 MG1655 ponB(I202F) lpoB<>frt MM45/pCP20
MM49 MG1655 ponB(E313D) lpoB<>frt MM46/pCP20
MM66 MG1655 ponB(E313D) lpoB<>frt ponA::aph MM49 x P1(JW3359)
MM67 MG1655 ponB(E313D) lpoB<>frt lpoA::aph MM49 x P1(JW5157)
TB28 MG1655 ΔlacIZYA<>frt (5)
TU121(attλTB309) TB28 ponA<>frt Para::ponA (19)
CB4(attλTB309) TB28 ponA<>frt lpoB::aph Para::ponA (19)
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Table 3.2. Strains used in this study. (Continued)
Straina Genotypeb Source, reference,or constructionc
MM33(attλTB309) TB28 ponA<>frt lpoB<>frt Para::ponA CB4/pCP20
ponBlin39 TB28 ponA<>frt lpoB<>frt ponB(Q411R) Para::ponA 
From cefsulodin 
selection
ponBlin65 TB28 ponA<>frt lpoB<>frt ponB(I202F) Para::ponA 
From cefsulodin 
selection
ponBlin222 TB28 ponA<>frt lpoB<>frt ponB(E313D) Para::ponA 
From cefsulodin 
selection
ponBlin425 TB28 ponA<>frt lpoB<>frt ponB(Q447K) Para::ponA 
From cefsulodin 
selection
MM36(attλTB309) TB28 ponA<>frt lpoB<>frt ponB(Q411R) Para::ponA 
P1(CAG12025) x 
ponBlin39
MM37(attλTB309) TB28 ponA<>frt lpoB<>frt ponB(I202F) Para::ponA 
P1(CAG12025) x 
ponBlin65
MM38(attλTB309) TB28 ponA<>frt lpoB<>frt ponB(E313D) Para::ponA 
P1(CAG12025) x 
ponBlin222
MM33(attλTB309)
(attHKMM6)
TB28 ponA<>frt lpoB<>frt Para::ponA 
Plac::gfp-ponBγ This study
MM33(attλTB309)
(attHKMM79)
TB28 ponA<>frt lpoB<>frt Para::ponA 
Plac::gfp-ponBγ(Q411R) This study
MM33(attλTB309)
(attHKMM80)
TB28 ponA<>frt lpoB<>frt Para::ponA 
Plac::gfp-ponBγ(I202F) This study
MM33(attλTB309)
(attHKMM81)
TB28 ponA<>frt lpoB<>frt Para::ponA 
Plac::gfp-ponBγ(E313D) This study
MM33(attλTB309)
(attHKMM89)
TB28 ponA<>frt lpoB<>frt Para::ponA 
Plac::gfp-ponBγ(Q447K) This study
aStrains constructed in this study.
bThe aph (KanR cassette) is flanked by frt sites for removal by FLP recombinase. An 
frt scar remains after removal using FLP expressed from pCP20.
cStrain constructions by P1 transduction are described using the shorthand: P1(donor) 
x recipient. In all cases, transductants were selected on LB-Kan plates. Strains 
resulting from the removal of the aph (KanR cassette) using pCP20 are indicated as: 
parental strain/pCP20.
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Table 3.3. Plasmids used in this study.
Plasmid Genotype Origin Source, reference,or construction
pCP20 bla cat cI857 repA(Ts) PR::#p pSC101 (9)
pTB102 cat cI857 repA(Ts) PR::intHK022 pSC101 (4)
pMM6 attHK022 bla lacIq Plac::gfp-ponBγ R6K (19)
pMM79 attHK022 bla lacIq Plac::gfp-ponBγ(Q411R) R6K This study
pMM80 attHK022 bla lacIq Plac::gfp-ponBγ(I202F) R6K This study
pMM81 attHK022 bla lacIq Plac::gfp-ponBγ(E313D) R6K This study
pMM89 attHK022 bla lacIq Plac::gfp-ponBγ(Q447K) R6K This study
151
Integrated vectors were transferred between strains by P1-mediated transduction. The 
construction of plasmids in the present study are described below. In all cases, PCR 
was performed using KOD polymerase (Novagen) according to the manufacturer’s 
instructions. Restriction sites for use in plasmid constructions are underlined in the 
primer sequences given below. Plasmid DNA was purified using either the Qiagen spin 
miniprep kit (Qiagen) or the Zippy miniprep kits (Zymo Research) while PCR fragments 
were purified using a Qiaquick PCR purification kit (Qiagen). The construction for the 
plasmids used in the present study are described below. For pMM79 [attHK022 bla 
lacIq Plac::gfp-ponB(Q411R)], pMM80 [attHK022 bla lacIq Plac::gfp-ponB(I202F)], and 
pMM81 [attHK022 bla lacIq Plac::gfp-ponB(E313D)], the ponB* genes were amplified 
from genomic DNA using the primers 5’-GTACGGATCCC CGCGCAAAGGTAAGGG-3’ 
and 5’-GTCACTCGAGATGGGATGTTATTTTACCGGATGG C-3’. The PCR product was 
then digested with BamHI and XhoI and ligated into the BamHI/SalI digested pTB183 
[attHK022 bla Plac::gfp-zapA] (3).
 Cefsulodin selection-screen. Cells of MM33(attλTB309) and TU121(attλTB309) 
were grown overnight in minimal M9 media containing 0.2% arabinose at 30°C. The 
next morning, the cultures were subcultured 1:100 into 50ml of fresh minimal M9 media 
containing 0.2% arabinose and grown to fresh saturation (OD600 0.96 to 1.0) at 30°C. 
Serial dilutions of each strain (10-1 to 10-7) were plated onto permissive conditions for 
colony counts. For MM33(attλTB309), the following volumes of the undiluted culture 
were centrifuged and plated onto minimal M9 media containing 0.2% arabinose and 
0.01 μg/ml: 1 ml, 2 ml, 5 ml and 10 ml. Plates were incubated at 30°C. After three days, 
14 suppressors arose on the plate containing 5 ml of culture, while the plate containing 
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10 ml of culture had 372 suppressors. The efficiency of plating (EOP) for 
MM33(attλTB309) between the permissive and non-permissive conditions was 1.7 x 
10-8. Upon repeating this procedure to potentially independently isolate the same set of 
mutations, the EOP was 1.4 x 10-6. 
	 Complementation of PBP1a-/LpoB- synthetic lethal phenotype in trans. See 
figure legend for details.
 Immunoblotting. Cultures of MG1655, CB2, CB7, MM41, MM42, MM43, 
MM47, MM48, and MM49 were grown overnight in LB at 30°C. The cultures were 
diluted 1:100 in 5 ml of LB (with duplicate of each strain) and grown at 30°C to an 
OD600 between 0.52 to 0.66. Cells were harvested by centrifugation at 4°C and 
resuspended in PBS and 2X Laemmli buffer. Samples were incubated at 100°C for 10 
min. Total protein concentrations of the cell extracts were measured using the Non-
Interfering™ Protein Assay (G Biosciences). 15 μg of total protein was loaded into each 
well, cell extracts were separated on a 12% acrylamide gel and transferred to Protran® 
nitrocellulose membranes (Whatman, 0.22 um). Processing of the immunoblots were 
performed as previously described (5). PBP1b antisera was used at a dilution of 
1:10,000.
 Ether-permeabilized cell assay. This assay was performed as described 
previously in (19) with the following changes. In Figure 3.6, ether-treated cells were 
prepared from cultures grown to an OD600 of 0.50 at 37˚C (A) or 30˚C (B).
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Chapter 4:
Summary and Future Directions
158
Summary
	 The PG layer protects the cytoplasmic membrane from rupture due to high 
internal turgor pressure (17, 37). Its growth is a complex and dynamic process that 
requires the interplay of numerous enzymes to build an intact meshwork that 
encompasses the entire cell. The PG synthases that polymerize and crosslink PG are 
called the penicillin-binding proteins (PBPs). They have been found to work in the 
context of large multi-enzyme complexes that are organized by cytoskeletal elements. 
Two distinct complexes are associated with the different phases of PG growth in rod-
shaped cells: elongation and division (6, 7). During elongation, a complex organized by 
the actin-like MreB directs the insertion of new material into the sidewall of the rod-
shaped cell. Following elongation, the mode of PG growth switches to a concentrated 
zone of synthesis at the division site directed by a complex of proteins called the 
divisome that is organized by the tubulin-like protein FtsZ (6, 7, 24). The two major PG 
synthases in E. coli, PBP1a and PBP1b, are thought to work in different complexes 
during these two phases of PG growth. In line with this hypothesis, crosslinking of 
proteins in Haemophilus influenzae cells by Alaedini et al. (1) revealed the existence of 
two different high molecular weight (HMW) complexes containing class A and class B 
PBPs (see Introduction for discussion of the HMW-PBPs). Recent evidence shows 
that PBP1a may interact with PBP2 and is likely to work with the MreB-directed PG 
synthetic machine during the elongation phase of PG assembly (33). On the other 
hand, PBP1b is thought to primarily work during cell division based on observed 
interactions with the division proteins PBP3 (FtsI) and FtsN (3, 26).
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 A major outstanding question has been whether or not multi-enzyme complexes 
contain factors required for PBP function. Using Escherichia coli as a model system, we 
took advantage of the synthetic lethal phenotype resulting from simultaneous 
inactivation of the two major HMW class A PBPs: PBP1a and PBP1b (19, 39). Using a 
screen for mutants synthetically lethal with the inactivation of PBP1b, I identified LpoA 
(YraM) as a factor required for PBP1a function. This is a 678 residue putative outer 
membrane (OM) lipoprotein with a C-terminal LppC domain of unknown function that is 
well conserved among γ-proteobacteria (16, 35). A colleague in the lab, Dr. Catherine 
Paradis-Bleau, performed the analogous screen for mutants synthetically lethal with the 
loss of PBP1a and identified LpoB (YcfM), a 213 amino acid predicted OM lipoprotein, 
as a factor necessary for PBP1b function (29). 
" Based on the sequence of their signal peptides, LpoA and LpoB were predicted 
to be OM lipoproteins. I confirmed their subcellular localization using a cytological assay 
for lipoprotein transport where I plasmolysed cells expressing fluorescently-tagged 
versions of LpoA and LpoB (adapted from (22)). Interestingly, OM localization was 
required for LpoA but not LpoB. Because our results suggested that the Lpo factors 
were promoting the in vivo activity of the PBPs, we wondered if they did so directly. We 
used a pull-down assay to show that the purified Lpo factors directly interacted with their 
cognate purified PBP1 partner. Combined with the knowledge of their subcellular 
localization, this indicated that they form specific trans-envelope complexes with their 
cognate PBPs (29). I also showed that loss of both LpoA and LpoB phenocopied the 
lysis observed in cells lacking PBP1a and PBP1b, indicating that the Lpo factors are 
critical components of their respective complexes (29).
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" To assess the effect of the Lpo proteins on PG assembly, we first compared the 
chemical compositions of PG isolated from wild-type cells to that isolated from PBP1a- 
PBP1b- or LpoA- LpoB- cells just before lysis occurred. The absence of either the 
PBP1s or the Lpo proteins caused a decrease in crosslinking, from 22% in the wild-type 
down to 18-19% in the case of the mutants (29). Even though this result may seem 
insignificant, any small decrease in cross-linking can potentially have detrimental effects 
for the cell in vivo, especially if there is a localized drop in crosslinking. We also 
examined the effect of LpoB on PG synthesis using ether-permeabilized cells and 
showed LpoB is required for PBP1b activity. The Lpo factors are needed to promote 
PBP1 activity, however, we did not know which activity they stimulated. To determine 
which activity they stimulated, we collaborated with the Kahne and Walker groups at 
Harvard to show that LpoB stimulated the peptidoglycan glycosyltransferase (PGT) 
activity of PBP1b, leading to the production of shorter glycan strands (29). 
" To investigate the role of LpoB in the PBP1b PG synthetic complex further, I 
took a genetic approach to identify PBP1b* variants capable of functioning in vivo in the 
absence of LpoB. To isolate these variants, I took advantage of the cefsulodin 
hypersensitive phenotype shared amongst ponB (encoding PBP1b) and lpoB mutants. 
We reasoned that the cefsulodin hypersensitivity of lpoB mutants results from a defect 
in PBP1b activity and that ponB* alleles encoding PBP1b* variants might be identified 
by a selection for increased cefsulodin resistance in a LpoB- strain background. Using 
this strategy, I isolated spontaneous suppressors of this phenotype and identified five 
mutations within the ponB gene that arise under these conditions. Preliminary 
characterization of these variants indicates that only one, PBP1bE313D, is capable of 
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synthesizing PG in the absence of LpoB. However, while this variant can function 
without LpoB in vivo, PBP1bE313D does not fully suppress a LpoB- defect and exhibits 
an elevated frequency of lysis similar to a lpoB mutant. These results suggest that 
LpoB might have additional functions within the cell other than PBP activation. Also, 
the location of this specific mutation provides us with some insight into a possible 
mechanism by which LpoB activates the PGT of PBP1b. 
	 Taken together, results from my work contribute to our understanding of the 
functional interplay between the Lpo factors and their PBP1 partner. The unexpected 
complexity observed in the control of PBP activity was surprising and revealed that 
these enzymes likely receive regulatory input from both the Lpo factors in the OM and 
cytoskeletal elements in the cytoplasm. In addition to increasing our knowledge of PG 
assembly, these studies help to lay the foundation for future investigations into roles 
the Lpo factors may play in vivo.
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Future directions
	 Chapter 2 describes the identification of LpoA and LpoB as the first critical 
activators for HMW class A PBP function. Chapter 3 goes one step further to identify 
variants of PBP1b that bypass the need for LpoB in vivo. Future study of these mutants 
is likely to reveal important insight into PBP1b function and its control by LpoB. At this 
point, however, the physiological significance of the Lpo factors is still unclear. This 
section includes a discussion of the potential roles the Lpo factors may play in the cell 
and describes experiments to investigate them in E. coli.
	 The Lpo factors coordinate the rates of PG synthesis and OM biogenesis. 
The Lpo factors are lipoproteins tethered to the OM and must traverse nearly the entire 
periplasm to interact with their cognate IM-retained PBP (29). Because these 
lipoproteins are attached to the OM, one potential role that these factors may play is to 
help coordinate the rate of PG synthesis with OM biogenesis. Regulation of these two 
processes would be particularly important during lateral PG synthesis to prevent any 
breaches in cell envelope integrity. If OM biogenesis were to lag behind PG synthesis 
the permeability barrier function of the OM may be compromised. Conversely, if OM 
biogenesis were to outpace PG synthesis, excess membrane would be wasted 
because it likely has to be shed by vesicle formation. 
 LpoA is thought to work with the elongation machinery during lateral wall PG 
synthesis (34), and only OM-tethered LpoA was capable of supporting PBP1a activity 
(Chapter 2) (29). Taken together, these results suggest a role for LpoA in coordinating 
PG synthesis and OM biogenesis. If this is true, a lpoA mutant may exhibit either 
increased OM permeability and/or increased OM vesicle formation. With the former 
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possibility, we would expect a lpoA mutant to be more sensitive to detergents and to 
large antibiotics that normally would not enter Gram-negative cells (like vancomycin or 
erythromycin). However, if OM biogenesis is increased compared to PG synthesis, then 
we would expect a lpoA mutant to show an elevated frequency of OM vesicles 
emanating from the cell. To test this, we could integrate a fluorescently-tagged OM 
marker (e.g. OM-anchored mCherry) and look for increased vesicle formation in a lpoA 
mutant using fluorescent microscopy.  Consistent with a role for LpoA in membrane 
biogenesis, the lpoA gene is genetically linked to the ecfH (yraP) gene in most γ-
proteobacteria. EcfH is predicted to be an OM lipoprotein containing two BON 
domains thought to bind phospholipids. This observation suggests that LpoA and EcfH 
may work together to properly control the rates of PG synthesis and OM biogenesis.
	 LpoB could also play a role in coordinating OM biogenesis with PG synthesis 
even though IM-anchored LpoB can activate PBP1b (Chapter 2) (29). When tested, the 
lpoB mutant did not exhibit any OM permeability defects. These cells were resistant to 
sodium dodecyl sulfate (SDS) and to vancomycin and erythromycin (data not shown). 
However, LpoA is still expressed and may be able to coordinate OM biogenesis and PG 
synthesis in the absence of LpoB. Since the loss of both LpoA and LpoB results in cell 
lysis, we cannot test a strain lacking both factors. In Chapter 3, I found that PBP1bE313D 
can complement this synthetic lethal defect. Thus we can test PBP1bE313D cells without 
the Lpo factors using the same assays described above for changes in OM integrity.
	 Control of glycan strand insertion by the Lpo factors. Another potential role 
that these OM-anchored Lpo factors may fulfill is to help guide where the multi-enzyme 
PG synthetic complexes insert new material. Adjacent glycan strands in the existing 
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PG structure would likely prevent lateral diffusion of the trans-envelope complexes 
containing the Lpo factors in the OM (Figure 1.1A and Figure 2.14) to promote the 
insertion of nascent PG along a directed path. This model is consistent with observed 
insertion of single strands of new PG between two old strands (9, 10), and previous 
studies suggesting that the existing PG networks acts as a template (16, 31). 
According to this model, without the Lpo factors, the PBP complexes would deviate 
from the template and insert new material in a less orderly manner. Thus, input from the 
OM and the cytoskeletal elements in the cytoplasm might allow the PG synthetic 
complexes to better adhere to the existing cell wall template, leading to robust 
duplication of the PG layer (Figure 2.14).
	 The Lpo factors may coordinate PG synthesis and PG hydrolysis. In order for 
the PG layer to grow, bonds in the existing PG structure need to be broken to insert 
new material. Components of the multi-enzyme PG synthetic complexes with PG 
hydrolase activity are thought to perform this function (17, 34, 36). These potentially 
dangerous enzymes need to be properly controlled to prevent breaches in the PG layer 
from forming. Because the Lpo factors are critical for PBP activity, they could 
potentially couple PBP synthetic activity to hydrolytic activity, thereby restricting PG 
cleavage to sites of PG growth (17, 33). In fact, PBP1b was shown to be connected to 
an OM-anchored lytic transglycosylase, MltA, via an adaptor protein MipA (36). 
Additionally, Typas et al. (34) suggest that LpoB may recruit a PG hydrolase to sites of 
PG synthesis at the septum. In Chapter 3, we showed that both a lpoB mutant exhibits 
an elevated frequency of lysis. Potentially, the rates of PG synthesis and hydrolysis are 
not coordinated with each other leading to increased lysis and further supporting the 
165
proposed idea. To test this, we plan to use a variant of PBP1b that can function in the 
absence of LpoB. Using a genetic approach, we could introduce lytic transglycosylase 
deletions (single or in combination) into a lpoB mutant expressing PBP1bE313D and test 
for suppression of this elevated lysis phenotype using the assays described in Chapter 
3.
	 Homeostatic mechanism for mechanical stress. As mentioned previously, the 
OM-attached Lpo factors must pass the PG layer to interact with their cognate PBP1s. 
Vollmer and colleagues provide an intriguing model for the regulation of PG synthesis 
by the Lpo factors in which they are only able to activate the PBPs when the pore size 
of the PG layer is large enough for them to pass through. Such a mechanism would 
make the activation responsive to the state of the PG pores. In growing E. coli cells, the 
PG network has the capacity to stretch up to three-fold in surface area due to turgor 
pressure (8). Rapid growth in rich media may also stretch the PG layer in a similar way 
and consequently increase pore size to allow the Lpo factors to interact with and 
activate their cognate PBP1s. On the other hand, during slow growth conditions (e.g. 
limited nutrients or during stationary phase) where little new PG material is needed, the 
pores are predicted to decrease in size, preventing activation of the PBPs by the Lpo 
factors. This model is attractive because it provides a potential mechanism to 
coordinate the rate of PG synthesis with environmental conditions and nutritional 
status. However, the model is unfortunately difficult to test and experimental support 
for it is limited.
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Specific roles of LpoA in vivo. In addition to the potential models for Lpo function 
above, LpoA may perform specific roles in the cell which LpoB cannot. In line with this 
idea, LpoA and LpoB do not share any sequence homology and are thus likely to have 
evolved to perform different specific functions in vivo. One idea is that LpoA only 
activates the transpeptidase (TP) activity of PBP1a, as shown by Typas et al. (34). 
Recently Tania Lupoli from the Kahne group developed an in vitro PBP TP assay (23) 
and confirmed that LpoA stimulated the TP activity of PBP1a approximately seven-fold 
(Tania Lupoli, personal communication). These results suggest that LpoA is stimulating 
the TP activity of PBP1a in vivo. To support this idea, we could identify lpoA mutants 
that no longer stimulate the TP activity of PBP1a.
" Furthermore, the H. influenzae LpoA homolog was suggested to play a potential 
role in iron acquisition. During normal H. influenzae growth in rich media, LpoA is 
expressed at low levels. However, it is expressed at high levels when an iron chelator, 
2,2-dipyridyl, is added to the medium (35). To support this idea, the HI1654 gene (yraL 
in E. coli) is upstream of the lpoA gene. This gene is thought to encode a putative 
tetrapyrrole methylase that is involved in porphyrin biosynthesis. These observations 
suggest that LpoA may play a role in acquiring iron. Saper and coworkers believe that 
this may be important for H. influenzae because iron and porphyrin acquisition are 
required for aerobic growth of this organism; however, all bacteria must use iron for 
growth and have created many mechanisms to obtain it (e.g. scavenging iron using 
siderophores). LpoA may be part of another potential route bacteria use to acquire iron. 
One idea is that PBP1a could require iron to function in vivo, and LpoA could provide 
this cofactor to PBP1a in vivo. To test whether LpoA plays a role in iron acquisition, we 
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could assay for growth of a lpoA mutant under no iron conditions or in the presence of 
2,2-dipyridyl.
Specific roles of LpoB in vivo. An attractive model for LpoB function is one in which 
LpoB coordinates both the PGT and TP activities of PBP1b. In Chapter 2, we show 
that LpoB stimulates the PGT activity of PBP1b (29) using the in vitro PGT assay 
system developed by the Walker and Kahne groups (2). Additionally, Vollmer and 
coworkers showed that LpoB also activates the TP activity of PBP1b (34), and this was 
recently confirmed by the Kahne group (Tania Lupoli, personal communication). Taken 
together, these results suggest that LpoB controls both activities of PBP1b. Therefore, 
binding of LpoB to PBP1b could induce a conformational change that places the TP 
domain in closer contact with the PGT domain to easily access elongating glycan 
strands for the crosslinking reaction (Figure 4.1). If this model is true, we would predict 
that a PBP1b* variant that bypasses the need for LpoB would require substitutions in 
both its PGT and TP domains to activate the enzyme. However, the likelihood of 
isolating these mutants using the genetic selection in Chapter 3 is very low. Instead, we 
identified a single substitution in the PGT domain of PBP1b that is LpoB-independent 
(PBP1bE313D) and three substitutions near the LpoB-binding domain that may partially 
bypass the need for LpoB (PBP1bI202F, PBP1bQ411R, and PBP1bQ447K). Perhaps 
combining these substitutions with E313D will lead to activation of both PBP1b 
activities without LpoB.
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Figure 4.1. LpoB binding induces conformational change in PBP1b. The figure 
above illustrates a potential conformational change that occurs when LpoB binds to 
PBP1b. This change may cause the transpeptidase (TP) domain to come into close 
proximity to the PG glycosyltransferase domain (PGT) of PBP1b.
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	 The Tol-Pal trans-envelope complex is critical for cell envelope integrity and OM 
invagination during cell division (15). However, these components are not essential, 
suggesting the existence of redundant systems. Vollmer and colleagues propose that 
the PBP1b-LpoB complex can perform this role in the absence of Tol-Pal because cells 
lacking both LpoB and Pal lead to cell lysis in no salt conditions (34). To potentially 
bypass this phenotype, we can use the LpoB-independent PBP1bE313D variant isolated 
in Chapter 3. Because it no longer needs LpoB to function in vivo, we can test whether 
PBP1bE313D can complement the synthetic lethal phenotype observed when lpoB 
mutants lack the Tol-Pal pathway. Our preliminary evidence shows that a lpoB tol 
double mutant that expresses PBP1bE313D can survive under no salt conditions (data 
not shown). However, even though these mutants effectively lack the Tol-Pal pathway, 
Pal is still expressed and may now work with PBP1bE313D in the absence of LpoB to 
invaginate the OM. Thus we plan to test a lpoB pal double mutant that expresses 
PBP1bE313D for its ability to complement under no salt conditions.
PBP activators in Gram-positive bacteria. While we identified factors that promote 
PBP activity in Gram-negative bacteria, one outstanding question is whether they exist 
in Gram-positive cells that have a thick PG layer. BLAST searches and bioinformatics 
analysis using the STRING program (25) show that many firmicutes contain weak 
homologs of either LpoA or LpoB with a maximum sequence identity of 40%. For 
example, Staphylococcus aureus contains a protein with weak homology to E. coli 
LpoA suggesting that these activators do exist in Gram-positive organisms. However, 
they must be tethered to the IM or soluble within the periplasmic compartment 
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because these bacteria lack an OM. In line with this idea, our results from Chapter 2 
show that both IM-attached and soluble periplasmic LpoB variants are capable of 
activating PBP1b (29), suggesting that cofactors in these locations can stimulate PBP 
activity.
	 However, the physiological significance of these activators is unclear. One 
potential idea is that to maintain cell wall thickness, these factors coordinate the PGT 
and TP activities of the PBPs to regulate the length of glycan polymers or the degree of 
crosslinking. Factors critical for PBP activity could also potentially couple PBP 
synthetic activity to hydrolytic activity, similar to the model proposed for the Lpo 
factors (see above) (17, 33). Moreover, the Gram-positive cell wall also contains 
covalently-attached polymers called lipoteichoic acids (LTAs). LTA biosynthesis is a 
complex process that requires a substantial energetic and material commitment on 
part of the cell (30), like PG synthesis. Thus, another attractive model for the function of 
these PBP cofactors is one where they coordinate PG synthesis with LTA biogenesis. 
	
The growing epidemic of antibiotic-resistant bacteria. Bacterial infections and 
disease are on the rise due to the growing epidemic of antibiotic-resistant bacteria. 
Infectious disease is now the second leading cause of death worldwide (27). Since the 
dawn of the antibiotic age, widespread misuse of antibiotics has led bacteria to evolve 
various mechanisms of antibiotic resistance, leading to resistance to most 
commercially available antibiotics (11). The most deadly classes of antibiotic resistant 
organisms include the ESKAPE pathogens, multi-drug resistant (MDR) and pandrug-
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resistant (PDR) Gram-negative bacteria (13), and MDR and extensively drug-resistant 
strains (XDR) of Mycobacterium tuberculosis (12, 14).
 The “ESKAPE” pathogens (Enterococcus faecium, Staphylococcus aureus, 
Klebsiella pneumoniae, Acinetobacteria baumanii, Pseudomonas aeruginosa, and 
Enterobacter species) currently cause the majority of hospital-acquired infections in the 
United States and are emerging as significant pathogens worldwide (5). These 
pathogens obtain their name because they effectively “escape” inhibition by clinically 
used antibacterials. Data from the Centers for Disease Control and Prevention (CDC) 
show increasing rates of infection due to methicillin-resistant S. aureus, vancomycin-
resistant E. faecium (VRE), and fluoroquinolone-resistant P. aeruginosa (28). About 
100,000 patients per year are infected with MRSA, and more people now die of MRSA 
infections (approximately 19,000 patients per year) in US hospitals than of HIV/AIDS 
and tuberculosis combined (4, 11, 20, 32). Drastic measures need to be taken to 
prevent infections caused by these ESKAPE pathogens from becoming a worldwide 
epidemic. 
New arsenal of antibacterials desperately needed. Antibiotics have been crucial in 
doubling the average life expectancy in the US (21). They are required to treat severe 
and life-threatening bacterial infections. But the overuse of these antibiotics has given 
rise to a breed of super bacteria that are resistant to most, if not all, currently used 
antibiotics (32). However, while antibiotic resistance is on the rise, the discovery of new 
antibiotics is not (14). Due to economic problems, many large pharmaceutical 
companies left the field of antibiotic discovery. Thus the number of antibiotics 
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approved by the US Food and Drug Administration (FDA) has decreased from sixteen 
in 1983 to only four in 2007 (Figure 4.2) (11). To combat infectious disease, efforts 
must continue to discover and develop new antibiotics.
PBP accessory factors and antibiotic development. The discovery of penicillin 
ushered in a new era for clinical medicine. Its ability to inhibit the PBPs and induce 
bacteriolysis opened new avenues for treating bacterial infections, and the PBPs 
themselves have proven to be very effective drug targets. Regardless of their precise 
biochemical function, the discovery of LpoA and LpoB as essential for the in vivo 
function of the PBPs suggests new avenues for antibiotic development to help combat 
drug-resistant bacteria. By investigating how the Lpo factors control PBP function, we 
may develop a better understanding of the PG synthesis process as a whole. 
	 Furthermore, the observation that LpoA is essential in H. influenzae (38) 
suggests that direct targeting of PBP accessory proteins might be effective in some 
circumstances. Bioinformatics analysis using the STRING program (25) shows that 
even the ESKAPE pathogens mentioned above many contain weak homologs of LpoA, 
LpoB, or both (Table 4.1). However, it is not known whether the organisms that contain 
only a LpoA homolog absolutely require it. Regardless, further study of the 
mechanisms by which these accessory factors influence PBP activity is likely to reveal 
novel ways to block PBP function for therapeutic purposes.
173
Figure 4.2. Antibiotics approved for clinical use by the US Food and Drug 
Administration (FDA). This graph shows the steady decline of the number of 
antibiotics approved by the FDA within the past two decades (11, 18, 32).
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Table 4.1. Lpo factor homologs in the ESKAPE pathogens.
Gram-positive or
Gram-negative?
LpoA
homolog?
LpoB
homolog?
Enterococcus spp. Gram-positive - -
Staphylococcus aureus Gram-positive ✓a -
Klebsiella pneumoniae Gram-negative ✓ ✓
Acinetobacter spp. Gram-negative ✓a -
Pseudomonas aeruginosa Gram-negative ✓ -
Enterobacter sp. 638 Gram-negative ✓ ✓
          aweak homology
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Appendix 1:
Identification of an ABC transporter-like complex that governs cell wall hydrolysis 
during cell division
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Author contributions:
 The work presented in this Appendix was a collaborative effort. All authors had a 
role in conceptualizing experiments, interpreting data, and editing the manuscript while 
Thomas Bernhardt wrote the manuscript. Much of the work described in this chapter 
was performed by Desirée C. Yang, a graduate student in our lab, and is a part of her 
dissertation. She had performed the necessary experiments to show: (i) the subcellular 
localization of EnvC in wild-type and FtsEX- cells, (ii) that EnvC interacts with loop 1 of 
FtsX using the bacterial two-hybrid assay and purified protein pulldowns, (iii) that 
ATPase-defective FtsE results in a cell separation defect, and (iv) that EnvC is no longer 
recruited to the site of division in FtsX mutants lacking loop 1. My contribution was to 
help establish a genetic link between FtsEX and EnvC. In the slb screen, I identified 
that transposon insertions in either gene are synthetically lethal with the absence of 
PBP1b. Nick Peters verified these results by using a PBP1b depletion strain that lacked 
FtsEX or EnvC. He also performed the localization experiments along with western 
blots showing that fluorescently-tagged EnvC was stable with and without FtsEX. 
Katherine Parzych performed experiments showing that ΔenvC and ΔftsEX mutants 
phenocopy each other in a ΔnlpD strain background. She also showed that EnvC is 
stable in the absence of FtsEX.
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Summary
	 ABC transporters are ubiquitous membrane protein complexes that move 
substrates across membranes. They do so using ATP-induced conformational changes 
in their nucleotide binding domains (NBDs) to alter the conformation of the transport 
cavity formed by their transmembrane domains (TMDs). In Escherichia coli, an ABC 
transporter-like complex composed of FtsE (NBD) and FtsX (TMD) has long been 
known to be important for cytokinesis, but its role in the process has remained 
mysterious. Here we identify FtsEX as a regulator of cell wall hydrolysis at the division 
site. Cell wall material synthesized by the division machinery is initially shared by 
daughter cells and must be split by hydrolytic enzymes called amidases to drive 
daughter cell separation. We recently showed that the amidases require activation at 
the cytokinetic ring by proteins with LytM domains, of which EnvC is the most critical. 
In this report, we demonstrate that the FtsEX directly recruits EnvC to the septum via 
an interaction between EnvC and a periplasmic loop of FtsX. Importantly, we also show 
that FtsEX variants predicted to be ATPase defective still recruit EnvC to the septum 
but fail to promote cell separation. Our results thus suggest the attractive possibility 
that amidase activation via EnvC in the periplasm is regulated by conformational 
changes in the FtsEX complex mediated by ATP hydrolysis in the cytoplasm. Since 
FtsE has been reported to interact with the tubulin-like FtsZ protein, this provides a 
potential mechanism for coupling amidase activity with the contraction of the FtsZ 
cytoskeletal ring.
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Introduction
	 Cytokinesis in Escherichia coli and other bacteria is mediated by a ring-shaped 
multi-protein machine called the septal ring or divisome (15). Assembly of this machine 
begins with the polymerization of the tubulin-like FtsZ protein into a ring-like structure 
just underneath the cell membrane at the prospective site of division (7). Several FtsZ-
binding proteins have been identified in E. coli (FtsA, ZipA, ZapA, and ZapC). Along 
with the ZapA-binding protein ZapB, they appear to play partially redundant roles in the 
formation and stabilization of the Z-ring structure (11, 17-19, 22, 26, 28, 42). Once 
formed, the Z-ring promotes septal ring assembly by facilitating the recruitment of the 
remaining essential and non-essential division proteins to the division site according to 
a mostly linear dependency pathway (15). 
	 Because the functions of many of its components are ill-defined, the 
mechanism(s) by which the septal ring promotes cell constriction remain largely 
mysterious (15). One of the most enigmatic division factors has been the ABC-
transporter-like complex formed by FtsE and FtsX (FtsEX) (49). ABC transporters are 
integral membrane protein complexes that use the energy of ATP hydrolysis to 
transport substrates across membranes (45). They are typically composed of two 
polytopic transmembrane domains (TMDs) and a pair of cytosolic nucleotide binding 
domains (NBDs) often called ATP-binding cassettes (ABCs). Structural studies of 
complete ABC-transporters indicate that these complexes undergo remarkable 
conformational changes in response to nucleotide binding and hydrolysis (45). The 
NBD subunits interconvert between an open and a closed conformation at the 
membrane surface during an ATP hydrolysis cycle (45). These conformational changes 
184
are, in turn, transmitted to the TMD subunits to promote transitions between outward-
facing and inward-facing conformations of the central cavity formed by the TMDs (45). 
Transport is thus promoted by alternating access of the substrate-binding site to 
opposing sides of the membrane. 
	 The role of the FtsEX complex in cell division has remained unclear for some 
time (21, 46). FtsE is the NBD component of the complex and FtsX is the TMD 
component (16) (Figure 1.1A-B). Both factors localize to the septal ring and are 
conditionally essential for cell division (49). In medium of low osmotic strength, such as 
LB without added NaCl, cells lacking FtsEX display a lethal division defect (16, 49). 
They form smooth filaments that assemble Z-rings, but these structures are 
compromised because they fail to recruit FtsK and other downstream division factors 
(49). This phenotype along with the observation that FtsE and FtsX interact with several 
different division proteins (10, 35) has lead to the idea that one important function of 
FtsEX is to stabilize the septal ring structure (1, 44, 48). Consistent with this idea, the 
division defect of FtsEX- cells can be partially suppressed by the overproduction of 
other division proteins (FtsZ, FtsN, or FtsP) (44). Increasing the osmolarity of the 
medium and lowering the growth temperature also restores division function to FtsEX- 
mutants (16, 44, 48, 49). The mechanisms by which high osmolarity or division protein 
overproduction 
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Figure A1.1. Domain structure of FtsEX and EnvC. A. Shown is a diagram of the 
FtsEX ABC system. FtsX (X) is the transmembrane domain (TMD) component and FtsE 
(E) is the ATPase component (16). The complex is in the inner membrane (IM) with FtsE 
located on the cytoplasmic face of the membrane. B. Membrane topology of FtsX as 
determined by Weiss and co-workers (1). The loop1 domain is composed of residues 
93-223. Membrane orientation is the same as in (A). C. Domain structure of EnvC. 
EnvC is a periplasmic protein. It possesses an N-terminal signal sequence (residues 
1-34), two relatively long segments predicted to form coiled-coils (CC domain, residues 
35-277), and a C-terminal LytM domain (residues 278-419) needed for amidase 
activation.
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bypass the FtsEX requirement for cell division are not known. However, these growth 
conditions presumably allow essential division proteins downstream of FtsEX in the 
recruitment hierarchy to assemble at the division site in the absence of the complex. 
Indeed, FtsN has been shown to localize to sites of constriction in FtsEX- cells grown in 
LB with 1% NaCl (49). Over the years, many functions for FtsEX have been proposed, 
most of them assuming that it must transport a substrate (1) (and references therein). In 
this report, we present evidence that FtsEX may not be a transporter at all but is 
instead an important regulator of cell wall turnover at the division site. 
	 Most bacteria surround themselves with a polysaccharide cell wall matrix called 
peptidoglycan (PG) (55). This meshwork is essential for cellular integrity and is 
composed of glycan strands connected to one another by crosslinks between attached 
peptide moieties (55) (Figure A1.2). During cytokinesis in gram-negative bacteria, 
septal PG is synthesized by the divisome (15). This material is thought to be initially 
shared by the developing daughter cells and must be split to facilitate outer membrane 
constriction and daughter cell separation (15) (Figure A1.2). Septal PG splitting is 
mediated by the periplasmic PG amidases, AmiA, AmiB, and AmiC (30). Amidases are 
PG hydrolases that break crosslinks in the PG meshwork by cleaving bonds that link 
stem peptides to the glycan strands. Mutants lacking amidase activity complete inner 
membrane constriction and fusion. However, they fail to split septal PG and form long 
chains of cells connected by shared layers of PG and a partially constricted outer 
membrane layer (30, 43).	
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Figure A1.2. Graphical summary of the results described in this paper. See text for 
details.
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	 The amidases must be tightly controlled to prevent them from creating lesions in 
the cell wall that can result in cell lysis. Part of this regulation appears to rely on the 
fact that the PG amidases alone are weakly active enzymes (54). To efficiently 
hydrolyze PG, they require activation by EnvC and NlpD (54), divisome-associated 
proteins with LytM domains (Pfam, Peptidase_M23) (4, 53). EnvC specifically activates 
AmiA and AmiB while NlpD specifically activates AmiC (24). Accordingly, mutants 
lacking both EnvC and NlpD have a chaining phenotype that resembles a triple 
amidase mutant (53). A major unresolved question has been understanding how the 
LytM factors are themselves controlled so that amidase activity at the septum is 
properly coordinated with other activities of the septal ring, such as membrane 
invagination and septal PG synthesis.
	 Using a genetic screen designed to identify factors involved in cell wall 
assembly (40), we found that mutations in ftsEX and envC are synthetically lethal with 
loss-of-function mutations in a common set of genes. This suggested that FtsEX and 
EnvC might participate in the same biochemical pathway. Indeed, when grown under 
permissive conditions, FtsEX- cells phenocopy the cell separation defect displayed by 
EnvC- cells. We further show that EnvC requires FtsEX for its recruitment to the division 
site and that EnvC interacts directly with the large periplasmic loop domain of FtsX. 
Importantly, we also show that FtsEX variants predicted to be ATPase defective still 
recruit EnvC to the septum but fail to promote cell separation. Our results thus suggest 
the attractive possibility that FtsX regulates amidase activation by EnvC in the 
periplasm via conformational changes induced by FtsE-mediated ATP hydrolysis on the 
opposite side of the membrane. Since FtsE has been reported to interact with FtsZ 
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(10), this provides a potential mechanism for directly coupling septal PG hydrolysis with 
the contraction of the Z-ring during cell constriction. Interestingly, the accompanying 
report by Sham and co-workers (50) similarly connects FtsEX with cell separation in the 
gram-positive pathogen Streptococcus pneumoniae, indicating that the regulation of 
cell wall turnover is likely to be a broadly conserved function for FtsEX.
Results
ftsEX and envC mutants share common genetic interactions. To identify factors 
important for cell wall biogenesis, we recently performed a genetic screen for 
mutations synthetically lethal with the inactivation of the PG synthase PBP1b (slb 
mutants) (40). In addition to mutants in the lpoA gene coding for a lipoprotein cofactor 
required for the activity of PBP1a (40, 52), we isolated mutants with transposon 
insertions in envC and ftsEX. The ftsEX mutant was isolated in a screen performed at 
room temperature, a condition that we find suppresses the lethal effects of FtsEX 
inactivation. To confirm the synthetic lethality of the mutant combinations, ΔenvC and 
ΔftsEX alleles were transduced into strain MM11 [Para::ponB] harboring the low copy 
plasmid pTB63 [ftsQAZ], which expresses the ftsQAZ operon from native promoters 
and suppresses the FtsEX- growth defect. In MM11, the native ponB promoter was 
replaced with Para such that ponB expression is arabinose-dependent (40). Depletion of 
PBP1b in the absence of FtsEX or EnvC was confirmed to be lethal (Figure A1.3A). The 
terminal phenotype in both cases was cell lysis. Since EnvC is needed to activate the 
amidases AmiA and AmiB at the developing septum, we tested whether the combined 
inactivation of AmiA and AmiB was also lethal upon PBP1b depletion. This indeed 
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proved to be the case (Figure A1.3A). We do not currently know why the inactivation of 
FtsEX, EnvC, or AmiA/AmiB renders PBP1b essential for growth. Nevertheless, the 
observed phenotypes suggested to us that FtsEX may function in the process of septal 
PG splitting with EnvC and the amidases.
 The loss of FtsEX function was previously shown to be synthetically lethal with 
the deletion of ftsP (sufI) (44). We confirmed this and found that the depletion of EnvC 
was also synthetically lethal with ΔftsP (Figure A1.3B-C), thus further connecting the 
functions of EnvC and FtsEX. As expected for proteins functioning in the same 
pathway, loss of EnvC function was not lethal upon FtsEX depletion (Figure A1.3B).
FtsEX is required for daughter cell separation. While performing the FtsEX depletion 
experiments in Figure A1.3B, we found that growth on minimal agar at 37oC partially 
suppressed the FtsEX- growth defect. We assume this is due to the higher osmolarity 
of the medium relative to standard LB (0.5% NaCl) and the slower overall growth rate 
of the cells. The suppression in liquid minimal medium was even more pronounced, 
especially when cells were grown at 30oC. Here, FtsEX- cells displayed a much more 
mild division defect resembling that typically observed for EnvC- cells (53) (see below). 
A similar division defect was also observed for ΔenvC and ΔftsEX mutants harboring an 
ftsQAZ overproducing plasmid (pTB63) when we grew them in LB (1% NaCl) (Figure 
A1.4A-C). It thus appeared that under conditions that suppressed the septal ring 
stability defect of FtsEX- cells, a potential role for the FtsEX complex in EnvC-mediated 
cell separation was revealed. Interestingly, we note that, although not as severe
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Figure A1.3. Shared synthetic lethal phenotypes of envC and ftsEX mutants. 
A. Cells of MM11/pTB63 [Para::ponB/ftsQAZ] and its ΔenvC, ΔftsEX, or ΔamiA ΔamiB 
derivatives were grown overnight in M9 arabinose medium supplemented with 5 µg/ml 
tetracycline (Tet5) at 37oC. Following normalization for cell density (OD600 = 2), the 
resulting cultures were serially diluted (10-1-10-6) and 5 µl of each dilution was spotted 
on the indicated medium. Plates were incubated overnight at 37oC and photographed. 
B. Cells of TU191(attλTU188) [ΔftsEX (Para::ftsEX)] and its ΔenvC or ΔftsP derivatives 
were processed as in (A) except growth was in the absence of tetracycline. C. Cells of 
TB140(attλTD25) [ΔenvC (Para::envC)] and its ΔftsP derivative were grown and 
processed as in (B).
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as the FtsEX- division defect, EnvC- cells display a lethal filamentation phenotype when 
grown in LB without added NaCl at 42oC (29, 33, 47). This suggests that at least part of 
the constriction defect of FtsEX- cells may be the result of EnvC inactivation. 
	 We previously showed that cells lacking EnvC become dependent on NlpD for 
cell separation (53). Cells lacking EnvC and NlpD appear to be completely defective in 
cell separation and form very long chains that resemble triple amidase mutants (53) 
(Figure A1.4D-F). We reasoned that if FtsEX is truly required for EnvC-mediated cell 
separation, the simultaneous inactivation of FtsEX and NlpD should also result in a 
severe chaining phenotype. This indeed proved to be the case (Figure A1.4D-F). We 
therefore conclude that FtsEX is required for EnvC to promote septal PG splitting. 
EnvC is stable and released into the periplasm in the absence of FtsEX. A potential 
reason for the FtsEX-EnvC connection is that EnvC requires FtsEX for its stable 
accumulation. To investigate this, we compared EnvC levels in total cell extracts 
prepared from WT versus ΔftsEX cells (Figure A1.5A). Immunoblotting with affinity-
purified, anti-EnvC polyclonal antibodies revealed that similar amounts of EnvC 
accumulate whether or not cells produce FtsEX (Figure A1.5A, compare lanes 1-3 
with 7-9). We did, however, observe low concentrations of smaller immuno-reactive 
species in the ΔftsEX extract that were not seen in the WT or ΔenvC extracts, 
indicating that a small portion of EnvC is probably proteolytically processed in the 
absence of FtsEX (Figure A1.5A). This low level of processing is unlikely to explain the 
EnvC- phenotype of ΔftsEX cells. 
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Figure A1.4. FtsEX- and EnvC- cells have similar division defects. Cells of TB28 
[WT] (A), KP4 [ΔenvC] (B), KP5 [ΔftsEX] (C), TB145 [ΔnlpD] (D), KP6 [ΔnlpD ΔenvC] 
(E), and KP7 [ΔnlpD ΔftsEX] (F) harboring pTB63 [ftsQAZ] were grown overnight in LB-
Tet5 [1.0% (A-C) or 1.5% (D-F) NaCl] at 30oC. Cultures were diluted 1:200 into the same 
medium and grown at 30oC to an OD600 of 0.6-0.8. Cells were then incubated with the 
fixable membrane stain FM1-43FX (5 µg/ml) for 10 min and fixed. Fixed cells were 
visualized on 2% agarose pads using DIC (panels A1-F1) and GFP (panels A2-F2) 
optics. Bars equal 4 microns.
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 Since FtsEX is related to ABC transporters, one possible way in which it might 
promote EnvC function is by facilitating its export to the periplasm. To investigate this, 
we fractionated cells to determine the subcellular localization of EnvC in the presence 
or absence of FtsEX. WT and ΔftsEX cells were suspended in buffer containing sucrose 
and converted to spheroplasts by the addition of EDTA and lysozyme. In WT cells, 
EnvC pelleted with the spheroplasts rather than remaining in the soluble periplasmic 
fraction like the MalE control (Figure A1.5B, lanes 1-3). In contrast, EnvC was found 
almost exclusively in the periplasmic fraction from FtsEX- cells. The FtsZ and MalE 
fractionation controls indicated that this change in EnvC localization was not due to 
altered fractionation properties of the FtsEX- cells (Figure A1.5B, lanes 4-6). Thus, 
FtsEX is not required for the export of EnvC to the periplasm. This is consistent with 
previous reports suggesting that EnvC is a Sec substrate (29) and that its signal 
sequence can be functionally replaced by alternative signal peptides for Tat- or Sec- 
mediated transport (4, 54). Furthermore, the fractionation results suggest that EnvC 
remains associated with the outer face of the inner membrane of WT cells, possibly 
through an interaction with FtsX, and that it is released into the periplasm in the 
absence of this interaction (see below). 
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Figure A1.5. Change in EnvC subcellular localization in the absence of FtsEX. A. 
Cells of TB28 [WT], KP4 [ΔenvC], or KP5 [ΔftsEX] harboring pTB63 [ftsQAZ] were 
grown overnight in LB (1.0% NaCl)-Tet5 at 30oC. Cultures were diluted 1:100 into LB-
Tet5 and grown at 30oC to an OD600 of 0.66-0.72. Cell extracts were then prepared and 
the indicated total protein amounts (µg) were subjected to immunoblotting using affinity 
purified EnvC antibodies. Arrow indicates position of FLEnvC bands, and the bar with the 
asterisk highlights what appears to be a small amount of EnvC degradation products in 
extracts from the ΔftsEX mutant. Positions of the molecular weight markers are 
indicated on the left. B. Cultures of the strains in (A) were grown as above to an OD600 
of 0.39-0.46. (Legend continued on next page.)
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Figure A1.5 (Continued) One aliquot of cells was used to prepare a total cell extract. 
The remaining cells were converted to spheroplasts and pelleted by centrifugation. The 
resulting pellet (P) and supernatant (S) fractions along with the total cell extract (T) were 
analyzed by SDS-PAGE and immunoblotting for EnvC, FtsZ, and MalE as indicated. 
FtsZ and MalE served as markers for the cytoplasm/spheroplast membranes and 
periplasm, respectively.
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FtsEX is required for the recruitment of EnvC to the septal ring. In addition to 
subcellular fractionations, we also investigated the role of FtsEX in the recruitment of 
EnvC to the septal ring. To do so, we constructed an FtsEX depletion strain 
NP69(attλTU188)(attHKTB316) [ΔftsEX ΔenvC zapA-gfp (Para::ftsEX)(Plac::envC-
mCherry)]. In this strain, the native ftsEX locus was deleted and a second copy of ftsEX 
under arabinose promoter (Para) control was integrated at the λ att site. The strain also 
encodes zapA-gfp at the native zapA locus and expresses envC-mCherry from an 
expression cassette integrated at the HK022 att site. When grown in M9 maltose 
medium containing a small amount of arabinose (0.01%), cells of NP69(attλTU188)
(attHKTB316) divided normally and displayed bands of both EnvC-mCherry and ZapA-
GFP at the division sites of most cells (Figure A1.6A). Conversely, when the same cells 
were grown in M9 maltose medium containing a small amount of glucose (0.01%) to 
repress Para::ftsEX, they displayed the heterogeneous cell constriction and separation 
phenotype typical of FtsEX- and EnvC- cells (Figure A1.6B). While most cells appeared 
capable of cell division, many were elongated and appeared to have difficulty 
completing cell separation. The Z-ring marker, ZapA-GFP, formed rings/bands in these 
elongated cells at fairly regular intervals, but EnvC-mCherry failed to be recruited to 
these structures (Figure A1.6B). Immunoblot analysis indicated that this localization 
defect was not due to excessive degradation of the EnvC-mCherry fusion (Figure 
A1.7). We thus conclude that FtsEX is required for the recruitment of EnvC to the septal 
ring. 
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Figure A1.6. FtsEX is required for the recruitment of EnvC to the division site. 
Cells of NP69(attλTU188)(attHKTB316) [ΔftsEX ΔenvC zapA-gfp (Para::ftsEX)
(Plac::envC-mCherry)] were grown overnight in M9 maltose supplemented with 0.01% 
arabinose. Cells were washed twice with and resuspended in an equal volume of M9 
medium without added sugar. They were then diluted 1:100 into M9 maltose and growth 
was continued at 30oC with the addition of either 0.01% arabinose (A) or 0.01% glucose 
(B). (Legend continued on next page.)
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Figure A1.6 (Continued) When the cultures reached an OD600 of 0.4-0.6, cells were 
visualized on 2% agarose pads using mCherry (panel 1), GFP (panel 2), or DIC (panel 
3) optics. Bar equals 4 microns. Note that a peripheral EnvC-mCherry signal was not 
observed in (B) as might be expected for a periplasmic protein. This is likely because 
too little fusion protein is present to raise the peripheral signal above background.
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Figure A1.7. EnvC-mCherry accumulation in FtsEX+ and FtsEX- cells. Cells of TB28 
[WT], TB140 [ΔenvC], and NP69(attλTU188)(attHKTB316) [ΔftsEX ΔenvC zapA-gfp 
(Para::ftsEX)(Plac::envC-mCherry)] were grown as described in the legend for Figure 
A1.6. When the cultures reached an OD600 of 0.4-0.6, cells were harvested for whole-
cell extract preparation. Proteins in the resulting extracts were separated by SDS-
PAGE, transferred to PVDF, and EnvC was detected with affinity purified anti-EnvC 
antibodies. Relevant genotypes and growth conditions are indicated above the 
corresponding lanes as well as the amount of total protein (µg) loaded per lane. Asterisk 
indicates an EnvC-mCherry breakdown product observed in both FtsEX+ and FtsEX- 
cells.
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The large periplasmic loop of FtsX interacts directly with EnvC. Our results thus far 
suggested that FtsEX may directly interact with EnvC to recruit it to the division site. 
The large periplasmic loop of FtsX (residues 93-223, Loop1FtsX) (Figure A1.1B) seemed 
a likely candidate for mediating the interaction with EnvC. We therefore tested the 
potential interaction between full-length, mature EnvC (FLEnvC) and Loop1FtsX using a 
bacterial two-hybrid (BACTH) assay based on the reconstitution of adenylate cyclase 
activity from the fragments T18 and T25 (34). FLEnvC-T25 showed a strong interaction 
signal when paired with a Loop1FtsX-T18 fusion (Figure A1.8A). EnvC contains three 
identifiable domains: a signal peptide (residues 1-34), a coiled coil (CC) domain 
(residues 35-271), and a LytM domain (residues 318-413) (4, 29, 33) (Figure A1.1C). An 
interaction signal with Loop1FtsX-T18 was not detected when an EnvC truncation lacking 
the CC domain (LytEnvC) was fused to T25 in place of FLEnvC (Figure A1.8A). This 
result suggests that the EnvC-FtsX interaction is mediated by contacts between 
Loop1FtsX and the CC domain of EnvC (CCEnvC). However, for reasons that are not clear, 
T25 fusions to CCEnvC did not show an interaction signal when co-expressed with 
Loop1FtsX-T18. 
 To further investigate the interaction between FtsX and EnvC, we purified 
untagged versions of FLEnvC, LytEnvC, and CCEnvC as well as a 10xHis (H)-tagged 
version of Loop1FtsX (H-Loop1FtsX). We then tested for interactions using “pull-up” assays 
with magnetic Ni-NTA beads. When FLEnvC was incubated with H-Loop1FtsX, it was 
found in the eluate from Ni-NTA beads following two wash steps (Figure A1.8B). 
Consistent with the BACTH results, this was not the case when LytEnvC was incubated 
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Figure A1.8. EnvC directly interacts with the large periplasmic loop of FtsX. A. 
Plasmid pairs encoding the indicated FLEnvC-T25 or LytEnvC-T25 and Loop1FtsX-T18 
fusion proteins were co-transformed into BTH101 [cya-99]. Individual colonies were 
patched on M9-glucose supplemented (Legend continued on next page.)
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Figure A1.8 (Continued) with Amp, Kan, X-gal, and 1 mM IPTG. Plates were incubated 
at room temperature and photographed after 72 hours. For this particular BACTH assay, 
interacting partners bring together T18 and T25 to reconstitute adenylate cyclase 
activity. This is detected using lacZ induction as a reporter. B-D. Purified H-Loop1FtsX 
was incubated with FLEnvC (B), LytEnvC (C), or CCEnvC (D) for 100 min at room 
temperature in binding buffer [20mM Tris-HCl (pH 7.4), 150mM NaCl]. Ni-NTA magnetic 
agarose beads (Qiagen) were then added to each reaction and they were further 
incubated for 120 min at 4oC with rotation. The magnetic beads were captured with a 
magnet, washed twice with binding buffer containing 50mM imadazole, and the proteins 
retained on the resin were eluted with sample buffer containing EDTA (100 mM). 
Proteins in the initial reaction (input), initial supernatant (UB), wash supernatants (W1 
and W2), and eluate were separated on a 15% Tris-Tricine polyacrylamide gel and 
stained with Coomassie Brilliant Blue. All proteins were present in the initial binding 
reaction at a concentration of 4 µM. Positions of molecular weight markers (numbers in 
kDa) are given to the left of each gel. Control reactions indicated that none of the 
purified EnvC derivatives could be pulled up with H-GFP.
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with H-Loop1FtsX (Figure A1.8C). Here, LytEnvC was found primarily in the unbound (UB) 
fraction. When we incubated CCEnvC with H-Loop1FtsX, only about half of the H-
Loop1FtsX was retained by the beads. It was accompanied in the eluate by a small 
fraction (about 10%) of the total CCEnvC, indicating that the two domains weakly 
interact. The remaining H-Loop1FtsX was found in the unbound fraction with the majority 
of CCEnvC. Since H-Loop1FtsX bound efficiently to the beads in the presence of FLEnvC 
and LytEnvC, the addition of CCEnvC appears to adversely affect the accessibility of the 
H-tag on H-Loop1FtsX. This may be the result of CCEnvC inducing some sort of 
conformational change in H-Loop1FtsX, but further investigation is required to test this 
possibility. 
 To determine the physiological relevance of the EnvC-Loop1FtsX interaction, we 
investigated the effect of deleting various portions of the FtsX loop domain on the 
recruitment of EnvC to the division site. To do so, we a generated a construct 
expressing the ftsEX operon under control of Plac with the ftsX reading frame fused to 
the coding sequence for GFP. The expression construct thus produces untagged FtsE 
as well as FtsX-GFP. For convenience, we will refer to the fusion as FtsEX-GFP. In 
addition to the WT fusion, we also generated several variants deleted for various 
portions of the Loop1 domain of FtsX. When produced as the only source of FtsEX in 
strain DY18(attλTD80)(attHKDY156) [ΔftsEX ΔenvC (Plac::envC-mCherry)(Plac::ftsEX-
gfp)], the FtsEX-GFP fusion corrected the ΔftsEX division phenotype, localized to the 
division site, and was functional for the recruitment of EnvC-mCherry to the septal ring 
(Figure A1.9A). All of the Loop1 deletion derivatives of FtsX-GFP we tested (Δ152-161, 
Δ146-165, Δ137-176, and Δ109-213) localized to the division site (Figure A1.9B and 
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Figure A1.10), indicating that the Loop1 domain is not an important localization 
determinant for FtsX. However, even the derivative with the smallest deletion 
(Δ152-161) failed to recruit EnvC to the septum, and cells expressing these derivatives 
displayed an EnvC- like division defect (Figure A1.9B and Figure A1.10). We conclude 
that the Loop1-EnvC interaction we detected in the BACTH and in vitro assays is 
required for the recruitment of EnvC to the septal ring. 
 
The ATPase activity of FtsE is likely required for amidase activation by EnvC. 
Weiss and co-workers recently showed that FtsE residues in and around the Walker A 
(GxxGxGKS/T, where x is any residue) and Walker B (ϕϕϕϕD, where ϕ is a 
hydrophobic residue) motifs predicted to be important for ATP hydrolysis are required 
for FtsEX to function in cell division (1). Interestingly, however, these residues were not 
found to be needed for the stability of FtsE or the recruitment of either FtsE or FtsX to 
the division site (1). Also, unlike ftsEX null mutants, division proteins downstream of 
FtsEX in the localization hierarchy were recruited to the septal ring in the presence of 
these predicted ATPase defective variants when mutant cells were grown under non-
permissive conditions (1). Thus, by all indications, complete septal rings were forming 
in the filamentous cells producing the FtsE mutants; they were just unable to promote 
cell constriction without ATP hydrolysis by FtsEX (1). 
	 Our results thus far indicate that FtsEX directly recruits EnvC to the septal ring. 
Given the findings of Arends et al. (2009), we also wondered if the ATPase activity of 
FtsE might be required to stimulate amidase activation by EnvC. We therefore 
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Figure A1.9. EnvC localization in cells producing FtsEX variants. Cells of 
DY18(attλTD80) [ΔftsEX ΔenvC (Plac::envC-mCherry)] harboring the integrated 
expression constructs (attHKDY156) [Plac::ftsEX-GFP] (A), (attHKDY161) 
[Plac::ftsEX(Δ152-161)-GFP] (B), or (attHKDY167) [Plac::ftsE(D162N)X-GFP] (C) were grown 
overnight at 30oC in LB (1% NaCl). They were then diluted 1:100 into M9 maltose 
supplemented with 500 µM IPTG. When cells reached an OD600 between 0.42-0.54 they 
were visualized as described in the legend for Figure A1.6.
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Figure A1.10. EnvC localization in cells producing Loop1FtsX deletions. Cells of 
DY18(attλTD80) [ΔftsEX ΔenvC (Plac::envC-mCherry)] harboring the integrated 
expression constructs (attHKDY162) [Plac::ftsEX (Δ146-165)-GFP] (A), (attHKDY163) 
[Plac::ftsEX(Δ137-176)-GFP] (B), or (attHKDY165) [Plac::ftsEX (Δ109-213)-GFP] (C) were grown 
and visualized as described in the legend for Figure A1.9.
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generated ftsE(K41M), ftsE(D162N), and ftsE(E163Q) derivatives of the Plac::ftsEX-gfp 
construct described above. The encoded FtsE variants (FtsE*) in these constructs are 
similar to those studied previously by Arends et al. (2009), except that more 
conservative amino acid changes were made. The K41M substitution in the Walker A 
motif of FtsE is predicted to greatly reduce affinity for ATP (14). The Walker B residue, 
D162, is predicted to coordinate Mg2+ in the active site (14). Substitutions at this 
residue in other NBDs abrogate ATP binding (14). An acidic residue, E163 in FtsE, 
typically follows the Walker B motif in ABC transporters. The role of this residue in the 
ATPase catalytic mechanism is controversial (14). NBDs with Glu to Gln substitutions at 
this position still bind ATP, but depending on the particular transporter, they may or 
may not retain residual ATPase activity (14). 
 The ability of the FtsE* variants to promote cell separation was first assessed by 
producing them from the Plac::ftsEX-gfp construct in ΔftsEX ΔnlpD cells. As expected, a 
construct producing WT FtsE completely reversed the severe chaining phenotype of 
the FtsEX- NlpD- mutants (Figure A1.11, Table A1.1). Constructs producing the FtsE* 
variants, on the other hand, all failed to restore normal cell separation Figure A1.11, 
Table A1.1). However, the mutants did not behave identically. While FtsE(D162N) 
appeared to be completely defective for cell separation, the FtsE(K41M) and 
FtsE(E163Q) variants appeared to retain partial function (Table A1.1). Based on results 
from the related LolCDE system, FtsE(K41M) is likely to retain weak affinity for ATP (35). 
This may allow enough ATPase activity to reduce the length of the chains observed in 
ΔftsEX ΔnlpD cells. For FtsE(E163Q), its ability to shorten ΔftsEX ΔnlpD chains may 
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Figure A1.11. FtsE ATP-binding site lesions result in a cell separation defect. Cells 
of KP7/pTB63 [ΔftsEX ΔnlpD/ftsQAZ ] without an integrated expression cassette (A) or 
harboring (attHKDY156) [Plac::ftsEX-GFP] (B), (attHKDY166) [Plac::ftsE(K41M)X-GFP] 
(C), (attHKDY167) [Plac::ftsE(D162N)X-GFP] (D), or (attHKDY168) [Plac::ftsE(E163Q)X-
GFP] (E)were grown and visualized as described in the legend to Figure A1.4 except 
that the medium contained 500 µM IPTG.
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Table A1.1. Cell separation phenotypes of FtsE* NlpD- cells. 
strain genotype #cellsa # cell unitsb
total L
(µm)c
avg. L
(µm)c
total 
septa
L/
septum
septa/
cell
KP7 ΔftsEX ΔnlpD 4 225 388 97 218 1.8 55
KP7
(attHKDY156)
ΔftsEX ΔnlpD
(Plac::ftsEX-GFP) 144 200 475 3.3 56 8.5 0.4
KP7
(attHKDY166)
ΔftsEX ΔnlpD
(Plac::ftsE(K41M)X-
GFP)
31 202 491 15.8 171 2.9 6
KP7
(attHKDY167)
ΔftsEX ΔnlpD
(Plac::ftsE(D162N)X
-GFP)
9 214 434 48.2 208 2.1 23
KP7
(attHKDY168)
ΔftsEX ΔnlpD
(Plac::ftsE(E163Q)X
-GFP)
74 200 618 8 127 4.9 2
aCell chains were considered as a single cell regardless of the number of segments they contained.
bIndicates the number of cell compartments in chaining cells. 
cLength measurements represent a minimum because many of the cell chains extended beyond the field 
of view.
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either indicate that ATP-binding alone is sufficient for low-level cell separation activity, 
or that the E/Q substitution in FtsEX does not completely abolish ATPase activity. 
Measurement of the ATPase activity of FtsE and the FtsE* variants is required to 
distinguish between these possibilities, but this has not been possible due to problems 
with FtsE solubility when it was overproduced. Nevertheless, the (partial) loss-of-
function phenotypes displayed by the FtsE* variants clearly highlight a role for key ATP-
binding site residues in FtsE for it to promote proper cell separation. Importantly, FtsX-
GFP remained capable of recruiting to septal rings in cells producing the FtsE* variants 
and the efficiency with which EnvC-mCherry was recruited to the FtsX-containing rings 
was largely unaffected by the FtsE lesions (Figure A1.9C, Figure A1.12, and Table 
A1.2). Furthermore, based on the results of Arends et al. (2009) with similar mutants, 
we assume that the FtsE* variants described here are also normally recruited to the 
septal ring. Thus, FtsE*X-EnvC complexes are likely forming at the division site in cells 
expressing the ftsE* alleles but they fail to function or function poorly in the septal PG 
splitting process. We therefore infer that the ATPase activity of the FtsEX complex 
plays an important role in promoting amidase activation by EnvC at the septum. 
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Figure A1.12. EnvC localization in cells producing FtsE* variants. Cells of 
DY18(attλTD80) [ΔftsEX ΔenvC (Plac::envC-mCherry)] harboring the integrated 
expression constructs (attHKDY166) [Plac::ftsE(K41M)X-GFP] (A) or (attHKDY168) 
[Plac::ftsE(E163Q)X-GFP] (B) were grown and visualized as described in the legend for 
Figure A1.9.
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Table A1.2. Length and localization measurements of FtsE* cells producing FtsX-
GFP and EnvC-mCherry.
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Discussion
	 The role of the FtsEX ABC system in cytokinesis has long remained mysterious. 
In this study, we have genetically and physically connected FtsEX with the process of 
septal PG splitting. Our results indicate that the complex is directly responsible for the 
recruitment of the amidase activator EnvC to the cytokinetic ring. Importantly, we also 
showed that variants of the FtsEX complex predicted to have inactive ATPase subunits 
still recruited EnvC to the septum but failed to induce septal PG splitting. Thus, in 
addition to connecting EnvC to the septal ring, FtsEX appears to use its ATPase activity 
to promote amidase activation. An attractive possibility is that it does so using ATPase-
induced conformational changes similar to those observed in other ABC systems (45) 
to allosterically regulate EnvC activity in the periplasm (Figure A1.13). 
 Consistent with this model, sequence analysis groups FtsEX with a sub-class of 
ABC systems comprised mainly of substrate binding protein (SBP)-dependent 
importers like the maltose transporter (MalFGK2) (14). The structure of MalFGK2 in 
complex with maltose binding protein (MalE) indicates that ATP-driven conformational 
changes in the transporter can alter the conformation of periplasmic MalE (36). In this 
case, MalE is converted from its closed, maltose-bound conformation to an open 
conformation that releases maltose into the outward-facing cavity of the transporter for 
subsequent import (36). We therefore propose that EnvC may be an SBP analog for 
FtsEX and envision that the conformation of EnvC is similarly modulated by the ABC 
system so that it interconverts between an “on” and “off” state during an ATPase cycle 
(Figure A1.13). Such a model is appealing for several reasons. Most significantly, it 
would provide a means for converting septal PG 
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Figure A1.13. Model for FtsEX function in regulating PG hydrolase activity at the 
division site. Shown is a schematic diagram of a putative FtsEX-EnvC-amidase 
complex at the Z-ring. We propose that conformational changes in FtsEX induced by 
FtsE-mediated ATP hydrolysis are transmitted to EnvC to control its ability to activate 
the amidases so that they can cleave the septal PG (not drawn). The model is not 
meant to reflect actual interaction stoichiometries as they have yet to be determined. In 
addition, it is not yet clear if the amidases remain in complex with EnvC as drawn or if 
this interaction is also regulated. See text for details.
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hydrolysis into a discrete process with a fixed number of PG bonds being broken per 
ATP hydrolyzed. This would afford the septal ring exquisite control over PG hydrolysis, 
which seems highly desirable given the inherent risks involved in promoting localized 
PG degradation. Additionally, since FtsE interacts with FtsZ in the cytoplasm, the 
ATPase activity of FtsE could be directly coupled to Z-ring dynamics. Thus, the FtsEX 
complex could serve as a molecular governor to properly coordinate the rate of septal 
PG hydrolysis with the contraction of the Z-ring. Finally, in addition to connecting the 
Z-ring with septal PG hydrolysis, interactions of FtsX with other transmembrane 
components of the divisome may help couple the activity of the integral membrane PG 
synthases with the cell separation amidases. For example, the FtsEX complex may 
only promote EnvC-activated amidase activity when it is engaged with an active PG 
synthetic complex. 
	 Control of EnvC activity by FtsEX is likely mediated in part by the observed 
interaction between the CC domain of EnvC and Loop1FtsX. Consistent with this 
possibility, the CC domain of EnvC was previously shown to be important for EnvC 
regulation (54). An EnvC truncation lacking the CC domain (LytEnvC) failed to be 
recruited to the division site and inappropriately activated AmiA and AmiB to induce 
cell lysis (54). Since cell lysis is not triggered when FLEnvC is displaced from the 
septum by CCEnvC overproduction (54) or by the deletion of ftsEX, proper regulation of 
amidase activation appears to entail more than just controlling EnvC localization. 
Because FLEnvC activates the amidases just as well as LytEnvC in vitro (54), we suspect 
that there is either something about the physiochemical environment of the periplasm 
that promotes the direct inhibition of FLEnvC activity by the CC domain itself or that 
217
inhibition is mediated by an additional factor that associates with the CC domain. 
According to our model for EnvC regulation by FtsEX, it is this auto- or trans-inhibition 
of EnvC that is cycled on and off in response to the ATPase activity of FtsEX (Figure 
A1.13). 
	 While we favor a model in which FtsEX serves as a transmembrane allosteric 
regulator of EnvC, scenarios in which FtsEX transports a molecule needed for EnvC 
activity are difficult to exclude. Arguing against a transport function is the fact that 
FtsEX is most similar to the LolCDE ABC system. Rather than catalyzing the transport 
of a substrate across a membrane, LolCDE facilitates the transfer of lipoproteins from 
the outer leaflet of the inner membrane to the periplasmic LolA carrier protein for their 
ultimate insertion into the outer membrane (56). The individual TMD components of 
both FtsEX and LolCDE have only four transmembrane helices, unlike most ABC-
transporters, which typically have at least six (1, 12, 14). Moreover, the membrane 
spanning helices of FtsX do not contain any charged amino acids as might be 
expected for a factor that transports an electrolyte (1). Based on these observations, 
Weiss and colleagues have also proposed that FtsEX may not be a transporter (1). 
Rather, they hypothesized that, as we propose here, FtsE uses ATP hydrolysis to drive 
a periplasmic activity via conformational changes in FtsX (1). Reconstitution of EnvC 
regulation by FtsEX is required to definitively demonstrate an allosteric control 
mechanism. So far, our attempts at reconstitution have been unsuccessful. Addition of 
purified Loop1FtsX or full-length FtsX to mixtures of EnvC and AmiB did not affect 
amidase activation using our standard reaction conditions (54). This suggests that the 
full FtsEX complex may be needed to observe regulation in vitro. Unfortunately, efforts 
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to purify the complete FtsEX complex have been hampered by the insolubility of FtsE 
when it is overproduced. This hurdle must be overcome before additional attempts at 
reconstitution can be pursued. 
	 A role for FtsEX in the process of septal PG splitting appears to be conserved. In 
an accompanying report (50), Sham et al. directly connect the essential cell separation 
factor PcsB (39) with FtsEX in S. pneumoniae. While their sequences are largely 
unrelated, the domain structures of PcsB and EnvC are strikingly similar. Like EnvC, 
PcsB has an N-terminal region predicted to form coiled-coils and a C-terminal PG 
hydrolase-like CHAP domain (39). However, it is currently not known whether PcsB 
directly degrades PG or if, analogous to EnvC, it is an activator of other PG hydrolases. 
Nevertheless, the results of Sham et al. (2011) (50) indicate that PcsB activity is likely 
governed by FtsEX to properly control the process of septal PG splitting in S. 
pneumoniae. Interestingly, FtsEX does not appear to be involved in cell division in 
Bacillus subtilis (20). We suspect this has to do with the different septal geometries of 
these organisms. Gram-negative bacteria like E. coli and ovococci like S. pneumoniae 
appear to couple septal PG splitting with the invagination of their cytoplasmic 
membrane to give their pre-divisional cells a constricted appearance (15, 31). This 
mode of division likely requires regulators of PG hydrolysis like FtsEX to be associated 
with the septal ring. B. subtilis and many other gram-positive bacteria, on the other 
hand, first construct a flat septum, the splitting of which appears to be uncoupled from 
membrane constriction and fission (8). Septal PG splitting in these cells is therefore 
likely to have regulatory requirements that differ from those of constricting cells. It is 
not clear what the function of FtsEX is in cells with a flat septal morphology, but it may 
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involve the regulation of PG hydrolysis needed for other aspects of cell wall growth and 
remodeling. 
	 In conclusion, we have identified a role for the FtsEX ABC system in the 
regulation of septal PG hydrolysis by the amidases AmiA and AmiB and the LytM factor 
EnvC. A second pathway for septal PG splitting involving AmiC and the LytM factor 
NlpD is also operative in E. coli (54). How this system is regulated is currently not 
known. However, since NlpD is an outer membrane lipoprotein (32) rather than a 
periplasmic protein like EnvC, its activity is likely to be modulated by a distinct 
mechanism. To our knowledge, this report describes the first example of an ABC 
system being implicated in the transmembrane regulation of enzymatic activity. Given 
the diversity and ubiquity of ABC systems in nature (14), it is likely that the ATP-driven 
conformational changes in these membrane complexes have been adapted to regulate 
a variety of biological processes. 
Materials and Methods
Media, bacterial strains, and plasmids
 Cells were grown in LB [1% tryptone, 0.5% yeast extract, (0.5%-1.5% NaCl as 
indicated)] or minimal M9 medium (37) supplemented with 0.2% casamino acids and 
0.2% sugar (glucose, maltose, or arabinose as indicated). Unless otherwise indicated, 
antibiotics were used at 5, 10, 15, 20, or 50 µg/ml for tetracycline (Tet), 
chloramphenicol (Cam), ampicillin (Amp), kanamycin (Kan), or spectinomycin (Spec), 
respectively. 
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 The bacterial strains used in this study are listed in Table A1.3. All strains used 
in the reported experiments are derivatives of MG1655 (23). Plasmids used in this 
study are listed in Table A1.4. Vectors with R6K origins are all derivatives of the CRIM 
plasmids developed by Wanner and co-workers (25). They were either maintained in 
the cloning strain DH5α(λpir) where they replicate as plasmids, or they were integrated 
into phage attachment sites (HK022 or λ) using the helper vectors pTB102 (5) or pInt-ts 
(25), respectively, as described previously (25). Single copy integrants were identified 
using diagnostic PCR (25). Integrated vectors were transferred between strains by P1-
mediated transduction. In all cases, PCR was performed using KOD polymerase 
(Novagen) according to the instructions. Unless otherwise indicated, MG1655 
chromosomal DNA was used as a template. Restriction sites for use in plasmid 
constructions are italicized and underlined in the primer sequences given below. 
Plasmid DNA and PCR fragments were purified using the Qiaprep spin miniprep kit 
(Qiagen) or the Qiaquick PCR purification kit (Qiagen), respectively.
pTU188
 To construct pTU188 [attλ cat Para::ftsE-ftsX], a fragment containing ftsE and ftsX 
was amplified with the primers 5’-GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ 
and 5’-GTCAAAGCTTTTATTATTCAGGCGTAAAGTGGCG-3’, digested with XbaI and 
HindIII, and inserted into the corresponding XbaI-HindIII sites of pTB285 (40)}. 
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Table A1.3. Bacterial strains used in this study.
Straina Genotypeb Source/Referencec
DH5α F
– hsdR17 deoR recA1 endA1 phoA supE44 thi-1 
gyrA96 relA1 Δ(lacZYA-argF)U169 ϕ80dlacZΔM15 Gibco BRL
BL21(λDE3) ompT rB– mB– (PlacUV5::T7gene1) Novagen
BTH101 F
–, glnV44(AS), recA1, endA1, gyrA96, thi1, 
hsdR17, spoT1, rfbD1 cya 34
BW25113 Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) rph-1 Δ(rhaD-rhaB)568 hsdR514 2
JW5646 BW25113 ΔenvC::KanR 2
JW2985 BW25113 ΔftsP(sufI)::KanR 2
MG1655 rph1 ilvG rfb-50 23
MM9 TB28 (KanR araC Para)::ponB 40
MM11 TB28 (frt araC Para)::ponB 40
TB10 rph1 ilvG rfb-50 λΔcro-bio nad::Tn10 4
TB28 MG1655 ΔlacIZYA::frt 4
TB140 TB28 ΔenvC::frt 53
TB145 TB28 ΔnlpD747::frt 53
TB172 TB28 ΔamiA::frt ΔamiB::frt (KanR araC Para)::ponB P1(MM9) x TU207
TU122 TB28 ΔponB::frt 40
TU189 TB10 ΔftsEX::KanR λRec
TU190** TB28 ΔftsEX::KanR P1(TU189) x TB28(attλTU188)
TU191 TB28 ΔftsEX::frt TU190/pCP20
TU195** TB28 ΔftsEX::frt ΔenvC::KanR P1(JW5646) x TU191(attλTU188)
TU196** TB28 ΔftsEX::frt ΔftsP(sufI)::KanR P1(JW2985) x TU191(attλTU188)
TU205*** TB28 ΔenvC::frt ΔftsP(sufI)::KanR P1(JW2985) x TB140(attλTD25)
TU207 TB28 ΔamiA::frt ΔamiB::frt 54
HC260 TB10 zapA-gfp CamR λRec
HC261 TB28 zapA-gfp CamR P1(HC260) x TB28
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Table A1.3. Bacterial strains used in this study. (Continued)
 
Straina Genotypeb Source/Referencec
HC262 TB28 ΔenvC::frt  zapA-gfp CamR P1(HC261) × TB140
NP32 TB28 ΔenvC::frt  zapA-gfp frt HC262/pCP20
NP65* TB28 (frt araC Para)::ponB ΔenvC::KanR P1(JW5646) x MM11/pTB63
NP66* TB28 (frt araC Para)::ponB ΔftsEX::KanR P1(TU190) x MM11/pTB63
NP69 TB28 ΔenvC::frt  zapA-gfp frt ΔftsEX::KanR P1(TU190) x NP32
KP4* TB28 ΔenvC::KanR P1(JW5646) x TB28/pTB63
KP5* TB28 ΔftsEX::KanR P1(TU190) x TB28/pTB63
KP6* TB28 ΔnlpD747::frt ΔenvC::KanR P1(JW5646) x TB145/pTB63
KP7* TB28 ΔnlpD747::frt ΔftsEX::KanR P1(TU190) x TB145/pTB63
DY18 TB28 ΔenvC::frt ΔftsEX::KanR P1(TU190) x TB140
a Stains marked with a single asterisk were made by transducing KanR cassettes into a recipient 
harboring plasmid pTB63. Stains marked with a double or triple asterisk were made by transducing KanR 
cassettes into recipients harboring attλTU188 or attλTD25, respectively. 
b The KanR cassette is flanked by frt sites for removal by FLP recombinase. An frt scar remains following 
removal of the cassette using FLP expressed from pCP20. 
c Strain constructions by P1 transduction are described using the shorthand: P1(donor) x recipient. 
Transductants were selected on LB Kan or Cam plates where appropriate. Strains resulting from the 
removal of a DrugR cassette using pCP20 are indicated as: Parental strain/pCP20. λRec indicates strains 
were constructed by recombineering (see Experimental Procedures for details).
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Table A1.4. Plasmids used in this studya. 
Plasmid Genotype Origin Source or reference
pCP20 bla cat cI875 repA(Ts) PR::flp pSC101 13
pInt-ts bla cI875 repA(Ts) PR::intλ pSC101 25
pKNT25 aph Plac::T25 p15A 34
pCH363 bla lacIq Plac::T18 pBR/colE1 3
pDY133 bla lacIq PT7::10H-loop1ftsX pBR/colE1 This study
pDY138 bla lacIq Plac:: loop1ftsX-T18 pBR/colE1 This study
pDY151 bla lacIq PT7::H-SUMO-envC(35-276) pBR/colE1 This study
pDY156 attHK bla Plac::ftsEX-GFP R6K This study
pDY161 attHK bla Plac::ftsEX(Δ152-161)-GFP R6K This study
pDY162 attHK bla Plac::ftsEX (Δ146-165)-GFP R6K This study
pDY163 attHK bla Plac::ftsEX (Δ137-176)-GFP R6K This study
pDY164 attHK bla Plac::ftsEX (Δ109-188)-GFP R6K This study
pDY165 attHK bla Plac::ftsEX (Δ109-213)-GFP R6K This study
pDY166 attHK bla Plac::ftsE(K41M)X-GFP R6K This study
pDY167 attHK bla Plac::ftsE(D162N)X-GFP R6K This study
pDY168 attHK bla Plac::ftsE(E163Q)X-GFP R6K This study
pTB63 tetAR ftsQAZ pSC101 4
pTB102 cat cI875 repA(Ts) PR::intHK022 pSC101 5
pTB316 attHK022 bla lacIq Plac::envC-mCherry R6K 53
pTB332 aph Plac::envC(277-419)-T25 p15A This study
pTB333 aph Plac::envC(34-419)-T25 p15A This study
pTD25 attλ cat Para::envC R6K 53
pTD80 attλ cat Plac::envC-mCherry R6K This study
pTU110 cat lacIq Plac::ponB lacZ F 40
pTU188 attλ cat Para::ftsEX R6K This study
a PR, Plac, and Para indicate the phage λR, lactose, and arabinose promoters, respectively. Psyn135 is a 
synthetic lac promoter with a consensus -35 element and no operators. Numbers in parenthesis indicate 
the codons included in the relevant clones. (Legend continued on next page.)
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Table A1.4. (legend continued) The GFP allele used in plasmid constructs was superfolder GFP (41) 
and mCherry was from Shaner and co-workers (51). The linker LEGPAGL was present between the 
fusion proteins and the protein of interest. 
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pTB332-333
 For pTB332 [aph Plac::envC(277-419)-T25], envC(278-419) was amplified with 
the primers 5’- GTACAAGCTTGACCGAAAGCGAAAAATCGCTGATG-3’ and 5’-
GTCAGGATCCTC TCTTCCCAACCACGGCTGTGG-3’. The resulting fragment was 
digested and ligated with HindIII and BamHI digested pKNT25 (34). pTB333 [aph 
Plac::envC(34-419)-T25] was constructed in the same manner except that envC(34-419) 
was amplified with the primers 5’-
GTACAAGCTTGGATGAGCGTGACCAACTCAAATCTATTC-3’ and 5’-
GTCAGGATCCTCT CTTCCCAACCACGGCTGTGG-3’. pTD80
 To construct pTD80 [attλ cat lacIq Plac::envC-mCherry], the Plac::envC-mCherry 
containing EcoRI-HindIII fragment of pTB316 [attHK022 bla lacIq Plac::envC-mCherry] 
(53) was used to replace the corresponding Para::envC fragment of pTD25 [attλ cat 
Para::envC] (53). 
pMT1
 pMT1 [cat Para::ftsEX] was constructed in multiple steps. First, pTU170 [attHK022 
bla Psyn135::gfp-zapA] was made by ligating the EcoRI-SalI digested fragment from 
pEZ4 (3) into the EcoRI-SalI digested backbone of pTB263 [attHK022 bla Plac::ssdsbA-
sfgfp] (53). Then pTU176 [attHK022 bla Psyn135::ssdsbA-sfgfp] was made by ligating the 
ssdsbA-sfgfp-containing XbaI-HindIII fragment from pTB263 (53) with XbaI-HindIII 
digested pTU170 to generate pTU176. The ssdsbA-sfgfp-containing XbaI-HindIII 
fragment from pTU176 was ligated with XbaI-HindIII digested pBAD18-cat (24) to 
generate pTU214 [cat Para::ssdsbA-sfgfp]. Using pTU188 [attλ cat Para::ftsEX] as a 
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template, RBSwk2-ftsEX was amplified with primers 5’-GTCATCTAGAA 
AAAAGGAAAAATGATTCGCTTTGAACATGTCAGCAAGG-3’ and 5’-GTCAAAGCTTTTA 
TTATTCAGGCGTAAAGTGGCG-3’. The resulting fragment was digested with HindIII 
and XbaI and ligated with pTU214 digested with the same enzymes to generate pMT1.
pDY133
 pDY133 [bla Plac::loop1ftsX-T18] was constructed in two steps. First, the amiA 
gene was amplified using the primers 5’- 
GTCATCTAGAAGGATCCGCCAAAGACGAACTTTTAAAA ACCAGC-3’ and 5’- 
GTCAGAGCTCGGCTCGAGTCGCTTTTTCGAATGTGCTTTCT GGTTG-3’. The resulting 
fragment was digested with XbaI and SacI and ligated with pCH363 [bla Plac::lacZ-T18] 
(3) digested with the same enzymes to generate pTU236 [bla Plac::amiA-T18]. Second, 
loop1ftsX was amplified from pMT1 [cat Para::RBSwk2-ftsEX] using the primers 5’-
GTCATTGGATCCGTGTACAAAAACGTTAACCAGGCGGCG-3’ and 5’-AGTTAAGCTT 
ATTACTCGAGGCGCCCGACCAGCCCGGTCAACGCC-3’. The resulting fragment was 
digested with BamHI and XhoI and ligated with pTU236 [bla Plac::amiA-T18] digested 
with the same enzymes to generate pDY133.
pDY138
 pDY138 [bla PT7::His10-ftsXloop1] was constructed in several steps.  pDY42 [bla 
PT7::His10-mcs] was made by using the synthetic oligonucleotides 5’-
CTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGCGTGGTTCTCACCACCAT
CACCACCATCACCACCATCATGCTAGCG-3’and 5’-
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GATCCGCTAGCATGATGGTGGTGATGG 
TGGTGATGGTGGTGAGAACCACGCATGGTATATCTCCTTCTTAAAGTTAAACAAAATTAT
TT-3’. These oligonucleotides were annealed, resulting in the formation of dsDNA with 
overhangs complementary to BamHI and XhoI restriction sites. pTD68 [bla Plac::ssdsbA-
linker-sfgfp] (38) was digested with BamHI and XhoI, and the resulting plasmid 
backbone was ligated with the complementary synthetic dsDNA. Finally, the loop1ftsX 
was amplified from pMT1 [cat Para::ftsEX] using the primers 5’-
GTCATTGGATCCGTGTACAAAAACGTTA ACCAGGCGGCG-3’ and 5’-
AGTTAAGCTTATTACTCGAGGCGCCCGACCAGCCCG GTCAACGCC-3’. The resulting 
fragment was digested with BamHI and XhoI and ligated with pDY42 digested with the 
same enzymes to generate pDY138.  
pDY151
 pDY151 [bla PT7::H-SUMO-ccenvC] was constructed in several steps. First, 
pTU138 [attHK022 bla Plac::ssdsbA-envC(35-419)-sfgfp] was made by amplifying flenvC 
using the primers 5’- GTCAGGATCCGGTGATGAGCGTGACCAACTCAAATCTATTC-3’ 
and 5’- GTCACTCGAGTCTTCCCAACCACGGCTGTGG-3’. The resulting fragment was 
digested with BamHI and XhoI and ligated with pTB282 [attHK022 bla Plac::ssdsbA-
sfgfp] (9) digested with the same enzymes. Using pTB138 as a template, ccenvC was 
amplified with the primers 5’- 
GTCAGGATCCGGTGATGAGCGTGACCAACTCAAATCTATTC-3’ and 5’- 
GTCACTCGAGCGGTTTGTAGGTGGTGCCTTTGC-3’. The resulting fragment was 
digested with BamHI and XhoI and ligated with pTB282 (11) digested with the same 
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enzymes to generate pTU150 [attHK022 bla Plac::ssdsbA-ccenvC-sfgfp]. Finally, the 
ccenvC-containing BamHI-XhoI fragment from pTU150 was ligated with BamHI-XhoI 
digested pTD68 [bla PT7::H-SUMO-mcs] (54) to generate pDY151.
pDY156
 pDY156 [attHK022 bla Plac::ftsEX-sfgfp] was constructed as follows. ftsEX was 
amplified from MG1655 with the primers 5’-
GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ and 5’-
GTCACTCGAGTTCAGGCGTAAAGTGGCGTAAATG-3’. The resulting fragment was 
digested with XbaI and XhoI and ligated with pTB311 [attHK022 bla Plac::ssdsbA-
amiB(23-445)-sfgfp] (54) digested with the same enzymes.
pDY158-160
 pDY158 [attλ cat Para::ftsE(K41M)X] was made by site-directed mutagenesis of 
pTU188 [attλ cat Para::ftsEX] using the QuickChange method (Stratagene) and the 
primer 5’-GATCAGCTTCAGGAGGGTACTCATCCCTGCGCCGGAATGACCGGT-3’.
 pDY159 [attλ cat Para::ftsE(D162N)X] was constructed by site-directed 
mutagenesis of pTU188 [attλ cat Para::ftsEX] using the QuickChange method 
(Stratagene) and the primer 5’-
GTCCAGGTTACCAGTCGGTTCGTTCGCCAGCAGTACCGCGGGCTT-3’.
 pDY160 [attλ cat Para::ftsE(E163Q)X] was constructed by site-directed 
mutagenesis of pTU188 [attλ cat Para::ftsEX] using the QuickChange method 
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(Stratagene) and the primer 5’- 
GTCGTCCAGGTTACCAGTCGGTTGGTCCGCCAGCAGTACCGCGGG-3’.
pDY161-pDY165
 pDY161 [attHK022 bla Plac::ftsEX(152-161)-sfgfp] was constructed as follows. To 
make the 10aa ftsX internal deletion ftsEX(152-161), two overlap extension PCR 
fragments were amplified with the primers 5’-
GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ and 5’-
GTTTTCTTCCAGCATATCCAGCTCACCCAGTGCGTCTTCACG-3’ as well as 5’-
CGTGAAGACGCACTGGGTGAGCTGGATATGCTGGAAGAAAAC-3’ and 5‘GTC 
ACTCGAGTTCAGGCGTAAAGTGGCGTAAATG-3’ using pDY156 [attHK022 bla 
Plac::ftsEX-sfgfp] as the DNA template. The resulting PCR fragments were purified and 
used together as the final DNA template to amplify the ftsEX(152-161) fragment using 
the primers 5’-GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ and 
5‘GTCACTCGAGTTCAG GCGTAAAGTGGCGTAAATG-3’. The resulting fragment was 
digested with XbaI and XhoI and ligated with pTB311 [attHK022 bla Plac::ssdsbA-
amiB(23-445)-sfgfp] (54) digested with the same enzymes.
pDY162
 pDY162 [attHK022 bla Plac::ftsEX(146-165)-sfgfp] was constructed as follows. To 
make the 20aa ftsX internal deletion ftsEX(146-165), two overlap extension PCR 
fragments were amplified with the primers 5’-
GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ and 5’- 
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TGCCGGAAGCGGGTTTTCTTCACGAGAAAGATAGTTCACTTT-3’ as well as 5’- 
AAAGTGAACTATCTTTCTCGTGAAGAAAACCCGCTTCCGGCA-3’ and 5‘GTCA 
CTCGAGTTCAGGCGTAAAGTGGCGTAAATG-3’ using pDY156 [attHK022 bla 
Plac::ftsEX-sfgfp] as the DNA template. The resulting PCR fragments were purified and 
used together as the final DNA template to amplify the ftsEX(146-165) fragment using 
the primers 5’-GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ and 
5‘GTCACTCGAGTTCAGGC GTAAAGTGGCGTAAATG-3’. The resulting fragment was 
digested with XbaI and XhoI and ligated with pTB311 [attHK022 bla Plac::ssdsbA-
amiB(23-445)-sfgfp] (54) digested with the same enzymes.
pDY163
 pDY163 [attHK022 bla Plac::ftsEX(137-176)-sfgfp] was constructed as follows. To 
make the 40aa ftsX internal deletion ftsEX(137-176), two overlap extension PCR 
fragments were amplified with the primers 5’-
GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ and 5’- 
CTGGAAATCGAGTTTCGGGATGCCTTGCTCGGCCTGCAACTG-3’ as well as 5’- 
CAGTTGCAGGCCGAGCAAGGCATCCCGAAACTCGATTTCCAG-3’ and 
5’GTCACTCGAGTTCAGGCGTAAAGTGGCGTAAATG-3’ using pDY156 [attHK022 bla 
Plac::ftsEX-sfgfp] as the DNA template. The resulting PCR fragments were purified and 
used together as the final DNA template to amplify the ftsEX(137-176) fragment using 
the primers 5’-GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ and 
5‘GTCACTCGAGTTCAGGC GTAAAGTGGCGTAAATG-3’. The resulting fragment was 
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digested with XbaI and XhoI and ligated with pTB311 [attHK022 bla Plac::ssdsbA-
amiB(23-445)-sfgfp] (54) digested with the same enzymes.
pDY164
 pDY164 [attHK022 bla Plac::ftsEX(109-188)-sfgfp] was constructed as follows. To 
make the 80aa ftsX internal deletion ftsEX(109-188), two overlap extension PCR 
fragments were amplified with the primers 5’-
GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ and 5’- 
GATACGATCACGCAGCGTATTTGACGGATAATACTGCGTCGC-3’ as well as 5’- 
GCGACGCAGTATTATCCGTCAAATACGCTGCGTGATCGTATC-3’ and 5‘GTCA 
CTCGAGTTCAGGCGTAAAGTGGCGTAAATG-3’ using pDY156 [attHK022 bla 
Plac::ftsEX-sfgfp] as the DNA template. The resulting PCR fragments were purified and 
used together as the final DNA template to amplify the ftsEX(109-188) fragment using 
the primers 5’-GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ and 
5‘GTCACTCGAGTTCA GGCGTAAAGTGGCGTAAATG-3’. The resulting fragment was 
digested with XbaI and XhoI and ligated with pTB311 [attHK022 bla Plac::ssdsbA-
amiB(23-445)-sfgfp] (54) digested with the same enzymes.
pDY165
 pDY165 [attHK022 bla Plac::ftsEX(109-213)-sfgfp] was constructed as follows. To 
make the 105aa ftsX internal deletion ftsEX(109-213), two overlap extension PCR 
fragments were amplified with the primers 5’-
GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ and 5’- 
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CAGCCCGGTCAACGCCGCCAGTGACGGATAATACTGCGTCGC-3’ as well as 5’- 
GCGACGCAGTATTATCCGTCACTGGCGGCGTTGACCGGGCTG-3’ and 5‘GTCA 
CTCGAGTTCAGGCGTAAAGTGGCGTAAATG-3’ using pDY156 [attHK022 bla 
Plac::ftsEX-sfgfp] as the DNA template. The resulting PCR fragments were purified and 
used together as the final DNA template to amplify the ftsEX(109-213) fragment using 
the primers 5’-GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ and 
5‘GTCACTCGAGTTCAGGCGTA AAGTGGCGTAAATG-3’. The resulting fragment was 
digested with XbaI and XhoI and ligated with pTB311 [attHK022 bla Plac::ssdsbA-
amiB(23-445)-sfgfp] (54) digested with the same enzymes.
pDY166-pDY168
 pDY166 [attHK022 bla Plac::ftsE(K41M)X-sfgfp] was constructed by amplifying 
ftsE(K41M)X with the primers 5’-GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ 
and 5’-GTCACTCGAGTTCAGGCGTAAAGTGGCGTAAATG-3’ using pDY158 [attλ cat 
Para::ftsE(K41M)X] as the DNA template. The resulting fragment was digested with XbaI 
and XhoI and ligated with pTB311 [attHK022 bla Plac::ssdsbA-amiB(23-445)-sfgfp] (54) 
digested with the same enzymes.
pDY167
 pDY167 [attHK022 bla Plac::ftsE(D162N)X-sfgfp] was constructed by amplifying 
ftsE(D162N)X with the primers 5’-GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ 
and 5’-GTCACTCGAGTTCAGGCGTAAAGTGGCGTAAATG-3’ using pDY159 [attλ cat 
Para::ftsE(D162N)X] as the DNA template. The resulting fragment was digested with 
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XbaI and XhoI and ligated with pTB311 [attHK022 bla Plac::ssdsbA-amiB(23-445)-sfgfp] 
(54) digested with the same enzymes.
pDY168
 pDY168 [attHK022 bla Plac::ftsE(E163Q)X-sfgfp] was constructed by amplifying 
ftsE(E163Q)X with the primers 5’-GTCATCTAGATTTGCCCGAGAGGATTAACAATG-3’ 
and 5’-GTCACTCGAGTTCAGGCGTAAAGTGGCGTAAATG-3’ using pDY160 [attλ cat 
Para::ftsE(E163Q)X] as the DNA template. The resulting fragment was digested with XbaI 
and XhoI and ligated with pTB311 [attHK022 bla Plac::ssdsbA-amiB(23-445)-sfgfp] (54) 
digested with the same enzymes.
Recombineering
 The ∆ftsEX::KanR allele was constructed by replacing the region between the 
2nd codon of ftsE and the 7th codon from the stop codon of ftsX with a KanR cassette 
as described previously (2, 57). The KanR cassette was amplified from pKD13 (13) 
using the primers 5'-ACTTTATAGAGGCACT TTTTGCCCGAGAGGAT 
TAACAATGATTCCGGGGATCCGTCGACC-3' and 5'-AGAGTATAACACGCTTTTATTATT 
CAGGCGTAAAGTGGCGTGTAGGCTGGAGCTG CTTCG-3'. The resulting product was 
electroporated into strain TB10 as described previously (4), and the recombinants were 
selected at 30˚C on an LB plate containing 1% NaCl and 20 µg/ml kanamycin to 
generate the chromosomal deletion.
 To generate a marker for the Z-ring, a zapA-gfp fusion was created at its native 
chromosomal locus by λ recombineering (57).  gfp-mut2 (4) coding sequence and a 
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linked cat cassette flanked by zapA 3’ end sequence and sequence downstream of 
zapA was amplified using pTB24 (3) as a template and the primers 5’-
ACAAGGTCGCATCACCGAAAAAACTAACC AAAACTTTGAAGATCCCCCCG 
CTGAATTCATG-3’ and 5’-TTGTCTTC ACGGTTACTCTACCACAGTAAACCGAAAAGT 
GGTGTAGGCTGGAGCTGCTTCG-3’. The resulting fragment was used for 
recombineering in strain TB10 as described previously (4). The zapA-gfp fusion linked 
to the cat cassette was transferred between strains by P1-transduction.
Synthetic lethal screen
 The screen for mutants with a Slb phenotype was performed as previously 
described (40). Briefly, TU122/pTU110 [ΔlacIZYA ΔponB/Plac::ponB lacZ ] was 
mutagenized with the EzTn-Kan2 transposome (Epicenter) as previously described (16). 
Mutants were selected for Kan resistance at room temperature, yielding a library of 
75,000 independent transposon insertions. This mutant library was plated on LB agar 
supplemented with 50 µM IPTG and X-gal (40 µg/ml) at 30˚C  and room temperature to 
identify mutants with a Slb phenotype. In addition to transposon the insertions in ponA 
and lpoA described previously (40), we also isolated mutants with insertions in envC 
(between codon 74 and 75) and ftsX (within codon 59). 
Fluorescence microscopy
	 Fluorescence microscopy was performed as described previously (53). See 
figure legends for specific growth conditions employed for each experiment. Cell 
fixation and membrane staining was performed as described previously (53). 
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Protein Purification, pull-up assays, and two-hybrid analysis 
	 FLEnvC and LytEnvC were purified as described previously (54). CCEnvC was 
overexpressed and purified with a 6xHis-SUMO (H-SUMO) tag fused to its N-terminus.  
H-SUMO- CCEnvC was purified from BL21(λDE3)/pDY151 and a 10xHis-tagged version 
of Loop1FtsX [H-Loop1FtsX] was purified from BL21(λDE3)/pDY138. Overnight cultures 
were grown at 37°C in LB supplemented with ampicillin (50 µg/ml) and glucose (0.2%). 
The cultures were diluted 1:100 into 0.1 L of LB supplemented with ampicillin (50 µg/
ml) and glucose (0.04%), and cells were grown at 30°C to an OD600 of 0.81 and 0.86 
respectively. IPTG was added to 1 mM and the cultures were grown for an additional 3 
hrs at 30°C. Cells were harvested by centrifugation and the cell pellets were 
resuspended in 3 ml of buffer A (50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol) 
with 20 mM imidazole and stored at -80°C. Cells were thawed, disrupted by sonication, 
and cell debris was pelleted by centrifugation at 20,000 x g for 20 min at 4°C. The 
supernatants were passed through 0.2 µM syringe filters and loaded onto ProPur IMAC 
mini spin columns (Nunc) equilibrated in buffer A with 20 mM imidazole. Columns were 
washed 3x using buffer A with 50 mM imidazole and eluted using buffer A with 300 mM 
imidazole. For H-SUMO- CCEnvC, the H-SUMO tag was cleaved with 6xHis-tagged 
SUMO protease (H-SP) as previously described (54). The cleavage reaction was 
passed through Ni-NTA resin (ProPur IMAC midi spin column) to remove free H-SUMO 
and H-SP, yielding a pure preparation of untagged CCEnvC. Amicon Centrifugal Filter 
Units (MWCO 10 kDa) were used to concentrate both protein preparations and 
exchange the buffer to buffer A without imidazole. Protein preparations were stored at 
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-80°C in buffer A. The BACTH assay and Ni-NTA “pull-up” assays are described in the 
legend to Figure A1.8. 
EnvC antisera and affinity purification of anti-EnvC antibodies 
	 Polyclonal rabbit antisera was raised agains purified FLEnvC by Covance 
according to their standard protocol. The resulting anti-EnvC antibodies were affinity 
purified using FLEnvC coupled to AminoLink resin (Pierce) as described previously for 
SlmA antibody purification (9). 
Cell fractionation and immunoblotting
 Whole-cell extracts for Figure A1.5 were prepared as described previously (27). 
The protein concentration in each extract was determined using the non-interfering 
protein assay (Genotech) according to the manufacturers instructions. Protein 
concentrations were normalized between extracts and 20, 10, or 5 µg of total protein 
from each extract was separated on a 12% SDS-PAGE gel. Proteins were transferred 
to a PVDF membrane (Whatman) and the membrane was blocked with Rapid-Block 
(Genotech) for 5 minutes. The membrane was incubated with anti-EnvC antibodies 
(1:5000 in Rapid-Block) for 1 hour at room temperature. The membrane was washed 
three times with 25 ml TBST (10 mM Tris-HCl pH7.5, 100 mM NaCl, 0.1% Tween-20) 
for 10 minutes. Following the wash, the membrane was incubated with goat anti-rabbit 
antibodies conjugated with HRP (Rockland) (1:20,000 in Rapid-Block) for 1 hour at 
room temperature. Finally, the membrane was washed an additional four times as 
above and developed using the Pierce Super-Signal West-Pico reagents. 
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Chemiluminescence was detected using a BioRad Chemidoc system. Cell 
fractionations and immunoblotting for Figure A1.5B were performed as described 
previously (6), except that 500 mM NaCl was added to the spheroplasts after they were 
formed and EnvC was detected as described above. NaCl addition was required to 
promote the complete release of EnvC to the periplasmic fraction in spheroplasts from 
FtsEX- cells.
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